var title_f25_6_25696="Physical activities PI";
var content_f25_6_25696=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F57200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F57200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Examples of moderate physical activity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 435px; height: 553px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A moderate amount of physical activity is roughly equivalent to physical activity that uses approximately 150 calories (kcal) of energy per day, or 1000 calories per week. Some activities can be performed at various intensities; the suggested durations correspond to the expected intensity of effort.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25696=[""].join("\n");
var outline_f25_6_25696=null;
var title_f25_6_25697="RTT onset developmental arrest";
var content_f25_6_25697=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56128&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56128&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rett syndrome, six to 18 months old",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    At six to 18 months of age, she began to show signs of developmental arrest and a flaccid, calm appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Glaze DG, Schultz RJ. Rett syndrome: meeting the challenge of this gender-specific neurodevelopmental disorder. Medscape Women's Health 1997; 2. Copyright &copy; 1997 Medscape.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25697=[""].join("\n");
var outline_f25_6_25697=null;
var title_f25_6_25698="Patient information: Prolactinoma (The Basics)";
var content_f25_6_25698=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15891\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/36/39503\">",
"         Pituitary gland",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/4/36930\">",
"         Patient information: Absent or irregular periods (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/42/40610\">",
"         Patient information: Infertility in men (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/16/11523\">",
"         Patient information: Infertility in women (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/58/35746\">",
"         Patient information: Osteoporosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/28/7619\">",
"         Patient information: Pituitary adenoma (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/24/386\">",
"         Patient information: Sex problems in men (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?25/0/25603\">",
"         Patient information: High prolactin levels and prolactinomas (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Prolactinoma (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/prolactinoma-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H2407954\">",
"      <span class=\"h1\">",
"       What are prolactinomas?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Prolactinomas are abnormal growths that form right below the brain, in an organ called the &ldquo;pituitary gland&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef72262 \" href=\"UTD.htm?38/36/39503\">",
"       figure 1",
"      </a>",
"      ). These growths can cause symptoms, such as absent monthly periods in women or low sex drive in men.",
"     </p>",
"     <p>",
"      The pituitary gland has different cells in it that make different hormones. Some of the cells in the pituitary gland make a hormone called &ldquo;prolactin.&rdquo;",
"     </p>",
"     <p>",
"      A prolactinoma forms when these cells change into abnormal cells and grow out of control. When that happens, the body&rsquo;s prolactin levels can get too high.",
"     </p>",
"     <p>",
"      Prolactinomas can cause symptoms in 2 ways. Symptoms can happen when:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A person has too much prolactin &mdash; This can throw off the levels of other hormones.",
"       </li>",
"       <li>",
"        A prolactinoma grows and presses on nearby tissues in the head, such as the nerves that go from the eyes to the brain",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Prolactinomas can grow in both men and women. They are most common in women younger than 50 years old.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2407961\">",
"      <span class=\"h1\">",
"       What are the symptoms of a prolactinoma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Too much prolactin can cause symptoms in men and in women who still get their monthly periods. (Women who no longer get their monthly periods do not get these symptoms.) Symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Absent or irregular monthly periods (in women)",
"       </li>",
"       <li>",
"        Trouble starting a pregnancy (in men and women)",
"       </li>",
"       <li>",
"        Milk leaking from the breasts (in women)",
"       </li>",
"       <li>",
"        Vaginal dryness and hot flashes (in women)",
"       </li>",
"       <li>",
"        Low energy, low sex drive, and trouble getting an erection (in men)",
"       </li>",
"       <li>",
"        Increase in breast size and breast soreness (in men)",
"       </li>",
"       <li>",
"        Bone loss (in men and women) &mdash; This takes a few years to happen.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      When a prolactinoma presses on nearby tissues, it can cause:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Vision problems",
"       </li>",
"       <li>",
"        Headaches",
"       </li>",
"       <li>",
"        Lower levels of other hormones that are made in the pituitary gland",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2407968\">",
"      <span class=\"h1\">",
"       Is there a test for a prolactinoma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse can do:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A blood test to measure the level of prolactin in your body",
"       </li>",
"       <li>",
"        An imaging test called an MRI &mdash; Imaging tests create pictures of the inside of the body.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2407975\">",
"      <span class=\"h1\">",
"       How are prolactinomas treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Prolactinomas are treated in different ways, depending on their size, the symptoms they cause, and other factors. Small prolactinomas that cause no symptoms do not usually need to be treated. Big prolactinomas that cause symptoms do need to be treated.",
"     </p>",
"     <p>",
"      Prolactinomas that need treatment are usually first treated with medicines called &ldquo;dopamine agonists.&rdquo; These medicines can shrink prolactinomas and lower prolactin levels to normal. When the prolactin levels get back to normal, most symptoms get better. People usually take these medicines for years.",
"     </p>",
"     <p>",
"      If these medicines do not work or cause too many side effects, there are other treatment options. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Surgery to remove the prolactinoma &mdash; Sometimes, doctors recommend surgery first. For example, women who have a big prolactinoma and want to get pregnant might be treated with surgery first.",
"       </li>",
"       <li>",
"        Other types of medicines",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2407982\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you want to get pregnant, talk with your doctor about the right treatment for you. Many women are able to get pregnant after treatment.",
"     </p>",
"     <p>",
"      Women who take dopamine agonist medicines must stop taking them during pregnancy. But without these medicines, their prolactinomas can start to grow.",
"     </p>",
"     <p>",
"      If you stop your medicines, tell your doctor or nurse about any vision changes or new or worse headaches. Having those symptoms could mean that your prolactinoma has grown. If that happens, your doctor will talk with you about possible treatments.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2407989\">",
"      <span class=\"h1\">",
"       What if I go through menopause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you are being treated for a prolactinoma and go through menopause, talk with your doctor or nurse. Some women can stop their treatment after menopause.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2407996\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11523?source=see_link\">",
"       Patient information: Infertility in women (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/42/40610?source=see_link\">",
"       Patient information: Infertility in men (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/28/7619?source=see_link\">",
"       Patient information: Pituitary adenoma (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/24/386?source=see_link\">",
"       Patient information: Sex problems in men (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/4/36930?source=see_link\">",
"       Patient information: Absent or irregular periods (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=see_link\">",
"       Patient information: Osteoporosis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/0/25603?source=see_link\">",
"       Patient information: High prolactin levels and prolactinomas (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?25/6/25698?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15891 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-218.28.111.102-3C51B1EE61-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25698=[""].join("\n");
var outline_f25_6_25698=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2407954\">",
"      What are prolactinomas?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2407961\">",
"      What are the symptoms of a prolactinoma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2407968\">",
"      Is there a test for a prolactinoma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2407975\">",
"      How are prolactinomas treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2407982\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2407989\">",
"      What if I go through menopause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2407996\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15891\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/36/39503\">",
"      Pituitary gland",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/4/36930?source=related_link\">",
"      Patient information: Absent or irregular periods (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/0/25603?source=related_link\">",
"      Patient information: High prolactin levels and prolactinomas (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/42/40610?source=related_link\">",
"      Patient information: Infertility in men (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11523?source=related_link\">",
"      Patient information: Infertility in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/28/7619?source=related_link\">",
"      Patient information: Pituitary adenoma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/24/386?source=related_link\">",
"      Patient information: Sex problems in men (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_6_25699="Patient information: Hyperosmolar nonketotic coma (The Basics)";
var content_f25_6_25699=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83155\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/63/7154\">",
"         Person having an ECG",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/62/32738\">",
"         Patient information: Dehydration (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/2/36898\">",
"         Patient information: Diabetic ketoacidosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/49/16147\">",
"         Patient information: Treatment for type 2 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/44/33475\">",
"         Patient information: Type 2 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/58/28579\">",
"         Patient information: Using insulin (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?18/28/18886\">",
"         Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/22/9572\">",
"         Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/37/36436\">",
"         Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/1/40980\">",
"         Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/43/39603\">",
"         Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Hyperosmolar nonketotic coma (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/hyperosmolar-nonketotic-coma-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H11646099\">",
"      <span class=\"h1\">",
"       What is hyperosmolar nonketotic coma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Hyperosmolar nonketotic coma is a life-threatening condition that can happen in people with diabetes when their blood sugar level gets very high. Sometimes this condition is called &ldquo;hyperosmolar hyperglycemic state.&rdquo;",
"     </p>",
"     <p>",
"      Doctors use the word &ldquo;hyperosmolar&rdquo; when the blood has too much sugar and salts in it. The word &ldquo;nonketotic&rdquo; means that people do not have any &ldquo;ketones&rdquo; in their blood or urine. Ketones are toxic chemicals the body sometimes makes when people with diabetes have high blood sugar levels. (There is a different condition in which people with high blood sugar do have ketones in their blood.)",
"     </p>",
"     <p>",
"      Hyperosmolar nonketotic coma is most common in older adults with type 2 diabetes. Most often, it happens after a person with diabetes:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Gets an infection or other illness",
"       </li>",
"       <li>",
"        Stops taking his or her diabetes medicine, or doesn&rsquo;t take the medicine as directed",
"       </li>",
"       <li>",
"        Takes other medicines that affect his or her sugar levels",
"       </li>",
"       <li>",
"        Gets dehydrated, which is when the body loses too much water",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Hyperosmolar nonketotic coma can also happen in people who have diabetes, but don&rsquo;t yet know it.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11646114\">",
"      <span class=\"h1\">",
"       What are the symptoms of hyperosmolar nonketotic coma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Hyperosmolar nonketotic coma causes a person to pass out (lose consciousness) and go into a coma. But before that happens, people usually have symptoms for a few days that include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Urinating much more than usual",
"       </li>",
"       <li>",
"        Being very thirsty, and drinking much more than usual",
"       </li>",
"       <li>",
"        Losing weight",
"       </li>",
"       <li>",
"        Having dark yellow or brown urine",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11646129\">",
"      <span class=\"h1\">",
"       Is there a test for hyperosmolar nonketotic coma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests for hyperosmolar nonketotic coma usually include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Urine tests",
"       </li>",
"       <li>",
"        An electrocardiogram (ECG or EKG) &ndash; This test measures the electrical activity in the heart (",
"        <a class=\"graphic graphic_figure graphicRef53145 \" href=\"UTD.htm?6/63/7154\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Other tests to look for an infection or illness causing the hyperosmolar nonketotic coma &ndash; These might include other blood tests or a chest X-ray.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11646167\">",
"      <span class=\"h1\">",
"       How is hyperosmolar nonketotic coma treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with hyperosmolar nonketotic coma are treated in the hospital with:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fluids and electrolytes &ndash; In hyperosmolar nonketotic coma, the body loses a lot of fluids. It also loses electrolytes, which are salts (such as sodium and potassium) that keep cells working normally. People will get fluids and electrolytes into their vein through a tube called an &ldquo;IV.&rdquo;",
"       </li>",
"       <li>",
"        Insulin &ndash; Insulin is a medicine that lowers a person&rsquo;s blood sugar level. The insulin is also usually given into a vein through an IV.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      The doctor will also treat any infection or illness causing the hyperosmolar nonketotic coma.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11646182\">",
"      <span class=\"h1\">",
"       Can hyperosmolar nonketotic coma be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To reduce the chances of getting this condition again, people with diabetes should:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Take their diabetes medicines as directed",
"       </li>",
"       <li>",
"        Check their blood sugar level often &ndash; A device called a &ldquo;blood glucose meter&rdquo; can be used to check blood sugar levels at home.",
"       </li>",
"       <li>",
"        Learn how to change their dose of diabetes medicine when they get sick",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11646197\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=see_link\">",
"       Patient information: Type 2 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/49/16147?source=see_link\">",
"       Patient information: Treatment for type 2 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/58/28579?source=see_link\">",
"       Patient information: Using insulin (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/62/32738?source=see_link\">",
"       Patient information: Dehydration (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/2/36898?source=see_link\">",
"       Patient information: Diabetic ketoacidosis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/22/9572?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/37/36436?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/28/18886?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/43/39603?source=see_link\">",
"       Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/1/40980?source=see_link\">",
"       Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?25/6/25699?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83155 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-3C5F28D7A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25699=[""].join("\n");
var outline_f25_6_25699=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11646099\">",
"      What is hyperosmolar nonketotic coma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11646114\">",
"      What are the symptoms of hyperosmolar nonketotic coma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11646129\">",
"      Is there a test for hyperosmolar nonketotic coma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11646167\">",
"      How is hyperosmolar nonketotic coma treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11646182\">",
"      Can hyperosmolar nonketotic coma be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11646197\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83155\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/63/7154\">",
"      Person having an ECG",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/62/32738?source=related_link\">",
"      Patient information: Dehydration (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/28/18886?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Insulin treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/22/9572?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/37/36436?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/2/36898?source=related_link\">",
"      Patient information: Diabetic ketoacidosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/1/40980?source=related_link\">",
"      Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/43/39603?source=related_link\">",
"      Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/49/16147?source=related_link\">",
"      Patient information: Treatment for type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=related_link\">",
"      Patient information: Type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/58/28579?source=related_link\">",
"      Patient information: Using insulin (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_6_25700="Sargramostim: Patient drug information";
var content_f25_6_25700=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sargramostim: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/43/5814?source=see_link\">",
"     see \"Sargramostim: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/49/4885?source=see_link\">",
"     see \"Sargramostim: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F220032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Leukine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F220033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Leukine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691773",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer patients who have had bone marrow problems caused by chemo.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691943",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat low white blood cell counts.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702906",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sargramostim or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705177",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not get this drug on the same day that you are getting chemo or radiation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698458",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. The dose of this drug may be changed depending on the results. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698078",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever and chills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699092",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the feet or hands.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697917",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bone pain. You may be given drugs before this shot to avoid these signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696433",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Aches and pains. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698206",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood pressure, a fast heartbeat, flushing, and passing out may rarely happen with the first dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11445 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-B6AD6E7C64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25700=[""].join("\n");
var outline_f25_6_25700=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220032\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220033\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017110\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017109\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017114\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017115\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017117\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017112\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017113\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017119\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/43/5814?source=related_link\">",
"      Sargramostim: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/49/4885?source=related_link\">",
"      Sargramostim: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_6_25701="Fusarium macroconidia";
var content_f25_6_25701=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fusarium macroconidia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fusarium oxysporum. Macroconidia with distinct foot cells. Phase contrast microscopy, 630X.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of www.doctorfungus.org &copy; 2006. Reproduced with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25701=[""].join("\n");
var outline_f25_6_25701=null;
var title_f25_6_25702="Lymphatic system PI";
var content_f25_6_25702=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F63854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F63854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Lymphatic system",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 707px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the organs of the lymphatic system, which include the bone marrow, thymus, spleen, and lymph nodes. These organs are connected by lymph vessels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25702=[""].join("\n");
var outline_f25_6_25702=null;
var title_f25_6_25703="Clinical features and diagnosis of candidemia in children";
var content_f25_6_25703=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of candidemia in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/6/25703/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/6/25703/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/6/25703/contributors\">",
"     Judith R Campbell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/6/25703/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/6/25703/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/6/25703/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/6/25703/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/6/25703/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 17, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term candidemia simply indicates the presence of",
"    <em>",
"     Candida",
"    </em>",
"    species in the blood.",
"    <em>",
"     Candida",
"    </em>",
"    in a blood culture should never be viewed as a contaminant and should always prompt a search for the source of the fungemia. For many patients, candidemia is a manifestation of disseminated candidiasis, while for others it reflects colonization of an indwelling intravenous catheter [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical manifestations, and diagnosis of candidemia in children will be discussed below. Treatment of candidemia in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/47/31481?source=see_link\">",
"     \"Overview of Candida infections in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3336?source=see_link\">",
"     \"Treatment of candidemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Candidal infections in neonates and adults also are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24039?source=see_link\">",
"     \"Epidemiology and risk factors for Candida infection in neonates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31720?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Candida infection in neonates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40760?source=see_link\">",
"     \"Treatment of Candida infection in neonates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37638?source=see_link\">",
"     \"Epidemiology and pathogenesis of candidemia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/6/36966?source=see_link\">",
"     \"Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Candida",
"    </em>",
"    spp. are important pathogens in neonatal intensive care unit (NICU) patients, critically ill patients, and those with underlying immunocompromising conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Prospective population-based surveillance in the United States indicates that the incidence of candidemia among individuals &lt;20 years of age has declined since the 1990s [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/4\">",
"     4",
"    </a>",
"    ]. However, the annual incidence remains high among children &lt;1 year of age (34.3 and 46.2 per 100,000 in Atlanta and Baltimore, respectively). The epidemiology of",
"    <em>",
"     Candida",
"    </em>",
"    infections in neonates is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24039?source=see_link\">",
"     \"Epidemiology and risk factors for Candida infection in neonates\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most often, the infecting strain is part of the host's colonizing flora. Nosocomial acquisition of",
"    <em>",
"     Candida",
"    </em>",
"    species has been described, originating from contaminated solutions in some cases or the hands of health care workers in others [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/5-7\">",
"     5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A change in the distribution of Candida species causing candidemia has been noted in several institutions, with increased isolation of non-albicans species [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/3,4,8-13\">",
"     3,4,8-13",
"    </a>",
"    ]. It is important to monitor this trend toward increasing non-albicans isolates and their susceptibility patterns as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    use increases. However, there may be factors other than azole use, such as geographic and host issues, that contribute to these trends [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/19/37176?source=see_link\">",
"     \"Biology of Candida infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunosuppressed patients, neonates, and those in intensive care units are most at risk for the development of candidemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients at special risk for candidemia include [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Those with hematologic malignancies",
"     </li>",
"     <li>",
"      Recipients of solid organ, bone marrow, or stem cell transplants",
"     </li>",
"     <li>",
"      Those given antineoplastic agents for a variety of different diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neutropenia is common in these settings, and most transplant recipients are also receiving corticosteroids. Other risk factors in these patients include chemotherapeutic agents, especially those associated with extensive gastrointestinal mucosal damage; broad-spectrum antibiotics; and central venous catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/3,15-18\">",
"     3,15-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for candidemia in neonates are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24039?source=see_link\">",
"     \"Epidemiology and risk factors for Candida infection in neonates\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Patients in ICU",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients in intensive care units (ICU) account for a large number of episodes of candidemia in most hospitals. Surgical units, especially those caring for trauma and burn patients, have the highest rates of Candida infections [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/5\">",
"     5",
"    </a>",
"    ]. Besides the risks associated with young age and trauma or burns, other factors include [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/2,10,16,19-26\">",
"     2,10,16,19-26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Central venous catheters",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"       Total parenteral nutrition",
"      </a>",
"     </li>",
"     <li>",
"      Broad-spectrum antibiotics",
"     </li>",
"     <li>",
"      High Acute Physiology and Chronic Health Evaluation (APACHE) II or Therapeutic Intervention Scoring System (TISS) scores",
"     </li>",
"     <li>",
"      Renal failure requiring hemodialysis",
"     </li>",
"     <li>",
"      Abdominal surgical procedures",
"     </li>",
"     <li>",
"      Gastrointestinal tract perforations and anastomotic leaks",
"     </li>",
"     <li>",
"      Mechanical ventilation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a case-control study limited to children hospitalized in the pediatric intensive care unit of a single tertiary-care children&rsquo;s hospital, factors independently associated with candidemia included central venous catheter, malignancy, and receipt of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    or agents active against anaerobic organism for &gt;3 days in the previous two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/27\">",
"     27",
"    </a>",
"    ]. Combinations of risk factors were strongly associated with increased risk of candidemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three major routes by which Candida gain access to the bloodstream:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Through the gastrointestinal tract mucosal barrier",
"     </li>",
"     <li>",
"      From a localized focus of infection, such as pyelonephritis or invasive fungal dermatitis in a premature neonate",
"     </li>",
"     <li>",
"      Via an intravascular catheter",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Penetration through the gastrointestinal tract mucosa is probably the most common mechanism for",
"    <em>",
"     Candida",
"    </em>",
"    species to enter the bloodstream in both immunosuppressed neutropenic patients and in ICU patients.",
"    <em>",
"     Candida",
"    </em>",
"    species are part of the normal bowel flora; many of the risk factors noted above lead to overgrowth of yeasts and subsequent egress out of the bowel into the blood. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Bloodstream invasion is relatively uncommon from a localized focus of infection but has been well described with ascending",
"    <em>",
"     Candida",
"    </em>",
"    urinary tract infection associated with either intrinsic obstruction (eg, from a fungus ball) or extrinsic compression preventing the flow of infected urine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/49/15128?source=see_link\">",
"     \"Candida infections of the bladder and kidneys\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/47/31481?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of Candida infections in children\", section on 'Urinary tract infections'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bloodstream infection associated with intravascular catheters has become increasingly important.",
"    <em>",
"     Candida",
"    </em>",
"    colonization of indwelling vascular devices, especially central catheters, can occur at either the insertion site or the hub and lead to subsequent candidemia.",
"   </p>",
"   <p>",
"    Most, but not all, studies have shown that colonization with",
"    <em>",
"     Candida",
"    </em>",
"    species is an independent predictor of candidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/17,18,24\">",
"     17,18,24",
"    </a>",
"    ]. Although colonization alone does not predict which patients will develop fungemia, candidemia is very uncommon in a patient who is free of colonizing yeasts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of candidemia vary from minimal fever to a fulminant sepsis syndrome indistinguishable from severe bacterial infection. Signs of multiorgan system failure may be present, and necropsy reveals widespread visceral microabscesses that are especially prominent in the kidneys (",
"    <a class=\"graphic graphic_picture graphicRef52139 \" href=\"UTD.htm?37/49/38672\">",
"     picture 1",
"    </a>",
"    ), heart, liver, spleen, lungs, and brain. Clinical clues to the occurrence of hematogenous spread of",
"    <em>",
"     Candida",
"    </em>",
"    include characteristic eye lesions, skin lesions, and, less commonly, muscle abscesses.",
"   </p>",
"   <p>",
"    Chorioretinitis is occasionally seen in children who are immunocompromised; it is more common in neonates. In a retrospective review, among 254 children with candidemia who had a dilated retinal examination, eight patients (3.2 percent) had ophthalmologic involvement: four with chorioretinitis only and four with involvement of the vitreous in addition to chorioretinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristic chorioretinal findings include focal, glistening, white, infiltrative, often mound-like lesions on the retina (",
"    <a class=\"graphic graphic_picture graphicRef58685 \" href=\"UTD.htm?25/1/25630\">",
"     picture 2",
"    </a>",
"    ). When vitreous extension occurs, a vitreal haze is present; sometimes fluffy white balls or \"snowballs\" in the vitreous are noted (",
"    <a class=\"graphic graphic_picture graphicRef73318 \" href=\"UTD.htm?24/39/25214\">",
"     picture 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13849?source=see_link&amp;anchor=H27883763#H27883763\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The skin lesions tend to appear suddenly as clusters of painless pustules on an erythematous base; they can occur on any area of the body. The lesions vary from tiny pustules that can be easily missed (",
"    <a class=\"graphic graphic_picture graphicRef55977 \" href=\"UTD.htm?33/63/34815\">",
"     picture 4",
"    </a>",
"    ) to others that are nodular, several centimeters in diameter, and appear necrotic in the center (",
"    <a class=\"graphic graphic_picture graphicRef75717 \" href=\"UTD.htm?24/42/25248\">",
"     picture 5",
"    </a>",
"    ). In severely neutropenic patients, the lesions may be macular rather than pustular. Material obtained by scraping the base of a pustule with a scalpel blade shows yeast on Gram stain (",
"    <a class=\"graphic graphic_picture graphicRef70812 \" href=\"UTD.htm?34/21/35166\">",
"     picture 6",
"    </a>",
"    ), and if enough material is obtained to perform a culture, this will yield",
"    <em>",
"     Candida",
"    </em>",
"    species. Alternatively, punch biopsies of skin lesions can be performed for histopathology and culture.",
"   </p>",
"   <p>",
"    Less commonly, patients describe soreness in a discrete muscle group. Examination reveals a tender muscle that may be warm and swollen. Biopsy shows microabscesses in the muscle, and special stains will show budding yeasts and often pseudohyphae characteristic of",
"    <em>",
"     Candida",
"    </em>",
"    species.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for the diagnosis of candidemia is a positive blood culture. However, because blood cultures require time to become positive, a number of more rapid diagnostic tests have been explored.",
"   </p>",
"   <p>",
"    Clinicians frequently must rely upon clinical judgment about the probability of candidemia as an explanation for a patient's symptoms while awaiting the return of blood cultures. Certain findings on physical examination, especially the presence of suggestive skin or eye lesions, can alert the clinician to the possibility of",
"    <em>",
"     Candida",
"    </em>",
"    infection. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Clinical manifestations'",
"    </a>",
"    above.) However, no obvious signs suggesting candidiasis are present in many patients. Depending upon the acuity of the illness and the patient's underlying disease, empiric treatment with an antifungal agent may be initiated. Several studies have shown that early treatment with an antifungal agent is associated with enhanced survival [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3336?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of candidemia in children\", section on 'Treatment recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Blood cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most obvious method to detect candidemia is to grow the organism from the blood. Unfortunately, blood culture techniques are relatively insensitive. Studies from several decades ago showed that blood cultures were positive in only approximately 50 percent of patients who were found to have disseminated candidiasis at autopsy.",
"   </p>",
"   <p>",
"    Similar autopsy-based studies have not been reported since the advent of modern blood culture techniques. The introduction of the lysis-centrifugation method (Dupont Isolator tube) improved the detection of yeasts when compared with other blood culture systems. Subsequent changes in the culture media used in the BACTEC and BactiAlert systems, allowing enhanced growth of yeasts, have made these systems as sensitive as the lysis-centrifugation technique for detecting",
"    <em>",
"     Candida",
"    </em>",
"    species in blood. One study of 74 neonates with 207 blood cultures positive for",
"    <em>",
"     Candida",
"    </em>",
"    species found that 97 percent of the cultures were positive by 72 hours using the",
"    <span class=\"nowrap\">",
"     BacT/Alert",
"    </span>",
"    system [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The combination of blood cultures with non-culture methods (eg, beta-D-glucan assay, polymerase chain reaction [PCR]) may increase sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/32\">",
"     32",
"    </a>",
"    ]. However, there is little experience with non-culture methods in children. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Non-culture methods'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A drawback of all blood culture systems as the primary means of establishing the diagnosis of candidemia is that one to two days are required for growth of the organism, and an additional one or two days for identification to the species level. Peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH) technology is a commercially available system that can identify yeasts as being",
"    <em>",
"     Candida albicans",
"    </em>",
"    or",
"    <em>",
"     Candida glabrata",
"    </em>",
"    within two hours of obtaining a positive blood culture [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Culture and stain of biopsy material",
"    </span>",
"    &nbsp;&mdash;&nbsp;Directed biopsy of sites of involvement often leads to a definitive diagnosis. Material obtained by scraping the base of a pustule should be submitted to the microbiology laboratory for Gram stain (",
"    <a class=\"graphic graphic_picture graphicRef70812 \" href=\"UTD.htm?34/21/35166\">",
"     picture 6",
"    </a>",
"    ) and culture. Punch biopsies of skin or tissue biopsy will show microabscesses, and special stains will show budding yeasts and sometimes hyphae characteristic of",
"    <em>",
"     Candida",
"    </em>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Non-culture methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substantial efforts have been directed at the development of a non-culture-based method for the diagnosis of candidemia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Antibody assays",
"      </strong>",
"      &ndash; The initial studies focused on",
"      <em>",
"       Candida",
"      </em>",
"      antibody assays as a diagnostic tool, but to date, no sensitive and specific",
"      <em>",
"       Candida",
"      </em>",
"      antibody assay has been developed that is useful for diagnosis. This is partly because",
"      <em>",
"       Candida",
"      </em>",
"      species are part of the normal microbiota and antibodies occur commonly, and partly because immunosuppressed hosts may be unable to generate a vigorous antibody response.",
"     </li>",
"     <li>",
"      <strong>",
"       Antigen assays",
"      </strong>",
"      &ndash; Detection of circulating",
"      <em>",
"       Candida",
"      </em>",
"      antigens or metabolites was thought to hold more promise than antibody-based methods [",
"      <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. However, assays for several cell wall components, cytoplasmic antigens, and the metabolite arabinitol were not sufficiently sensitive for diagnostic purposes [",
"      <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/34-37\">",
"       34-37",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The most promising antigen assay is based on the detection of beta-D-glucan, which is present in the cell wall of many fungi; it is not specific for",
"      <em>",
"       Candida",
"      </em>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/38-41\">",
"       38-41",
"      </a>",
"      ]. In one multicenter study of 163 patients with proven or probable invasive fungal infections and 170 patients without invasive fungal infections, 107 patients had proven candidiasis [",
"      <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/39\">",
"       39",
"      </a>",
"      ]. Depending on the cut-off value chosen as positive, between 78 and 81 percent of the 107 patients with proven candidiasis had positive results on the beta-D-glucan assay.",
"      <br/>",
"      <br/>",
"      There is limited experience with beta-D-glucan assays for the diagnosis of candidemia in children.",
"     </li>",
"     <li>",
"      <strong>",
"       PCR",
"      </strong>",
"      &ndash; The development of a PCR assay for candidemia and invasive candidiasis is a current focus of investigation [",
"      <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/42\">",
"       42",
"      </a>",
"      ]. As is true of cultures, PCR can identify",
"      <em>",
"       Candida",
"      </em>",
"      to the species level.",
"      <br/>",
"      <br/>",
"      The sensitivity of initial PCR assays for the detection of candidemia has been reported to be similar to that of blood cultures, though in occasional cases PCR assisted in establishing the diagnosis of invasive candidiasis when cultures were negative [",
"      <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/43-45\">",
"       43-45",
"      </a>",
"      ]. Newer real-time PCR assays appear to be more sensitive than blood cultures and the beta-D-glucan assay in detecting invasive candidiasis in adult patients [",
"      <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/32\">",
"       32",
"      </a>",
"      ]; combining PCR with blood cultures may further increase the sensitivity.",
"      <br/>",
"      <br/>",
"      Experience with PCR assays for invasive candidiasis in children is limited.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     ADDITIONAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once blood cultures are positive, confirming the diagnosis of candidemia, all patients should undergo a formal ophthalmologic examination, whether or not they have ocular symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/28,46-48\">",
"     28,46-48",
"    </a>",
"    ]. Sight-threatening ocular abnormalities, including chorioretinitis and endophthalmitis, may occur in as many as 8 percent of children with candidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?25/6/25703/abstract/19,28\">",
"     19,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation of neonates with candidemia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31720?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Candida infection in neonates\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3939823\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The term candidemia refers to the presence of",
"      <em>",
"       Candida",
"      </em>",
"      species in the blood.",
"      <em>",
"       Candida",
"      </em>",
"      in a blood culture should never be viewed as a contaminant and should always prompt a search for the source of the fungemia. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <em>",
"       Candida",
"      </em>",
"      spp. causing infection almost always are part of the host's colonizing microbiota. Risk factors for candidemia include immunosuppression, age &lt;28 days, hospitalization in an intensive care unit, central venous catheters, and many other factors common to patients in an ICU. Some institutions have noted increased isolation of non-albicans species causing candidemia. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The gold standard for the diagnosis of candidemia is a positive blood culture. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants and children with candidemia should undergo formal ophthalmologic examination for chorioretinitis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Additional evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/1\">",
"      Fridkin SK. The changing face of fungal infections in health care settings. Clin Infect Dis 2005; 41:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/2\">",
"      Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/3\">",
"      Blyth CC, Chen SC, Slavin MA, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009; 123:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/4\">",
"      Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/5\">",
"      Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/6\">",
"      Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/7\">",
"      Vazquez JA, Sanchez V, Dmuchowski C, et al. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993; 168:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/8\">",
"      Trofa D, G&aacute;cser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/9\">",
"      Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol 2006; 44:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/10\">",
"      Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G. Nosocomial candidaemia in children: results of a 9-year study. Mycoses 2008; 51:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/11\">",
"      Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J 2011; 30:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/12\">",
"      Dotis J, Prasad PA, Zaoutis T, Roilides E. Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children. Pediatr Infect Dis J 2012; 31:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/13\">",
"      Steinbach WJ, Roilides E, Berman D, et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J 2012; 31:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/14\">",
"      Oeser C, Lamagni T, Heath PT, et al. The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. Pediatr Infect Dis J 2013; 32:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/15\">",
"      Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/16\">",
"      Nucci M, Colombo AL, Silveira F, et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998; 19:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/17\">",
"      Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/18\">",
"      Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/19\">",
"      Zaoutis TE, Greves HM, Lautenbach E, et al. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004; 23:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/20\">",
"      Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/21\">",
"      Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis 1999; 34:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/22\">",
"      Chow JK, Golan Y, Ruthazer R, et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008; 36:1993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/23\">",
"      Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008; 46:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/24\">",
"      Playford EG, Marriott D, Nguyen Q, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 2008; 36:2034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/25\">",
"      Garcia-San Miguel L, Cobo J, Martos I, et al. Risk factors for candidemia in pediatric patients with congenital heart disease. Infect Control Hosp Epidemiol 2006; 27:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/26\">",
"      Zaoutis TE. Pediatric fungal infections: A conundrum in children. J Pediatr 2010; 156:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/27\">",
"      Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 2010; 51:e38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/28\">",
"      Fierro JL, Prasad PA, Fisher BT, et al. Ocular manifestations of candidemia in children. Pediatr Infect Dis J 2013; 32:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/29\">",
"      Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/30\">",
"      Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49:3640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/31\">",
"      Schelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. J Pediatr 2003; 142:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/32\">",
"      Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, &beta;-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54:1240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/33\">",
"      Shepard JR, Addison RM, Alexander BD, et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/34\">",
"      Matthews RC. Comparative assessment of the detection of candidal antigens as a diagnostic tool. J Med Vet Mycol 1996; 34:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/35\">",
"      Reiss E, Obayashi T, Orle K, et al. Non-culture based diagnostic tests for mycotic infections. Med Mycol 2000; 38 Suppl 1:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/36\">",
"      Walsh TJ, Hathorn JW, Sobel JD, et al. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991; 324:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/37\">",
"      Walsh TJ, Merz WG, Lee JW, et al. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am J Med 1995; 99:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/38\">",
"      Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/39\">",
"      Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/40\">",
"      Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1--&gt;3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/41\">",
"      Mohr JF, Sims C, Paetznick V, et al. Prospective survey of (1&rarr;3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011; 49:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/42\">",
"      Kourkoumpetis TK, Fuchs BB, Coleman JJ, et al. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis 2012; 54:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/43\">",
"      Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40:2483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/44\">",
"      McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/45\">",
"      Lau A, Halliday C, Chen SC, et al. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 2010; 48:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/46\">",
"      Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/47\">",
"      Krishna R, Amuh D, Lowder CY, et al. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye (Lond) 2000; 14 ( Pt 1):30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/6/25703/abstract/48\">",
"      Enzenauer RW, Calderwood S, Levin AV, et al. Screening for fungal endophthalmitis in children at risk. Pediatrics 1992; 90:451.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5976 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-A161942C46-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25703=[""].join("\n");
var outline_f25_6_25703=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3939823\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Neonates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Patients in ICU",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Culture and stain of biopsy material",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Non-culture methods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      ADDITIONAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3939823\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5976\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5976|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/49/38672\" title=\"picture 1\">",
"      Disseminated candidiasis kidney",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/1/25630\" title=\"picture 2\">",
"      Candida endophthalmitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/39/25214\" title=\"picture 3\">",
"      Vitritis in endophthalmitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/63/34815\" title=\"picture 4\">",
"      Disseminated candidiasis skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/42/25248\" title=\"picture 5\">",
"      Disseminated candidiasis nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/21/35166\" title=\"picture 6\">",
"      Budding yeast Gram stain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/19/37176?source=related_link\">",
"      Biology of Candida infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/49/15128?source=related_link\">",
"      Candida infections of the bladder and kidneys",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31720?source=related_link\">",
"      Clinical manifestations and diagnosis of Candida infection in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/6/36966?source=related_link\">",
"      Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37638?source=related_link\">",
"      Epidemiology and pathogenesis of candidemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24039?source=related_link\">",
"      Epidemiology and risk factors for Candida infection in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13849?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/47/31481?source=related_link\">",
"      Overview of Candida infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40760?source=related_link\">",
"      Treatment of Candida infection in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=related_link\">",
"      Treatment of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3336?source=related_link\">",
"      Treatment of candidemia in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_6_25704="Ventric premature beat tutorial";
var content_f25_6_25704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1046px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ventricular premature beat",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 438px; height: 150px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The fourth beat is a ventricular premature beat (VPB). It has a wide, bizarre morphology, with a duration &gt;0.16 seconds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 456px\">",
"   <div class=\"ttl\">",
"    Sinus rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 103px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCABnAcgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3W6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKLq53fa/9Ns23QBflX733uB83Xn36jii6ud32v/TbNt0AX5V+997gfN159+o4ournd9r/ANNs23QBflX733uB83Xn36jikn/X3eZ7EY7adun+H+7/AF+WP9p3eL9e/wBNs23aVaL8q/e/eXfA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVj/ad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFRTen9d/Upx1Wnbp/h/u/1+WP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/wCm2bboAvyr9773A+brz79RxQn733f1uCj7q0/D/D/d/r8i6ud32v8A02zbdAF+Vfvfe4HzdeffqOKx/tO7xfr3+m2bbtKtF+VfvfvLvgfN159+o4rYurnd9r/02zbdAF+Vfvfe4HzdeffqOKx/tO7xfr3+m2bbtKtF+VfvfvLvgfN159+o4ob1j/XT1CEdNu3T/D/d/r8ti6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/wCm2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiib91/1+oUo+9HTt0/w/wB3+vyZ4x8Y6X4Ztri41rUVjtpYdvnQ2M0yDkjDNHuCHLgDdjOeOho0DxhpfiuyvrvRNRW4tTCFEsljNAsvLjEZkxuIIIO3OOM478r+0bcb/hH4mH2u1k3R2gwg+9i6TgfMeR1PXr2qH9nmbb8F9JX7TbpmC4XYw+Y/6TPwPm68+nccetoxi37Tlt0XT08v0Oz+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4rH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4qKb0/rv6mzjqtO3T/AA/3f6/LH8d3O7wh4o/02zbdpUy/Kv3v3cnA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVj+O7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4rYurnd9r/wBNs23QBflX733uB83Xn36jihP3vu/rcFH3Vp+H+H+7/X5F1c7vtf8Aptm26AL8q/e+9wPm68+/UcVj/ad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVj/AGnd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcUN6x/rp6hCOm3bp/h/u/1+WxdXO77X/ptm26AL8q/e+9wPm68+/UcVj+O7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4rYurnd9r/wBNs23QBflX733uB83Xn36jisfx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFE37r/r9QpR96Onbp/h/u/1+WxdXO77X/ptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFF1c7vtf8Aptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFWn/AF93mTGO2nbp/h/u/wBflj/ad3i/Xv8ATbNt2lWi/Kv3v3l3wPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFY/2nd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcVsXVzu+1/wCm2bboAvyr9773A+brz79RxUU3p/Xf1KcdVp26f4f7v9flj+O7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4rYurnd9r/wBNs23QBflX733uB83Xn36jisfx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFbF1c7vtf8Aptm26AL8q/e+9wPm68+/UcUJ+9939bgo+6tPw/w/3f6/Iurnd9r/ANNs23QBflX733uB83Xn36jisf7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jisf7Tu8X69/ptm27SrRflX737y74HzdeffqOKG9Y/109QhHTbt0/w/3f6/LYurnd9r/wBNs23QBflX733uB83Xn36jisfx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFbF1c7vtf8Aptm26AL8q/e+9wPm68+/UcVj+O7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4om/df9fqFKPvR07dP8P8Ad/r8ti6ud32v/TbNt0AX5V+997gfN159+o4ournd9r/02zbdAF+Vfvfe4HzdeffqOKLq53fa/wDTbNt0AX5V+997gfN159+o4ournd9r/wBNs23QBflX733uB83Xn36jirT/AK+7zJjHbTt0/wAP93+vyx/tO7xfr3+m2bbtKtF+VfvfvLvgfN159+o4rYurnd9r/wBNs23QBflX733uB83Xn36jisf7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/wDTbNt0AX5V+997gfN159+o4qKb0/rv6lOOq07dP8P93+vyx/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/wCm2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v8A02zbdAF+Vfvfe4HzdeffqOKE/e+7+twUfdWn4f4f7v8AX5F1c7vtf+m2bboAvyr9773A+brz79RxWP8Aad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVj/ad3i/Xv8ATbNt2lWi/Kv3v3l3wPm68+/UcUN6x/rp6hCOm3bp/h/u/wBflsXVzu+1/wCm2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v8A02zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP8ATbNt2lTL8q/e/dycD5uvPv1HFE37r/r9QpR96Onbp/h/u/1+WxdXO77X/ptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFF1c7vtf+m2bboAvyr9773A+brz79RxRdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFWn/X3eZMY7adun+H+7/X5crr/iOy0LX9fvdSvk+zf2XaK729pLPgB7wkkR7ioAByx4GRnHGW6d8SvD2vWmpXWkalPfW8cIR3g0i7IY5xsX5eW/eKcDJwc4wCap/EG53WHxD/ANNs23eF1Hyr97i94HzdeffqOK4f9k2XZ8NteXz4Y91/INrjl/3MfC8jn8+tTT2/rv6kyb9oo26Lp6eR1mqfEvw34q8OeJ7bQdX+2ynSplYpptyiD91KQGdgFQnBxuPJ4GTxXol1c7vtf+m2bboAvyr9773A+brz79RxXyv+zlLs8C/FJfPhj3aag2uOX/dXPC8jn8+tfVF1c7vtf+m2bboAvyr9773A+brz79RxQn77+QUW504trr2/w+X9fkXVzu+1/wCm2bboAvyr9773A+brz79RxWP9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxWP8Aad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxSb1j/XT1NIR027dP8P93+vy2Lq53fa/9Ns23QBflX733uB83Xn36jisfx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiib91/wBfqFKPvR07dP8AD/d/r8ti6ud32v8A02zbdAF+Vfvfe4HzdeffqOKLq53fa/8ATbNt0AX5V+997gfN159+o4ournd9r/02zbdAF+Vfvfe4HzdeffqOKLq53fa/9Ns23QBflX733uB83Xn36jirT/r7vMmMdtO3T/D/AHf6/LH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4rH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4qKb0/rv6lOOq07dP8P93+vyx/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFY/ju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jihP3vu/rcFH3Vp+H+H+7/X5F1c7vtf+m2bboAvyr9773A+brz79RxRRdXO77X/ptm26AL8q/e+9wPm68+/UcUV0UjtwKsn8vy9EZF0deb7Z/wAVB4fbdAF+XTZPm+9wP9J68+/UUXR15vtn/FQeH23QBfl02T5vvcD/AEnrz79RWvdXO77X/ptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFYpf193mcUb6adun+H+6cmX1pvFOuBdd0JpTpdqGYae+1xvusKo+0cMOcnJzuHAxzq3R15vtn/FQeH23QBfl02T5vvcD/SevPv1FJ9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxUQ2/rv6lO91p26f4f7v8AX5cn41fWv+EW8SGbXdCliOlyh1j091Zxskyqk3Bw3PXB6jj11bo6832z/ioPD7boAvy6bJ833uB/pPXn36ik8d3O7wh4o/02zbdpUy/Kv3v3cnA+brz79RxWxdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFC+L7v63BX5Vp+H+H+7/X5ZF0deb7Z/xUHh9t0AX5dNk+b73A/wBJ68+/UVlF9abxTrgXXdCaU6XahmGnvtcb7rCqPtHDDnJyc7hwMc9ZdXO77X/ptm26AL8q/e+9wPm68+/UcVj/AGnd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcUPdf109Qhe23bp/h/u/wBfkt0deb7Z/wAVB4fbdAF+XTZPm+9wP9J68+/UVleNX1r/AIRbxIZtd0KWI6XKHWPT3VnGyTKqTcHDc9cHqOPXrLq53fa/9Ns23QBflX733uB83Xn36jisfx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFE/hf9fqFK/NHTt0/w/3f6/Lz/wCPb63deBNV0sXttqk99HAI7fTNGuGZ9k6sR5iyusZA5+YfMOBzUPwM/ty2+G0Ol/a7bTJ7SCRZLXUdHuFcb5pmAV2lRXJDZ+UHG5Qeevr11c7vtf8Aptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFWv6/q5lGHvqdu3T0/u/1+XJl9abxTrgXXdCaU6XahmGnvtcb7rCqPtHDDnJyc7hwMc6t0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RSfad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVENv67+pq73Wnbp/h/u/1+XJ+NX1r/hFvEhm13QpYjpcodY9PdWcbJMqpNwcNz1weo49dW6OvN9s/wCKg8PtugC/Lpsnzfe4H+k9effqKTx3c7vCHij/AE2zbdpUy/Kv3v3cnA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcUL4vu/rcFflWn4f4f7v9flkXR15vtn/ABUHh9t0AX5dNk+b73A/0nrz79RWUX1pvFOuBdd0JpTpdqGYae+1xvusKo+0cMOcnJzuHAxz1l1c7vtf+m2bboAvyr9773A+brz79RxWP9p3eL9e/wBNs23aVaL8q/e/eXfA+brz79RxQ91/XT1CF7bdun+H+7/X5LdHXm+2f8VB4fbdAF+XTZPm+9wP9J68+/UVleNX1r/hFvEhm13QpYjpcodY9PdWcbJMqpNwcNz1weo49esurnd9r/02zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcUT+F/1+oUr80dO3T/D/AHf6/Jbo6832z/ioPD7boAvy6bJ833uB/pPXn36ii6OvN9s/4qDw+26AL8umyfN97gf6T159+orXurnd9r/02zbdAF+Vfvfe4HzdeffqOKLq53fa/wDTbNt0AX5V+997gfN159+o4q0v6+7zJjfTTt0/w/3Tky+tN4p1wLruhNKdLtQzDT32uN91hVH2jhhzk5Odw4GOdW6OvN9s/wCKg8PtugC/Lpsnzfe4H+k9effqKT7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jioht/Xf1Kd7rTt0/w/3f6/Lk/Gr61/wi3iQza7oUsR0uUOsenurONkmVUm4OG564PUceurdHXm+2f8VB4fbdAF+XTZPm+9wP8ASevPv1FJ47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKF8X3f1uCvyrT8P8AD/d/r8si6OvN9s/4qDw+26AL8umyfN97gf6T159+orKL603inXAuu6E0p0u1DMNPfa433WFUfaOGHOTk53DgY56y6ud32v8A02zbdAF+Vfvfe4HzdeffqOKx/tO7xfr3+m2bbtKtF+VfvfvLvgfN159+o4oe6/rp6hC9tu3T/D/d/r8lujrzfbP+Kg8PtugC/Lpsnzfe4H+k9effqKyvGr61/wAIt4kM2u6FLEdLlDrHp7qzjZJlVJuDhueuD1HHr1l1c7vtf+m2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiifwv+v1Clfmjp26f4f7v9fkt0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RRdHXm+2f8AFQeH23QBfl02T5vvcD/SevPv1Fa91c7vtf8Aptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFWl/X3eZMb6adun+H+6cmX1pvFOuBdd0JpTpdqGYae+1xvusKo+0cMOcnJzuHAxzq3R15vtn/FQeH23QBfl02T5vvcD/AEnrz79RSfad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFRDb+u/qU73Wnbp/h/u/1+XJ+NX1r/hFvEhm13QpYjpcodY9PdWcbJMqpNwcNz1weo49dW6OvN9s/4qDw+26AL8umyfN97gf6T159+opPHdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFC+L7v63BX5Vp+H+H+7/X5ZF0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RWUX1pvFOuBdd0JpTpdqGYae+1xvusKo+0cMOcnJzuHAxz1l1c7vtf+m2bboAvyr9773A+brz79RxWP9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFD3X9dPUIXtt26f4f7v9fkt0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RWV41fWv+EW8SGbXdCliOlyh1j091Zxskyqk3Bw3PXB6jj16y6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcUT+F/wBfqFK/NHTt0/w/3f6/Jbo6832z/ioPD7boAvy6bJ833uB/pPXn36ii6OvN9s/4qDw+26AL8umyfN97gf6T159+orXurnd9r/02zbdAF+Vfvfe4HzdeffqOKLq53fa/9Ns23QBflX733uB83Xn36jirS/r7vMmN9NO3T/D/AHTzD4h3erRweMYH1SwvJ73QorRY7HR55mmLi8CooSVzGc7gXbKjcuQP4uJ+AE2seGfBOu2d55+lSNO1x5F3oF3cPKpWNMoyMoJyfugEgAt0BI9t+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v8A02zbdAF+Vfvfe4HzdeffqOKiG39d/UTh76lbounp/d/r8vlT4MWuteH/AAx48tL+C40r+0NPO1b3SbhhOEhnLBZQVSI4bGXzksMAng/Sl0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RSeO7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4rYurnd9r/02zbdAF+Vfvfe4HzdeffqOKa1k/l/W4U4ckEkuvb/AA/3f6/LIujrzfbP+Kg8PtugC/Lpsnzfe4H+k9effqKyi+tN4p1wLruhNKdLtQzDT32uN91hVH2jhhzk5Odw4GOesurnd9r/ANNs23QBflX733uB83Xn36jisf7Tu8X69/ptm27SrRflX737y74HzdeffqOKT3X9dPUuF7bdun+H+7/X5LdHXm+2f8VB4fbdAF+XTZPm+9wP9J68+/UVleNX1r/hFvEhm13QpYjpcodY9PdWcbJMqpNwcNz1weo49esurnd9r/02zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcUT+F/1+oUr80dO3T/D/AHf6/Jbo6832z/ioPD7boAvy6bJ833uB/pPXn36ii6OvN9s/4qDw+26AL8umyfN97gf6T159+orXurnd9r/02zbdAF+Vfvfe4HzdeffqOKLq53fa/wDTbNt0AX5V+997gfN159+o4q0v6+7zJjfTTt0/w/3Tky+tN4p1wLruhNKdLtQzDT32uN91hVH2jhhzk5Odw4GOdW6OvN9s/wCKg8PtugC/Lpsnzfe4H+k9effqKT7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jioht/Xf1Kd7rTt0/w/3f6/Lk/Gr61/wi3iQza7oUsR0uUOsenurONkmVUm4OG564PUceurdHXm+2f8VB4fbdAF+XTZPm+9wP8ASevPv1FJ47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKF8X3f1uCvyrT8P8AD/d/r8si6OvN9s/4qDw+26AL8umyfN97gf6T159+oorXurnd9r/02zbdAF+Vfvfe4HzdeffqOKK3pRT/AOH/AOCduBbSenbp5eiMi68YaCftn/FU+H23QAfLcx/N9/gfvOvPv1FF14w0E/bP+Kp8PtugA+W5j+b7/A/edeffqK17q53fa/8ATbNt0AX5V+997gfN159+o4ournd9r/02zbdAF+Vfvfe4HzdeffqOKzV+/wDWnmcEVHTTt/7b/d/r8uTPivRf+Ep1yU+JdCMUml2sauLhNrkPdEqp3/eG4Z6/eHHrq3XjDQT9s/4qnw+26AD5bmP5vv8AA/edeffqKT7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jiog3bf+r+pTUbrTt/7b/d/r8uT8a+K9FuPC3iSKHxLoU0sulyxokdwhaQlJAFUBz83Pv1HHrq3XjDQT9s/4qnw+26AD5bmP5vv8D95159+opPHdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFCvzb9v63BKPKtP693+7/X5ZF14w0E/bP+Kp8PtugA+W5j+b7/A/edeffqKyj4r0X/hKdclPiXQjFJpdrGri4Ta5D3RKqd/3huGev3hx69ZdXO77X/ptm26AL8q/e+9wPm68+/UcVj/ad3i/Xv8ATbNt2lWi/Kv3v3l3wPm68+/UcUNu61/q3qEFG23b/wBt/u/1+S3XjDQT9s/4qnw+26AD5bmP5vv8D95159+orK8a+K9FuPC3iSKHxLoU0sulyxokdwhaQlJAFUBz83Pv1HHr1l1c7vtf+m2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiid+V6/194U1Hmjp2/wDbf7v9fkt14w0E/bP+Kp8PtugA+W5j+b7/AAP3nXn36ii68YaCftn/ABVPh9t0AHy3Mfzff4H7zrz79RWvdXO77X/ptm26AL8q/e+9wPm68+/UcUXVzu+1/wCm2bboAvyr9773A+brz79RxVq/f+tPMmKjpp2/9t/u/wBflyZ8V6L/AMJTrkp8S6EYpNLtY1cXCbXIe6JVTv8AvDcM9fvDj11brxhoJ+2f8VT4fbdAB8tzH833+B+868+/UUn2nd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcVsXVzu+1/wCm2bboAvyr9773A+brz79RxUQbtv8A1f1Kajdadv8A23+7/X5cn418V6LceFvEkUPiXQppZdLljRI7hC0hKSAKoDn5uffqOPXVuvGGgn7Z/wAVT4fbdAB8tzH833+B+868+/UUnju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jihX5t+39bglHlWn9e7/d/r8si68YaCftn/ABVPh9t0AHy3Mfzff4H7zrz79RWUfFei/wDCU65KfEuhGKTS7WNXFwm1yHuiVU7/ALw3DPX7w49esurnd9r/ANNs23QBflX733uB83Xn36jisf7Tu8X69/ptm27SrRflX737y74HzdeffqOKG3da/wBW9Qgo227f+2/3f6/JbrxhoJ+2f8VT4fbdAB8tzH833+B+868+/UVleNfFei3HhbxJFD4l0KaWXS5Y0SO4QtISkgCqA5+bn36jj16y6ud32v8A02zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP8ATbNt2lTL8q/e/dycD5uvPv1HFE78r1/r7wpqPNHTt/7b/d/r8luvGGgn7Z/xVPh9t0AHy3Mfzff4H7zrz79RRdeMNBP2z/iqfD7boAPluY/m+/wP3nXn36ite6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKLq53fa/9Ns23QBflX733uB83Xn36jirV+/8AWnmTFR007f8Atv8Ad/r8uTPivRf+Ep1yU+JdCMUml2sauLhNrkPdEqp3/eG4Z6/eHHrq3XjDQT9s/wCKp8PtugA+W5j+b7/A/edeffqKT7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jiog3bf+r+pTUbrTt/7b/d/r8uT8a+K9FuPC3iSKHxLoU0sulyxokdwhaQlJAFUBz83Pv1HHrq3XjDQT9s/4qnw+26AD5bmP5vv8D95159+opPHdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/wCm2bboAvyr9773A+brz79RxQr82/b+twSjyrT+vd/u/wBflkXXjDQT9s/4qnw+26AD5bmP5vv8D95159+orKPivRf+Ep1yU+JdCMUml2sauLhNrkPdEqp3/eG4Z6/eHHr1l1c7vtf+m2bboAvyr9773A+brz79RxWP9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFDbutf6t6hBRtt2/wDbf7v9fkt14w0E/bP+Kp8PtugA+W5j+b7/AAP3nXn36isrxr4r0W48LeJIofEuhTSy6XLGiR3CFpCUkAVQHPzc+/UcevWXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFY/ju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOKJ35Xr/AF94U1Hmjp2/9t/u/wBfkt14w0E/bP8AiqfD7boAPluY/m+/wP3nXn36ii68YaCftn/FU+H23QAfLcx/N9/gfvOvPv1Fa91c7vtf+m2bboAvyr9773A+brz79RxRdXO77X/ptm26AL8q/e+9wPm68+/UcVav3/rTzJio6adv/bf7v9flyZ8V6L/wlOuSnxLoRik0u1jVxcJtch7olVO/7w3DPX7w49dW68YaCftn/FU+H23QAfLcx/N9/gfvOvPv1FJ9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxUQbtv/V/UpqN1p2/9t/u/wBflyfjXxXotx4W8SRQ+JdCmll0uWNEjuELSEpIAqgOfm59+o49dW68YaCftn/FU+H23QAfLcx/N9/gfvOvPv1FJ47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4oV+bft/W4JR5Vp/Xu/wB3+vyyLrxhoJ+2f8VT4fbdAB8tzH833+B+868+/UVlHxXov/CU65KfEuhGKTS7WNXFwm1yHuiVU7/vDcM9fvDj16y6ud32v/TbNt0AX5V+997gfN159+o4rH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiht3Wv9W9Qgo227f+2/3f6/JbrxhoJ+2f8VT4fbdAB8tzH833+B+868+/UVleNfFei3HhbxJFD4l0KaWXS5Y0SO4QtISkgCqA5+bn36jj16y6ud32v/TbNt0AX5V+997gfN159+o4rH8d3O7wh4o/02zbdpUy/Kv3v3cnA+brz79RxRO/K9f6+8KajzR07f8Atv8Ad/r8luvGGgn7Z/xVPh9t0AHy3Mfzff4H7zrz79RRdeMNBP2z/iqfD7boAPluY/m+/wAD95159+orXurnd9r/ANNs23QBflX733uB83Xn36jii6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKtX7/ANaeZMVHTTt/7b/d/r8uTPivRf8AhKdclPiXQjFJpdrGri4Ta5D3RKqd/wB4bhnr94ceurdeMNBP2z/iqfD7boAPluY/m+/wP3nXn36ik+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v/AE2zbdAF+Vfvfe4HzdeffqOKiDdt/wCr+pTUbrTt/wC2/wB3+vy5Pxr4r0W48LeJIofEuhTSy6XLGiR3CFpCUkAVQHPzc+/UceurdeMNBP2z/iqfD7boAPluY/m+/wAD95159+opPHdzu8IeKP8ATbNt2lTL8q/e/dycD5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxQr82/b+twSjyrT+vd/u/1+WRdeMNBP2z/iqfD7boAPluY/m+/wAD95159+orKPivRf8AhKdclPiXQjFJpdrGri4Ta5D3RKqd/wB4bhnr94cevWXVzu+1/wCm2bboAvyr9773A+brz79RxWP9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFDbutf6t6hBRtt2/9t/u/wBfkt14w0E/bP8AiqfD7boAPluY/m+/wP3nXn36isrxr4r0W48LeJIofEuhTSy6XLGiR3CFpCUkAVQHPzc+/UcevWXVzu+1/wCm2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiid+V6/194U1Hmjp2/9t/u/1+S3XjDQT9s/4qnw+26AD5bmP5vv8D95159+oouvGGgn7Z/xVPh9t0AHy3Mfzff4H7zrz79RWvdXO77X/ptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFWr9/608yYqOmnb/wBt/u/1+XJnxXov/CU65KfEuhGKTS7WNXFwm1yHuiVU7/vDcM9fvDj11brxhoJ+2f8AFU+H23QAfLcx/N9/gfvOvPv1FJ9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxUQbtv/V/UpqN1p2/9t/u/1+XJ+NfFei3HhbxJFD4l0KaWXS5Y0SO4QtISkgCqA5+bn36jj11brxhoJ+2f8VT4fbdAB8tzH833+B+868+/UUnju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOK2Lq53fa/8ATbNt0AX5V+997gfN159+o4oV+bft/W4JR5Vp/Xu/3f6/LIuvGGgn7Z/xVPh9t0AHy3Mfzff4H7zrz79RRWvdXO77X/ptm26AL8q/e+9wPm68+/UcUVvT5ns/6+87cDypPTt+Xogurnd9r/02zbdAF+Vfvfe4HzdeffqOKLq53fa/9Ns23QBflX733uB83Xn36jisi6OvN9s/4qDw+26AL8umyfN97gf6T159+ooujrzfbP8AioPD7boAvy6bJ833uB/pPXn36is1L+vu8zgjBafLp/h/uifad3i/Xv8ATbNt2lWi/Kv3v3l3wPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFcmX1pvFOuBdd0JpTpdqGYae+1xvusKo+0cMOcnJzuHAxzL4r1PXtJ0DXtT/ALb8P3H2TTpJ/LXT5F83YkjbAftBwTjGcHqOPWIS0/rv6jlFKzfl08o/3f6/KlP4ttfGHwq1vXLCYQ215pVyqRXMQSU7RMhGBIwBypPU8EcV2l1c7vtf+m2bboAvyr9773A+brz79RxXh3wwOpj9naXytU0uKzOl3oNvLaM0pHmXGVD+cBuOTg7ONw4OOfWro6832z/ioPD7boAvy6bJ833uB/pPXn36ine038v63FCN4Rf6f4f7pr3Vzu+1/wCm2bboAvyr9773A+brz79RxWP9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFLdHXm+2f8VB4fbdAF+XTZPm+9wP9J68+/UVlF9abxTrgXXdCaU6XahmGnvtcb7rCqPtHDDnJyc7hwMcpvVf109SoQVvu6f4f7v9fl1l1c7vtf8Aptm26AL8q/e+9wPm68+/UcVj+O7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4pbo6832z/AIqDw+26AL8umyfN97gf6T159+orK8avrX/CLeJDNruhSxHS5Q6x6e6s42SZVSbg4bnrg9Rx6k37r/r9QpQXNH5dP8P93+vy6TWtVgsNP1W9vNRs1tYLNpZXVCfkUOTgBicgZ6Z6jj1S31a31TTjfWWo2k1reWaSxOIyhkRgzLgFsg4I4IzyOK4f4u6pqulfDzxTc3utaPc28mn/AGVkttOcO5lLRAKTckDBkBJwcDnBxgz+ATrR+HehCHW9ESI6HaKkb6e7OB5PCEi4GWGeTgdegq0/6/pmUV7/AC+S6en906L7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/wDTbNt0AX5V+997gfN159+o4rky+tN4p1wLruhNKdLtQzDT32uN91hVH2jhhzk5Odw4GOdW6OvN9s/4qDw+26AL8umyfN97gf6T159+oqIPT+u/qauCuvl0/wAP93+vyTx3c7vCHij/AE2zbdpUy/Kv3v3cnA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVyfjV9a/wCEW8SGbXdCliOlyh1j091Zxskyqk3Bw3PXB6jj11bo6832z/ioPD7boAvy6bJ833uB/pPXn36ihP3vu/rcFBcq/wAv8P8Ad/r8te6ud32v/TbNt0AX5V+997gfN159+o4rH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jilujrzfbP+Kg8PtugC/Lpsnzfe4H+k9effqKyi+tN4p1wLruhNKdLtQzDT32uN91hVH2jhhzk5Odw4GORvVf109QhBW+7p/h/u/wBfl0i6ta339pfY9W0268pTby+QwbbIu7MZw5w4yMg88jj1z/Hdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcV5l8Eb6/1PTvHd/pOtaStrea7dzK82nyE3G4A7kBmUoCCMKQxGeSa7nxq+tf8It4kM2u6FLEdLlDrHp7qzjZJlVJuDhueuD1HHq5v3X/AF+pNCKbi/Tp/h/u/wBfl1l1c7vtf+m2bboAvyr9773A+brz79RxRdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFZF0deb7Z/wAVB4fbdAF+XTZPm+9wP9J68+/UUXR15vtn/FQeH23QBfl02T5vvcD/AEnrz79RVKX9fd5hGC0+XT/D/dE+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4rky+tN4p1wLruhNKdLtQzDT32uN91hVH2jhhzk5Odw4GOdW6OvN9s/4qDw+26AL8umyfN97gf6T159+oqIPT+u/qU4K6+XT/AA/3f6/JPHdzu8IeKP8ATbNt2lTL8q/e/dycD5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxXJ+NX1r/AIRbxIZtd0KWI6XKHWPT3VnGyTKqTcHDc9cHqOPXVujrzfbP+Kg8PtugC/Lpsnzfe4H+k9effqKE/e+7+twUFyr/AC/w/wB3+vy17q53fa/9Ns23QBflX733uB83Xn36jisf7Tu8X69/ptm27SrRflX737y74HzdeffqOKW6OvN9s/4qDw+26AL8umyfN97gf6T159+orKL603inXAuu6E0p0u1DMNPfa433WFUfaOGHOTk53DgY5G9V/XT1CEFb7un+H+7/AF+XWXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFY/ju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOKW6OvN9s/4qDw+26AL8umyfN97gf6T159+orK8avrX/CLeJDNruhSxHS5Q6x6e6s42SZVSbg4bnrg9Rx6k37r/r9QpQXNH5dP8P8Ad/r8usurnd9r/wBNs23QBflX733uB83Xn36jii6ud32v/TbNt0AX5V+997gfN159+o4rIujrzfbP+Kg8PtugC/Lpsnzfe4H+k9effqKLo6832z/ioPD7boAvy6bJ833uB/pPXn36irUv6+7zJjBafLp/h/uifad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVyZfWm8U64F13QmlOl2oZhp77XG+6wqj7Rww5ycnO4cDHOrdHXm+2f8VB4fbdAF+XTZPm+9wP8ASevPv1FRB6f139SnBXXy6f4f7v8AX5J47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v8A02zbdAF+Vfvfe4HzdeffqOK5Pxq+tf8ACLeJDNruhSxHS5Q6x6e6s42SZVSbg4bnrg9Rx66t0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RQn733f1uCguVf5f4f7v9flr3Vzu+1/6bZtugC/Kv3vvcD5uvPv1HFY/2nd4v17/AE2zbdpVovyr9795d8D5uvPv1HFLdHXm+2f8VB4fbdAF+XTZPm+9wP8ASevPv1FZRfWm8U64F13QmlOl2oZhp77XG+6wqj7Rww5ycnO4cDHI3qv66eoQgrfd0/w/3f6/LrLq53fa/wDTbNt0AX5V+997gfN159+o4rH8d3O7wh4o/wBNs23aVMvyr9793JwPm68+/UcUt0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RWV41fWv+EW8SGbXdCliOlyh1j091Zxskyqk3Bw3PXB6jj1Jv3X/X6hSguaPy6f4f7v9fl1l1c7vtf+m2bboAvyr9773A+brz79RxRdXO77X/ptm26AL8q/e+9wPm68+/UcVkXR15vtn/FQeH23QBfl02T5vvcD/SevPv1FF0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RVqX9fd5kxgtPl0/wAP90T7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/wDTbNt0AX5V+997gfN159+o4rky+tN4p1wLruhNKdLtQzDT32uN91hVH2jhhzk5Odw4GOdW6OvN9s/4qDw+26AL8umyfN97gf6T159+oqIPT+u/qU4K6+XT/D/d/r8k8d3O7wh4o/02zbdpUy/Kv3v3cnA+brz79RxWxdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFcn41fWv+EW8SGbXdCliOlyh1j091Zxskyqk3Bw3PXB6jj11bo6832z/ioPD7boAvy6bJ833uB/pPXn36ihP3vu/rcFBcq/y/w/3f6/LXurnd9r/02zbdAF+Vfvfe4HzdeffqOKx/tO7xfr3+m2bbtKtF+VfvfvLvgfN159+o4pbo6832z/ioPD7boAvy6bJ833uB/pPXn36isovrTeKdcC67oTSnS7UMw099rjfdYVR9o4Yc5OTncOBjkb1X9dPUIQVvu6f4f7v9fl1l1c7vtf8Aptm26AL8q/e+9wPm68+/UcVj+O7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4pbo6832z/AIqDw+26AL8umyfN97gf6T159+orK8avrX/CLeJDNruhSxHS5Q6x6e6s42SZVSbg4bnrg9Rx6k37r/r9QpQXNH5dP8P93+vy6y6ud32v/TbNt0AX5V+997gfN159+o4ournd9r/02zbdAF+Vfvfe4HzdeffqOKyLo6832z/ioPD7boAvy6bJ833uB/pPXn36ii6OvN9s/wCKg8PtugC/Lpsnzfe4H+k9effqKtS/r7vMmMFp8un+H+6J9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFbF1c7vtf8Aptm26AL8q/e+9wPm68+/UcVyZfWm8U64F13QmlOl2oZhp77XG+6wqj7Rww5ycnO4cDHOrdHXm+2f8VB4fbdAF+XTZPm+9wP9J68+/UVEHp/Xf1KcFdfLp/h/u/1+SeO7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4rYurnd9r/wBNs23QBflX733uB83Xn36jiuT8avrX/CLeJDNruhSxHS5Q6x6e6s42SZVSbg4bnrg9Rx66t0deb7Z/xUHh9t0AX5dNk+b73A/0nrz79RQn733f1uCguVf5f4f7v9flr3Vzu+1/6bZtugC/Kv3vvcD5uvPv1HFFZF0deb7Z/wAVB4fbdAF+XTZPm+9wP9J68+/UUVvSk+39feduBgknr2/L0Rr3Vzu+1/6bZtugC/Kv3vvcD5uvPv1HFF1c7vtf+m2bboAvyr9773A+brz79RxWHf8Ajjw3G12svi7w2Ga3AwbyIbh8/A/edfz6imXXjzwuftn/ABWPhlt0AHy3sXzff4H7zrz79RULX+vTzPM5oxaT8v8A23+7/X5T/ad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxVf4l3O7wD4x/02zbdotwPlX737qXgfN159+o4rhvGHxi8O+HPF2oFbwa3He6Xbp5ujpHcJHskuMh280BT+8B79eQOMt+NXjzRtV+E/iA6D4q0u4ubq1tgsVrOEneNpl3Ls37x8jMGUjOCQQOaiF7f1/mTVnBx07fov7v8AX5cv8Bb2Z/gH4zimvV8uJbuKKOZi2FNuG2pkjaNzscAdWJ78/Qd1c7vtf+m2bboAvyr9773A+brz79RxXz34G1rQvDWifFDwhHqFjaNI97c6cplEkV1bvFtjWKXeQz4C/KSW57lWx7Hq3j/wvaRajJceLvDxCW2WWO5RnYAOdqqHJLewBJyMD1ad56eRcbRppy6P/wCR8v6/Lobq53fa/wDTbNt0AX5V+997gfN159+o4rH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jivMta+Ld/wCKNT1Ox+H+p+HLbT4rLbNq2tM1sJJGB2rbxsdxZck5ZSMjkAbd7/AHxK8zXvEVh451rQrTVrawgtRdxzqbbUUjaY+bHJkIGImXK9c5+UYZVHq1/X6ihJWu1pprbT7PkexXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFY/ju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOKLjxjoEi3TL4q8Pur24wVuo/nHzcD95159+orkviR8T/CdrpWuaVJ4n02a+vNMeKJbaJ5lZmWRVUuhZUOT/ABHoQTgclSd4tL+vxLglBxclZaf+2/3f6/I/aNuN/wAI/Ew+12sm6O0GEH3sXScD5jyOp69e1SfAvVbnUPhBo0t7e27SrZNbAMgDFIpZY0QYI5CKozjJ4zk8nC+PniPTNY0DTdHtvEmmTWeqarZWl/8AY5omYW+6Riclm27WVDu+meMgx/s/+LNEtfhRbadda7plneWkc0M9tdSCKQEzTOAAzDOQ4OQCOcdQatNWvcyjTaq7dF09PL9D0r7Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jiuRl8XaFH4m124l8T6AIH0u1jEhuYwrkSXWVU+ZjcNy+v3l49eL8WfGe9udS1mw8CWuj6oltGkEmpXt9FawM+W3CJHkUygDI3K3XBwRtLRB6X/AK/M1n7skra2Wltdo/3T0rx3c7vCHij/AE2zbdpUy/Kv3v3cnA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcV4XbfGSfW9J8RaX4tg03SLrU9Jml0xoJRNHIhjfbBIwc7J+ejYJJA2qdob1268YaCftn/FU+H23QAfLcx/N9/gfvOvPv1FCa5t+39bjhHmirLZ9v8P9017q53fa/wDTbNt0AX5V+997gfN159+o4rH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jim3/AI08OxrdtL4s8OhWgC5N3GA33/lH7zr+fUcVzfiLxvpllN4v1PT/ABDoFzKmgxNbATKyTyIbthGuJOTyuQDn5h6jI38L/rb1CK5U7rZLp/h/u/1+XnP7IuqSnw54t0xpbaKCKSKdd6ne7SI6sAdwHSJccdzXtnju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOK8L/AGbLvSfDD+LrW58QaXGLmx064QzyJGZC8DyPGuX5KNJsPXkcgdK9g8a+K9FuPC3iSKHxLoU0sulyxokdwhaQlJAFUBz83Pv1HHqVJe69TPBxlJRduvbzXl/X5dZdXO77X/ptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFcJ47+Lnhrw0ArapDq895H5awaSi3DhQHyx/eYUDI6nJzwDg4qeAfjBpHi/StQl1K6sdB1OKPy5rK8kClh85UxszLuBB54yCcEYwWpP+v6Y4pXSt26en93+vy677Tu8X69/ptm27SrRflX737y74HzdeffqOK2Lq53fa/9Ns23QBflX733uB83Xn36jiuTPivRf+Ep1yU+JdCMUml2sauLhNrkPdEqp3/eG4Z6/eHHrq3XjDQT9s/4qnw+26AD5bmP5vv8D95159+oqISVt/6v6mrpyuvd7dP8P93+vyTx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFbF1c7vtf8Aptm26AL8q/e+9wPm68+/UcVyfjXxXotx4W8SRQ+JdCmll0uWNEjuELSEpIAqgOfm59+o49dW68YaCftn/FU+H23QAfLcx/N9/gfvOvPv1FCkubft/W4KnLlXu/h/h/u/1+WvdXO77X/ptm26AL8q/e+9wPm68+/UcVj/AGnd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcUt14w0E/bP+Kp8PtugA+W5j+b7/A/edeffqKyj4r0X/hKdclPiXQjFJpdrGri4Ta5D3RKqd/3huGev3hx6jkrrX+reoQpyt8Pbp/h/u/1+XWXVzu+1/wCm2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiluvGGgn7Z/xVPh9t0AHy3Mfzff4H7zrz79RWV418V6LceFvEkUPiXQppZdLljRI7hC0hKSAKoDn5uffqOPUnJcr1/r7wp05c0fd7dP8P8Ad/r8usurnd9r/wBNs23QBflX733uB83Xn36jii6ud32v/TbNt0AX5V+997gfN159+o4rIuvGGgn7Z/xVPh9t0AHy3Mfzff4H7zrz79RRdeMNBP2z/iqfD7boAPluY/m+/wAD95159+oq1Jd/608yY0pae726f4f7v9fkn2nd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFcmfFei/wDCU65KfEuhGKTS7WNXFwm1yHuiVU7/ALw3DPX7w49dW68YaCftn/FU+H23QAfLcx/N9/gfvOvPv1FRCStv/V/Up05XXu9un+H+7/X5J47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiqPxT8Tt4b8DeI9VivYWnjshFC0MSsfNdjGhAZ8fKzqTnPHY9D5X8QPjm8tv4kstP0q0vNHkaTRzqK3yBmJRgZVhUsxT5mIfO0jbyCcVt/H/xZpmr+B30fSdc0K/k1q7tLIyw3a7IF8xpPMbazfKDGAT23g9sFr4n8v63MG06do7/AP7P93v/AF27vwB4kbxJ4C03VZNTtri4utNjFw5i8svMoZZVAyMEOGHAweMDGM3PtO7xfr3+m2bbtKtF+VfvfvLvgfN159+o4rzb4AeKtGtfhNa2F1rmmWd3apPDNb3TiJwxmlcKNzDPyupyARzjqDXanxXov/CU65KfEuhGKTS7WNXFwm1yHuiVU7/vDcM9fvDj1JSV1r/X3mtGm3G9ui6f4f7p1l1c7vtf+m2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jivMfGPxV1LxBq2qaJ8P8AUtDtoYQsVxr9/cxww5UOxSFHLGTOAu8Bh83QAq9SWvxYTxD4d8WaN4mbTNH8QJpUirFHcpNBeAwt/qZFcru3NjZljzxkhsE37rX9fmTRacou2l1rb0/unsV1c7vtf+m2bboAvyr9773A+brz79RxRdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFZF14w0E/bP8AiqfD7boAPluY/m+/wP3nXn36isbxz8S9C8P+HtW1KPWtJ1OWO3RI7W0uIzJOzMyhV+c4xuyxwcLk4OMGlJd/608w5eRc0lZLy/w/3f6/LY+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiuL+IHxCm0f4ueFvD6amkdjf20n23Zbq6TGQOlugOWZW8wHkED5lJyM4oeDPipb6t4t8SxeKJNI8PXv2C2hiia+S4iuFUzMdkykRlv3yjaCT14+VsebfGTX7TVfjRZa79v06TS/D9zptq81vL5hmRmedpVVc5VPmRsE4O3u2AoabmdSW1vK+nZLyXY+jPHdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFcn418V6LceFvEkUPiXQppZdLljRI7hC0hKSAKoDn5uffqOPWXxR8RfDWjaVqd/c+JNIuES3AEVpIsssxJYBEUOSWyevQZycAE0oyXNv2/rc3ceWCclZen+H+7/AF+XT3Vzu+1/6bZtugC/Kv3vvcD5uvPv1HFY/wBp3eL9e/02zbdpVovyr9795d8D5uvPv1HFeMXfxV8dzmbxHFH4Xj0l7dI30FtSha6MW0uZgdwbzPvJs+8CQDETzXb+Efid4e8T6nrmpR6va6erafb27W+oqtvKHWS6yoBkIJwynKlh8wHBBFDautf6+8mmn8LjZ6dPOP8Ad/r8vSLq53fa/wDTbNt0AX5V+997gfN159+o4rH8d3O7wh4o/wBNs23aVMvyr9793JwPm68+/UcUt14w0E/bP+Kp8PtugA+W5j+b7/A/edeffqK5f4p/EPQNO8Ha2Brmn3897aGxhgsCs0kjyLIoAAf5QMkljxj1JAJJ3i0n/X3lQg4tSktFbp/h/u/1+Xf3Vzu+1/6bZtugC/Kv3vvcD5uvPv1HFcRL4/E3xd1Dwil/pbW6aN5zuY2SRrndkQoS+G/dPv4B7+hFJ4U+K/h3xZpup3aanbaW0Y+ztb6mY4JnwCcqvmnj5sZ9QeOOfFU8QWN9+1BN4ga+tIdLaa5sxdSyxojNFZGIkfOcKzY2MThtwxzkC09TnkmuRpaXXT08j6K+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4rkz4r0X/AISnXJT4l0IxSaXaxq4uE2uQ90Sqnf8AeG4Z6/eHHrL4o+IvhrRtK1O/ufEmkXCJbgCK0kWWWYksAiKHJLZPXoM5OACainJW3/r7zonHltJrTTp/h/ul/wAd3O7wh4o/02zbdpUy/Kv3v3cnA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcV89638dbq9sdfj1fSFt9E1aymtdOlgKyXCEbo83EfmZj3FyemQBwJB81e2XHjHQJFumXxV4fdXtxgrdR/OPm4H7zrz79RQn7179v63FGN0o219P8P93+vy2Lq53fa/8ATbNt0AX5V+997gfN159+o4orHuPGOgSLdMvirw+6vbjBW6j+cfNwP3nXn36iitqcordndgIS5XZdunl6IXxDoWg63dT3OsWWgalcpbCNJbmzjlfALnapYkjkk/j09aFx4J8Hf6Vt0Dwmf3I27dMhGT83C+h6fpXTXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFF1c7vtf+m2bboAvyr9773A+brz79RxUL+vw8zzowWmn4en905fRdO0rRfE/iGDRYtGsIJdMtGeOytkhWRt90OinG7GOee1Z3iH4X+BNXZjc6LoaGCImP7FGbUMTnIxE67jwOucZ4Ayc9D9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxUQen9d/UpwWit26f4f7pxHxd8MeH/Enh7WL3WYNMu72y095be4ClJQyJKVUOrgkAsTtJKkkEjinad8NPA2j2t5b2WiaBLGyeYDcwfaXLEEYVpXZh0HAOOenXO747ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v/TbNt0AX5V+997gfN159+o4oT977v63BU1yp2/D/D/dC6ud32v/AE2zbdAF+Vfvfe4HzdeffqOK5TWdJ0bXfGOrtrVtoeptDpVqITc2iSlcyXWQm4naTgZx7eldXdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFY/2nd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcUN6x/rp6jhHTbt0/w/wB3+vy4yb4K/DpftGzS7M7Ygy7by55PzcD9914Hr1HHra1XwT4W8NfD3xhp+i2mmRWl3p8ksqHdKZXRHKYZ5GOVIBHPBOQAeT6DdXO77X/ptm26AL8q/e+9wPm68+/UcVj+O7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4ok/df9fqKnTjzL3e3T0/unDP8ABfwjZ6vBe6Rf3OnxWckF4LK2ui0FxNEzlGYSM5LDJHB4DcAZJOp4u+HGka54lvPEFtr+oaPq81uEuLjSLwwtdrgKEbLNwBGnC4zwSCcV3t1c7vtf+m2bboAvyr9773A+brz79RxRdXO77X/ptm26AL8q/e+9wPm68+/UcVS/r8PMmNNaK34en93+vy8h034ReDbfxPqS35XWbmC1gvftV/cPJJPPJLcFi4DhXJ2ICCpBAGQSWLeqW0FlpljPZaW2l2lmkGEgtYVjj5LkhVVsA5Yk+7dPWj9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxUwen9d/UrkSasu3T/AA/3Tlvivp2na94I8QQ6s2n3kcNi1zDlSCssayMpQh8hgfTqGwRgkHmD8ING06S+Xw74t1/Q7KRRL9h0vUjHCzbdpADFmJO0ZJJ69hgV3Hju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOK2Lq53fa/wDTbNt0AX5V+997gfN159+o4oT977v63BU00nb8P8P9084t/hVokeq/b9c8Qaj4pe1t3W3i125F3EhfIJVTxuwo65HIOMgEczc/CdLbVNb0rwv431HS7H+z0P2Rn+0W7Qztdq9uIyw4GSVJLEF2P3jur226ud32v/TbNt0AX5V+997gfN159+o4rH+07vF+vf6bZtu0q0X5V+9+8u+B83Xn36jihvVf109RRpRlFpr+vd/u/wBflxviH4ZwX1j4dew8T/2frvhvTorS01G1hT98qrtKuhYlgQrDbux+8bIIJBy/GHgfXLjRtfv/ABD8T9Wv3g01zFDYKlhDKFWRikkaMVfOQOgODjnjHr11c7vtf+m2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jinJ+6/6/UVOjFyjddv08v6/LH8GeAfDHgaO9/wCEeWzW6ls1hlupGaSWYDOQCXIUkgEhQATt+XgUvxA8FaV4u1CDUZ9Vk0/VrCLEGoaXL5E5Qhw0W7JyDuPqeeMAtu6+6ud32v8A02zbdAF+Vfvfe4HzdeffqOKLq53fa/8ATbNt0AX5V+997gfN159+o4ql/X4eYRgtFb8PT+6eR2vhLxbY67rFlpvxTmMcdjCyy3enw3U0sbS3JWJndssV+b5u+8DACgV65dXO77X/AKbZtugC/Kv3vvcD5uvPv1HFY/2nd4v17/TbNt2lWi/Kv3v3l3wPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFTB3X9d/UapKLVl27/AN3y/r8sfx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFbF1c7vtf+m2bboAvyr9773A+brz79RxWL4+nL+EfEpGoWv8AyC5gQij95+6l+UfMeec8e347V1c7vtf+m2bboAvyr9773A+brz79RxST977v63KUfdWn4f4f7v8AX5F1c7vtf+m2bboAvyr9773A+brz79RxWP8Aad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVj/ad3i/Xv8ATbNt2lWi/Kv3v3l3wPm68+/UcUN6x/rp6hCOm3bp/h/u/wBflsXVzu+1/wCm2bboAvyr9773A+brz79RxWP47ud3hDxR/ptm27Spl+Vfvfu5OB83Xn36jiti6ud32v8A02zbdAF+Vfvfe4HzdeffqOKx/Hdzu8IeKP8ATbNt2lTL8q/e/dycD5uvPv1HFE37r/r9QpR96Onbp/h/u/1+WxdXO77X/ptm26AL8q/e+9wPm68+/UcUXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFF1c7vtf+m2bboAvyr9773A+brz79RxRdXO77X/AKbZtugC/Kv3vvcD5uvPv1HFWn/X3eZMY7adun+H+7/X5eT33w30+bx34on0zxZrWjreQw6hPFpV95KTzSPOHBBJJ5TOMnBc4wMAWP8AhS/g+SS+uNcvLrxFfyKJPtupX0jTNhdoQFHUHAUdQTyO2BXcfad3i/Xv9Ns23aVaL8q/e/eXfA+brz79RxWxdXO77X/ptm26AL8q/e+9wPm68+/UcVEHdf1/mDpK607dP8P93+vy5LxTo+kad8M9d0Wyj0pdKt9JkWG2EQZMqruuMscuGw245O4huvJpW3wv8DadrsusWOl6Wl/Fm4iKtIY1kO77kZkKKRwQAuFO0gDArovHdzu8IeKP9Ns23aVMvyr9793JwPm68+/UcVsXVzu+1/6bZtugC/Kv3vvcD5uvPv1HFCfvfd/W41BWTt+H+H+6fNOkaRe+Ivin4z8Ea1qAs9BGo3XiC5t7dh/xMNzxmKNnDcIQ6Pgcg5z8wBXuR8Hvh+fEeq2o02zaCCwt5olW7uP9Yz3AbB87OcRp1yOnHXPoVlolnpviPxTrVvqUcl1rcVubhWxszFG0arGAcg465LckdKf9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFDeq/r9SKNHR8yv8vOP93sWdLsdP0LSDpejvp9tp9vaiKKGFeMfOcDLkliSSScklsnnrzfxf8P6L4m8LatNra6feTafYy3FpINyOkgRzhWVweuCVOQcLkHArs7q53fa/9Ns23QBflX733uB83Xn36jisfx3c7vCHij/TbNt2lTL8q/e/dycD5uvPv1HFOT91/wBfqaU4JtJrt0/w/wB3+vy4i/8Agp4FFveJpi/2bcGAqtzZXswkwwYOi75GU7lyjAg5VyMDrWhpnwo8B6Jqf9oabpunrd2qeZA7TTSgPhhlVeVhuHBBIODgjBGa7+6ud32v/TbNt0AX5V+997gfN159+o4ournd9r/02zbdAF+Vfvfe4HzdeffqOKpf1+HmRGmrp27dPT+6cV4p8N6B4t8T63D4hg0rUAulWYjdo8SL+9uWxHIH3KcgZweRgEY68t8S/AujeHfg94x0/wAHWtjCJ4oLqZUlLNIIpQ7fPJIT8qKx25PU4GTz6N9p3eL9e/02zbdpVovyr9795d8D5uvPv1HFXPEUEWsaRrOnXN/b+Re2L20jRABirq6kLliA2G9D1HHrEHp/X+YVKSasl0XTyj/dPCNM8N2PxD8Aa34/8bXSahrd3Z3E1pCzvFHYrEZlSKJVkGRld3zbs7hkE7mf0TTPhR4D0TU/7Q03TdPW7tU8yB2mmlAfDDKq8rDcOCCQcHBGCM1sa5aQaL8M9W0m01CCW2stBa0iZwC8ixwuoGQ2N2Bzgd+grp7q53fa/wDTbNt0AX5V+997gfN159+o4pp+9939bhCkoxjp+H+H+6F1c7vtf+m2bboAvyr9773A+brz79RxXm3i3wTYeI/iJqmpxeILzR76LSrdXm0acWz3YZ5gVkPJY4ijH0CjsK9Jurnd9r/02zbdAF+Vfvfe4HzdeffqOKx/tO7xfr3+m2bbtKtF+VfvfvLvgfN159+o4pN6r+unqVGCa1Xbp/h/unE3nw0vY47hLH4o+KtsiIJzPfCYyxBtxjjOQY3yo+cZ4YgghiDS8Q/DHSbLTdY1bVPEuq+JLqw0u5NmNZu/tKRO0bfNGOMONox1AJBxkKR63dXO77X/AKbZtugC/Kv3vvcD5uvPv1HFY/ju53eEPFH+m2bbtKmX5V+9+7k4HzdeffqOKJv3X/X6hSppTi7dv0/u/wBflzXjL4a+H/EOv3OvLqVxpuvFVkOoaZdNFLJiNo/LGWZQCoUHAyePU54L4taDafD3wNpU+kzXGsC18R2+r3s80pkluJMS5eR+QMnYucdWXOSSW96urnd9r/02zbdAF+Vfvfe4HzdeffqOK5z4l6EvjLwjrOhtrFpbC7ihPnJFv5jl8wALvGT8uOv8Q/G0/wCvu8zNwfL7q19PT+7/AF+XmPhnw3rXjK6vdd8R+O9Wsr3UdNtNQW20W7NvDHFKZ9lvg5ztVQfrI2dxyzddp3wx0my12PVtU8S6p4jurGFjZjWbv7SkTt/Eg4w42jHUAkHGQpHTWhhtfEusW1pcafFbx6PZQxRQxhUCq90AiANgYHGB7cVu3Vzu+1/6bZtugC/Kv3vvcD5uvPv1HFTB3X9d/UtUlG2nb/23+7/X5Y3j6cSeDvFKteWbq+kzqQF+/wDu5PlHzdeffqOK4hfhJp+nx3Nvo/jnxRp1gqs8VlZapshQMzt5aDk4BJ6kn5uck5PceO7nd4Q8Uf6bZtu0qZflX737uTgfN159+o4rYurnd9r/ANNs23QBflX733uB83Xn36jikn733f1uPkTitPw/w/3f6/KLMNrazW1pcafFbx2qwxRQxhUCqGARAGwMDjA9uKKlurnd9r/02zbdAF+Vfvfe4HzdeffqOKK6KR3YFWT+X5eiM+8tfE/+nbtX0U/6MN2NKlGR8/A/0njvReWvif8A07dq+in/AEYbsaVKMj5+B/pPHeiio5EeVGtLTbp0X93yMp7bxH/wlOvD+1dI80aVal2/syTay77rAA+0cEfNk5OcjgY51by18T/6du1fRT/ow3Y0qUZHz8D/AEnjvRRUQirf13K9rK626dF/d8jK8cW3iNfC3ic3Gq6RJENKlMix6ZIjMuyTIBNwcHryQfp66t5a+J/9O3avop/0YbsaVKMj5+B/pPHeiihRXN9wRqy5Y7fcv7vkF5a+J/8ATt2r6Kf9GG7GlSjI+fgf6Tx3rKe28R/8JTrw/tXSPNGlWpdv7Mk2su+6wAPtHBHzZOTnI4GOSihxV1/XQKdWVunTov7vkat5a+J/9O3avop/0YbsaVKMj5+B/pPHesrxxbeI18LeJzcarpEkQ0qUyLHpkiMy7JMgE3BwevJB+nqUUTiuVhSqy5o7dOi/u+Rq3lr4n/07dq+in/RhuxpUoyPn4H+k8d6Ly18T/wCnbtX0U/6MN2NKlGR8/A/0njvRRV8iJjWlpt06L+75GU9t4j/4SnXh/aukeaNKtS7f2ZJtZd91gAfaOCPmycnORwMc6t5a+J/9O3avop/0YbsaVKMj5+B/pPHeiiohFW/ruV7WV1t06L+75GV44tvEa+FvE5uNV0iSIaVKZFj0yRGZdkmQCbg4PXkg/T11by18T/6du1fRT/ow3Y0qUZHz8D/SeO9FFCiub7gjVlyx2+5f3fILy18T/wCnbtX0U/6MN2NKlGR8/A/0njvWU9t4j/4SnXh/aukeaNKtS7f2ZJtZd91gAfaOCPmycnORwMclFDirr+ugU6srdOnRf3fI1by18T/6du1fRT/ow3Y0qUZHz8D/AEnjvWV44tvEa+FvE5uNV0iSIaVKZFj0yRGZdkmQCbg4PXkg/T1KKJxXKwpVZc0dunRf3fI1by18T/6du1fRT/ow3Y0qUZHz8D/SeO9F5a+J/wDTt2r6Kf8ARhuxpUoyPn4H+k8d6KKvkRMa0tNunRf3fIyntvEf/CU68P7V0jzRpVqXb+zJNrLvusAD7RwR82Tk5yOBjnVvLXxP/p27V9FP+jDdjSpRkfPwP9J470UVEIq39dyvayutunRf3fIyvHFt4jXwt4nNxqukSRDSpTIsemSIzLskyATcHB68kH6eureWvif/AE7dq+in/RhuxpUoyPn4H+k8d6KKFFc33BGrLljt9y/u+QXlr4n/ANO3avop/wBGG7GlSjI+fgf6Tx3rKe28R/8ACU68P7V0jzRpVqXb+zJNrLvusAD7RwR82Tk5yOBjkoocVdf10CnVlbp06L+75GreWvif/Tt2r6Kf9GG7GlSjI+fgf6Tx3rK8cW3iNfC3ic3Gq6RJENKlMix6ZIjMuyTIBNwcHryQfp6lFE4rlYUqsuaO3Tov7vkat5a+J/8ATt2r6Kf9GG7GlSjI+fgf6Tx3ovLXxP8A6du1fRT/AKMN2NKlGR8/A/0njvRRV8iJjWlpt06L+75GU9t4j/4SnXh/aukeaNKtS7f2ZJtZd91gAfaOCPmycnORwMc6t5a+J/8ATt2r6Kf9GG7GlSjI+fgf6Tx3ooqIRVv67le1ldbdOi/u+RleOLbxGvhbxObjVdIkiGlSmRY9MkRmXZJkAm4OD15IP09dW8tfE/8Ap27V9FP+jDdjSpRkfPwP9J470UUKK5vuCNWXLHb7l/d8gvLXxP8A6du1fRT/AKMN2NKlGR8/A/0njvWU9t4j/wCEp14f2rpHmjSrUu39mSbWXfdYAH2jgj5snJzkcDHJRQ4q6/roFOrK3Tp0X93yNW8tfE/+nbtX0U/6MN2NKlGR8/A/0njvWV44tvEa+FvE5uNV0iSIaVKZFj0yRGZdkmQCbg4PXkg/T1KKJxXKwpVZc0dunRf3fI1by18T/wCnbtX0U/6MN2NKlGR8/A/0njvReWvif/Tt2r6Kf9GG7GlSjI+fgf6Tx3ooq+RExrS026dF/d8jKe28R/8ACU68P7V0jzRpVqXb+zJNrLvusAD7RwR82Tk5yOBjnVvLXxP/AKdu1fRT/ow3Y0qUZHz8D/SeO9FFRCKt/Xcr2srrbp0X93yMrxxbeI18LeJzcarpEkQ0qUyLHpkiMy7JMgE3BwevJB+nrq3lr4n/ANO3avop/wBGG7GlSjI+fgf6Tx3oooUVzfcEasuWO33L+75BeWvif/Tt2r6Kf9GG7GlSjI+fgf6Tx3rKe28R/wDCU68P7V0jzRpVqXb+zJNrLvusAD7RwR82Tk5yOBjkoocVdf10CnVlbp06L+75GreWvif/AE7dq+in/RhuxpUoyPn4H+k8d6yvHFt4jXwt4nNxqukSRDSpTIsemSIzLskyATcHB68kH6epRROK5WFKrLmjt06L+75GreWvif8A07dq+in/AEYbsaVKMj5+B/pPHei8tfE/+nbtX0U/6MN2NKlGR8/A/wBJ470UVfIiY1pabdOi/u+RlPbeI/8AhKdeH9q6R5o0q1Lt/Zkm1l33WAB9o4I+bJyc5HAxzq3lr4n/ANO3avop/wBGG7GlSjI+fgf6Tx3ooqIRVv67le1ldbdOi/u+RleOLbxGvhbxObjVdIkiGlSmRY9MkRmXZJkAm4OD15IP09dW8tfE/wDp27V9FP8Aow3Y0qUZHz8D/SeO9FFCiub7gjVlyx2+5f3fILy18T/6du1fRT/ow3Y0qUZHz8D/AEnjvRRRW0IL+mz0MtqNxlt06Lsf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal P wave in sinus rhythm is slightly notched since activation of the right atrium precedes that of the left atrium. The P wave is upright in a positive direction in leads I and II. A P wave with a uniform morphology precedes each QRS complex. The rate is between 60 and 100 beats per minute and the cycle length is uniform between sequential P waves and QRS complexes. In addition, the P wave morphology and PR intervals are identical from beat to beat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25704=[""].join("\n");
var outline_f25_6_25704=null;
var title_f25_6_25705="Erythromycin (systemic): Drug information";
var content_f25_6_25705=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Erythromycin (systemic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?22/23/22901?source=see_link\">",
"    see \"Erythromycin (systemic): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/32/22025?source=see_link\">",
"    see \"Erythromycin (systemic): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8086256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      E.E.S.&reg;;",
"     </li>",
"     <li>",
"      Ery-Tab&reg;;",
"     </li>",
"     <li>",
"      EryPed&reg;;",
"     </li>",
"     <li>",
"      Erythro-RX;",
"     </li>",
"     <li>",
"      Erythrocin&reg;;",
"     </li>",
"     <li>",
"      Erythrocin&reg; Lactobionate-I.V.;",
"     </li>",
"     <li>",
"      PCE&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8086257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Erythro Base&reg;;",
"     </li>",
"     <li>",
"      Apo-Erythro E-C&reg;;",
"     </li>",
"     <li>",
"      Apo-Erythro-ES&reg;;",
"     </li>",
"     <li>",
"      Apo-Erythro-S&reg;;",
"     </li>",
"     <li>",
"      EES&reg;;",
"     </li>",
"     <li>",
"      Erybid&trade;;",
"     </li>",
"     <li>",
"      Eryc&reg;;",
"     </li>",
"     <li>",
"      Novo-Rythro Estolate;",
"     </li>",
"     <li>",
"      Novo-Rythro Ethylsuccinate;",
"     </li>",
"     <li>",
"      Nu-Erythromycin-S;",
"     </li>",
"     <li>",
"      PCE&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F8089967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Macrolide",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F8086406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Due to differences in absorption, 400 mg erythromycin ethylsuccinate produces the same serum levels as 250 mg erythromycin base or stearate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Base: 250-500 mg every 6-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Ethylsuccinate: 400-800 mg every 6-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Lactobionate: 15-20 mg/kg/day divided every 6 hours or 500 mg to 1 g every 6 hours, or given as a continuous infusion over 24 hours (maximum: 4 g/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      <i>",
"       Bartonella sp",
"      </i>",
"     </b>",
"     <b>",
"      infections (bacillary angiomatosis [BA], peliosis hepatis [PH]) (unlabeled use):",
"     </b>",
"     Oral: 500 mg (base) 4 times/day for 3 months (BA) or 4 months (PH)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Chancroid (unlabeled use):",
"     </b>",
"     Oral: 500 mg (base) 3 times/day for 7 days;",
"     <b>",
"      Note:",
"     </b>",
"     Not a preferred agent; isolates with intermediate resistance have been documented (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Gastrointestinal prokinetic (unlabeled use):",
"     </b>",
"     I.V.: 200 mg initially followed by 250 mg (base) orally 3 times/day 30 minutes before meals. Lower dosages have been used in some trials.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Granuloma inguinale (donovanosis) (unlabeled use):",
"     </b>",
"     Oral: 500 mg (base) 4 times/day for 21 days (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Legionnaires&rsquo; disease:",
"     </b>",
"     Oral: 1.6-4 g (ethylsuccinate)/day or 1-4 g (base)/day in divided doses for 21 days.",
"     <b>",
"      Note:",
"     </b>",
"     No longer preferred therapy and only used in nonhospitalized patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Lymphogranuloma venereum:",
"     </b>",
"     Oral: 500 mg (base) 4 times/day for 21 days;",
"     <b>",
"      Note:",
"     </b>",
"     Preferred therapy for pregnant or lactating women (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Nongonococcal urethritis (including coinfection with",
"     </b>",
"     <b>",
"      <i>",
"       C. trachomatis):",
"      </i>",
"     </b>",
"     Oral: 500 mg (base) 4 times/day for 7 days or  800 mg (ethylsuccinate) 4 times/day for 7 days.",
"     <b>",
"      Note:",
"     </b>",
"     May use 250 mg (base) or 400 mg (ethylsuccinate) 4 times/day for 14 days if gastrointestinal intolerance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Pertussis:",
"     </b>",
"     Oral: 500 mg (base) every 6 hours for 14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Preop bowel preparation:",
"     </b>",
"     Oral: 1 g erythromycin base at 1, 2, and 11 PM on the day before surgery combined with mechanical cleansing of the large intestine and oral neomycin",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F8086405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/32/22025?source=see_link\">",
"      see \"Erythromycin (systemic): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Due to differences in absorption, 400 mg erythromycin ethylsuccinate produces the same serum levels as 250 mg erythromycin base or stearate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Usual dosage range:",
"     </b>",
"     Infants and Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Base: 30-50 mg/kg/day in 2-4 divided doses; maximum: 2 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Ethylsuccinate: 30-50 mg/kg/day in 2-4 divided doses; maximum: 3.2 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Stearate: 30-50 mg/kg/day in 2-4 divided doses; maximum: 2 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Lactobionate: 15-50 mg/kg/day divided every 6 hours, not to exceed 4 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"     Infants and Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      <i>",
"       Bartonella sp",
"      </i>",
"     </b>",
"     <b>",
"      infections (bacillary angiomatosis [BA], peliosis hepatis [PH]) (unlabeled use):",
"     </b>",
"     Oral: 40 mg/kg/day (ethylsuccinate) in 4 divided doses (maximum: 2 g/day) for 3 months (BA) or 4 months (PH)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Chlamydial infection",
"     </b>",
"     <b>",
"      <i>",
"       (C. trachomatis):",
"      </i>",
"     </b>",
"     Children &lt;45 kg: Oral: 50 mg/kg/day (base or ethylsuccinate) in 4 divided doses for 14 days (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Community-acquired pneumonia (CAP) (IDSA/PIDS, 2011):",
"     </b>",
"     Infants &gt;3 months and Children:",
"     <b>",
"      Note:",
"     </b>",
"     A beta-lactam antibiotic should be added if typical bacterial pneumonia cannot be ruled out.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Presumed atypical",
"     <i>",
"      (M. pneumoniae, C. pneumoniae, C. trachomatis)",
"     </i>",
"     infection, mild atypical infection or step-down therapy (alternative to azithromycin): Oral: 10 mg/kg/dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Moderate-to-severe atypical infection (alternative to azithromycin): I.V.: 5 mg/kg/dose every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Mild/moderate infection:",
"     </b>",
"     Oral: 30-50 mg/kg/day in divided doses every 6-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Pertussis:",
"     </b>",
"     Oral: 40-50 mg/kg/day in 4 divided doses for 14 days; maximum 2 g/day (not preferred agent for infants &lt;1 month due to IHPS)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Pharyngitis, tonsillitis (streptococcal):",
"     </b>",
"     Oral: 20 mg (base)/kg/day or 40 mg (ethylsuccinate)/kg/day in 2 divided doses for 10 days.",
"     <b>",
"      Note:",
"     </b>",
"     No longer preferred therapy due to increased organism resistance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Preop bowel preparation:",
"     </b>",
"     Oral: 20 mg (base)/kg  at 1, 2, and 11 PM on the day before surgery combined with mechanical cleansing of the large intestine and oral neomycin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Severe infection:",
"     </b>",
"     I.V.: 15-50 mg/kg/day; maximum: 4 g/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F8086407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F8086408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Slightly dialyzable (5% to 20%); supplemental dose is not necessary in hemo- or peritoneal dialysis or in continuous arteriovenous or venovenous hemofiltration.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15837929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8086458\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, delayed release, enteric coated pellets, oral, as base: 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Granules for suspension, oral, as ethylsuccinate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     E.E.S.&reg;: Erythromycin activity 200 mg/5 mL (100 mL, 200 mL) [contains sodium 25.9 mg (1.1 mEq)/5 mL; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as lactobionate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Erythrocin&reg; Lactobionate-I.V.: Erythromycin activity 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder, for prescription compounding:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Erythro-RX: USP: 100% (50 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral, as ethylsuccinate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     EryPed&reg;: Erythromycin activity 200 mg/5 mL (100 mL) [contains sodium 117.5 mg (5.1 mEq)/5 mL; fruit flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     EryPed&reg;: Erythromycin activity 400 mg/5 mL (100 mL) [contains sodium 117.5 mg (5.1 mEq)/5 mL; banana flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as base: 250 mg, 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as ethylsuccinate: Erythromycin activity 400 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     E.E.S.&reg;: Erythromycin activity 400 mg [contains potassium 10 mg (0.3 mEq)/tablet, sodium 47 mg (2 mEq)/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as stearate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Erythrocin&reg;: Erythromycin activity 250 mg [contains potassium 5 mg (0.1 mEq)/tablet, sodium 56.7 mg (2.5 mEq)/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Erythrocin&reg;: Erythromycin activity 500 mg [sodium free; contains potassium 7 mg (0.2 mEq)/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, delayed release, enteric coated, oral, as base:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ery-Tab&reg;: 250 mg [contains sodium 8.3 mg (0.4 mEq)/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ery-Tab&reg;: 333 mg [contains sodium 11.2 mg (0.5 mEq)/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ery-Tab&reg;: 500 mg [contains sodium 16.7 mg (0.7 mEq)/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, polymer coated particles, oral, as base:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PCE&reg;: 333 mg [contains sodium 0.5 mg (0.02mEq)/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PCE&reg;: 500 mg [dye free, sodium free]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8086259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Capsule,  tablet (as base, ethylsuccinate, and stearate)",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F8086411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Do not crush enteric coated drug product. GI upset, including diarrhea, is common. May be administered with food to decrease GI upset. Do not give with milk or acidic beverages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Infuse 1 g over 20-60 minutes. I.V. infusion may be very irritating to the vein. If phlebitis/pain occurs with used dilution, consider diluting further (eg, 1:5) if fluid status of the patient will tolerate, or consider administering in larger available vein. The addition of lidocaine or bicarbonate does not decrease the irritation of erythromycin infusions.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F8086368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Erythromycin lactobionate:",
"     </b>",
"     Stable in NS;",
"     <b>",
"      incompatible",
"     </b>",
"     with D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      10",
"     </sub>",
"     W;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, amiodarone, anidulafungin, bivalirudin, cyclophosphamide, cyclosporine, dexmedetomidine, diltiazem, doxapram, enalaprilat, esmolol, famotidine, fenoldopam, foscarnet, hetastarch in lactate electrolyte injection (Hextend&reg;), hydromorphone, idarubicin, labetalol, linezolid, lorazepam, magnesium sulfate, meperidine, midazolam, morphine, multivitamins, nicardipine, oxytocin, tacrolimus, theophylline, vitamin B complex with C, zidovudine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Cefepime, fluconazole.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftazidime, heparin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Ampicillin, cloxacillin, heparin.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F8086260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Treatment of susceptible bacterial infections including",
"     <i>",
"      S. pyogenes",
"     </i>",
"     , some",
"     <i>",
"      S. pneumoniae,",
"     </i>",
"     some",
"     <i>",
"      S. aureus",
"     </i>",
"     ,",
"     <i>",
"      M. pneumoniae",
"     </i>",
"     ,",
"     <i>",
"      Legionella pneumophila",
"     </i>",
"     , diphtheria, pertussis,",
"     <i>",
"      Chlamydia",
"     </i>",
"     , erythrasma,",
"     <i>",
"      N. gonorrhoeae",
"     </i>",
"     ,",
"     <i>",
"      E. histolytica",
"     </i>",
"     , syphilis and nongonococcal urethritis, and",
"     <i>",
"      Campylobacter",
"     </i>",
"     gastroenteritis; used in conjunction with neomycin for decontaminating the bowel",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F8086262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of gastroparesis, chancroid; preoperative gut sterilization",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F8085309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Erythromycin may be confused with azithromycin, clarithromycin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Eryc&reg; may be confused with Emcyt&reg;, Ery-Tab&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F8086285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Frequency not defined. Incidence may vary with formulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation, torsade de pointes, ventricular arrhythmia, ventricular tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Erythema multiforme, pruritus, rash, Stevens-Johnson syndrome, toxic epidermal necrolysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, diarrhea, infantile hypertrophic pyloric stenosis, nausea, oral candidiasis, pancreatitis, pseudomembranous colitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic jaundice (most common with estolate), hepatitis, liver function tests abnormal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Phlebitis at the injection site, thrombophlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Hearing loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylaxis, hypersensitivity reactions, interstitial nephritis, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F8086273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to erythromycin, any macrolide antibiotics, or any component of the formulation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Concomitant use with pimozide, cisapride, ergotamine or dihydroergotamine, terfenadine, astemizole, lovastatin, or simvastatin",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F8086274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered cardiac conduction: Macrolides have been associated with rare QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation and ventricular arrhythmias, including torsade de pointes; use with caution in patients at risk of prolonged cardiac repolarization; avoid use in patients with prolonged QT interval, uncorrected hypokalemia or hypomagnesemia, clinically significant bradycardia, or concurrent use of Class IA (eg, quinidine, procainamide) or Class III (eg, amiodarone, dofetilide, sotalol) antiarrhythmic agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with pre-existing liver disease; hepatic impairment, including hepatocellular and/or cholestatic hepatitis, with or without jaundice, has been observed. Discontinue if symptoms of malaise, nausea, vomiting, abdominal colic, and fever.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Erythromycin has been associated with aggravation of weakness associated with myasthenia gravis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Major inhibitor of CYP3A4: Use caution with any agents with substantial metabolism through the CYP3A4 pathway; high potential for drug interactions exists. Avoid concurrent use with strong CYP3A4 inhibitors; may increase the risk of sudden cardiac death (Ray, 2004).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;	Infants: Use of erythromycin has been associated with infantile hypertrophic pyloric stenosis (IHPS); observe for non-bilious vomiting or irritability with feeding.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: May be at increased risk of adverse events, including hearing loss and/or torsade de pointes when dosage &ge;4 g/day, particularly if concurrent renal/hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F8086288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2B6 (minor), CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP3A4 (moderate), P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8086289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfentanil: Macrolide Antibiotics may decrease the metabolism of Alfentanil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): Macrolide Antibiotics may decrease the metabolism of Antifungal Agents (Azole Derivatives, Systemic). Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Macrolide Antibiotics.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antineoplastic Agents (Vinca Alkaloids): Macrolide Antibiotics may increase the serum concentration of Antineoplastic Agents (Vinca Alkaloids). Macrolides may also increase the distribution of Vinca Alkaloids into certain cells and/or tissues.  Management: Consider an alternative to using a macrolide antibiotic when possible in order to avoid the potential for increased vinca alkaloid toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Avanafil: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Avanafil.  Management: The maximum avanafil adult dose is 50 mg per 24-hour period when used together with a moderate CYP3A4 inhibitor.  Patients receiving such a combination should also be monitored more closely for evidence of adverse effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Macrolide Antibiotics may decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Budesonide (Systemic, Oral Inhalation): CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Budesonide (Systemic, Oral Inhalation).  Management: Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor.  This interaction is likely less severe with orally inhaled budesonide.  Monitor patients closely for signs/symptoms of corticosteroid excess.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BusPIRone: Macrolide Antibiotics may decrease the metabolism of BusPIRone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Macrolide Antibiotics may decrease the metabolism of Calcium Channel Blockers.  Management: Consider using a noninteracting macrolide. Monitor for increased therapeutic effects of calcium channel blockers if an interacting macrolide antibiotic is initiated, or decreased effects if a macrolide is discontinued.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Macrolide Antibiotics may decrease the metabolism of CarBAMazepine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Macrolide Antibiotics may increase the serum concentration of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cilostazol: Macrolide Antibiotics may decrease the metabolism of Cilostazol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cisapride: Macrolide Antibiotics may decrease the metabolism of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: Macrolide Antibiotics may diminish the therapeutic effect of Clopidogrel.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Macrolide Antibiotics may decrease the metabolism of CloZAPine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Colchicine.  Management: Reduce colchicine dose as directed when using with a moderate CYP3A4 inhibitor, and increase monitoring for colchicine-related toxicity.  Use extra caution in patients with impaired renal and/or hepatic function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Macrolide Antibiotics may decrease the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Macrolide Antibiotics may decrease the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Dabigatran dose reductions may be needed.  Specific recommendations vary considerably according to US vs Canadian labeling, specific P-gp inhibitor, renal function, and indication for dabigatran treatment.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Macrolide Antibiotics may enhance the QTc-prolonging effect of Disopyramide. Macrolide Antibiotics may decrease the metabolism of Disopyramide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eletriptan: Macrolide Antibiotics may decrease the metabolism of Eletriptan.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: Macrolide Antibiotics may decrease the metabolism of Eplerenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: Macrolide Antibiotics may enhance the adverse/toxic effect of Ergot Derivatives. Specifically leading to the development of ergotism.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cabergoline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etravirine: May decrease the serum concentration of Macrolide Antibiotics. Clarithromycin AUC is reduced and levels of the active metabolite (14-hydroxy-clarithromycin) are modestly increased. Management: For the treatment of",
"     <i>",
"      Mycobacterium avium",
"     </i>",
"     complex, consider changing to alternative agent, such as azithromycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of FentaNYL.  Management: Monitor patients extra closely for several days following initiation of the combination, and fentanyl dosage reductions should be made as appropriate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fexofenadine: Erythromycin (Systemic) may increase the serum concentration of Fexofenadine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: Moderate Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Macrolide Antibiotics may decrease the metabolism of HMG-CoA Reductase Inhibitors.  Management: Avoid lovastatin or simvastatin with erythro-, clarithro-, or telithromycin. Limit pitavastatin to a 1 mg/day maximum adult dose with erythromycin.  Atorvastatin dose adjustments may be required. Increase monitoring for toxicity with any such combination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Fluvastatin; Pravastatin; Rosuvastatin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ifosfamide: CYP3A4 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Ifosfamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ivacaftor.  Management: Decrease ivacaftor dose to 150 mg daily in patients also receiving moderate CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lincosamide Antibiotics: May diminish the therapeutic effect of Erythromycin (Systemic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lomitapide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lovastatin: Erythromycin (Systemic) may increase the serum concentration of Lovastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lurasidone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lurasidone.  Management: U.S. labeling: start at 20 mg/day and limit to max of 80 mg/day with moderate CYP3A4 inhibitor.  Canadian labeling: limit to max of 40 mg/day with moderate CYP3A4 inhibitor; avoid concomitant use of grapefruit products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Moderate Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of Pimecrolimus.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: Macrolide Antibiotics may enhance the QTc-prolonging effect of Pimozide. Macrolide Antibiotics may decrease the metabolism of Pimozide. This mechanism may not apply to azithromycin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Macrolide Antibiotics may decrease the metabolism of QuiNIDine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: Macrolide Antibiotics may increase the serum concentration of QuiNINE.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Repaglinide: Macrolide Antibiotics may increase the serum concentration of Repaglinide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: Macrolide Antibiotics may decrease the metabolism of Rifamycin Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Rifapentine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Erythromycin (Systemic) may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salmeterol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Salmeterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Macrolide Antibiotics may decrease the metabolism of Selective Serotonin Reuptake Inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     FluvoxaMINE; PARoxetine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sildenafil: Erythromycin (Systemic) may increase the serum concentration of Sildenafil.  Management: When used for treatment of pulmonary artery hypertension, concurrent use with erythromycin is not recommended.  When used for treatment of erectile dysfunction, consider using a lower starting dose of 25 mg in patients who are also taking erythromycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Silodosin: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Silodosin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Simvastatin: Erythromycin (Systemic) may increase the serum concentration of Simvastatin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sirolimus: Macrolide Antibiotics may decrease the metabolism of Sirolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Macrolide Antibiotics may increase the serum concentration of Tacrolimus (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): Macrolide Antibiotics may increase the serum concentration of Tacrolimus (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Erythromycin (Systemic) may increase the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Erythromycin (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Temsirolimus: Macrolide Antibiotics may enhance the adverse/toxic effect of Temsirolimus. Levels of sirolimus, the active metabolite, may be increased, likely due to inhibition of CYP-mediated metabolism.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Terfenadine: Macrolide Antibiotics may enhance the QTc-prolonging effect of Terfenadine. Macrolide Antibiotics may increase the serum concentration of Terfenadine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Macrolide Antibiotics may decrease the metabolism of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Tolvaptan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vardenafil: Erythromycin (Systemic) may increase the serum concentration of Vardenafil.  Management: Limit dose of vardenafil film-coated tablets (Levitra)  to 5 mg per 24 hours with concomitant use of erythromycin. Concomitant use of vardenafil orally disintegrating tablets (Staxyn) with erythromycin is not recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Macrolide Antibiotics may increase the serum concentration of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zafirlukast: Erythromycin (Systemic) may decrease the serum concentration of Zafirlukast.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zopiclone: Macrolide Antibiotics may increase the serum concentration of Zopiclone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F8086293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Ethanol may decrease absorption of erythromycin or enhance effects of ethanol. Management: Avoid ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Erythromycin serum levels may be altered if taken with food (formulation-dependent). GI upset, including diarrhea, is common. Management: May be taken with food to decrease GI upset, otherwise take around-the-clock with a full glass of water. Do not give with milk or acidic beverages (eg, soda, juice).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease erythromycin levels. Management: Avoid St John's wort.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8086263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8086264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Erythromycin crosses the placenta and low concentrations are found in the fetal serum. Most reports do not identify an increase in risk for congenital abnormalities due to prenatal exposure to erythromycin. Cardiovascular anomalies following exposure in early pregnancy have been reported in some observational studies. Most studies also do not support a link between prenatal exposure to erythromycin and pyloric stenosis in the neonate. In general, serum concentrations of erythromycin are lower in pregnant women. Erythromycin therapy in patients with preterm, premature rupture of membranes is associated with a range of health benefits to the neonate and no long-term adverse events to the child have been observed. However, maternal use of erythromycin in women with preterm labor, intact membranes, and no documented infection does not improve neonatal health and may have adverse effects in childhood (use is not recommended). In patients with acute infections during pregnancy, erythromycin may be given if an antibiotic is required and appropriate based on bacterial sensitivity.  Erythromycin is the antibiotic of choice for preterm premature rupture of membranes (with membrane rupture prior to 34 weeks gestation), the treatment of granuloma inguinale and lymphogranuloma venereum in pregnancy, and the treatment of or long-term suppression of",
"     <i>",
"      Bartonella",
"     </i>",
"     infection in HIV-infected pregnant patients. Erythromycin may be appropriate as an alternative agent for the treatment of chlamydial infections in pregnant women (consult current guidelines).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F8086266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP considers &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F8086272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Erythromycin is excreted in breast milk; therefore, the manufacturer recommends that caution be exercised when administering erythromycin to breast-feeding women.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Due to the low concentrations in human milk, minimal toxicity would be expected in the nursing infant. One case report and a cohort study raise the possibility for a connection with pyloric stenosis in neonates exposed to erythromycin via breast milk and an alternative antibiotic may be preferred for breast-feeding mothers of infants in this age group. Nondose-related effects could include modification of bowel flora.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F8086410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Drug may cause GI upset; may take with food. Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F8086461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsule, enteric pellets",
"     </b>",
"     (Erythromycin Base Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $379.15",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Erythrocin Lactobionate Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (1): $27.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 mg (1): $45.06",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (E.E.S. Granules Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/5 mL (100 mL): $135.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (EryPed 200 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/5 mL (100 mL): $142.08",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (EryPed 400 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg/5 mL (100 mL): $155.81",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, EC",
"     </b>",
"     (Ery-Tab Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $250.01",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     333 mg (100): $257.57",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $268.99",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, EC",
"     </b>",
"     (PCE Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     333 mg (60): $348.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $605.22",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (E.E.S. 400 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg (100): $326.22",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Erythrocin Stearate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $284.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Erythromycin Base Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $339.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $399.28",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Erythromycin Ethylsuccinate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg (100): $326.22",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10962015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Abboticin (DK);",
"     </li>",
"     <li>",
"      Abomacetin (JP);",
"     </li>",
"     <li>",
"      Ai Jia Xing (CL);",
"     </li>",
"     <li>",
"      Ao Shu Xin (CL);",
"     </li>",
"     <li>",
"      Baknyl (EC);",
"     </li>",
"     <li>",
"      Dothrocyn (ID);",
"     </li>",
"     <li>",
"      E-Mycin (AU, HK, IL, PK);",
"     </li>",
"     <li>",
"      Emu-V E (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      ERA (NZ);",
"     </li>",
"     <li>",
"      Erase (IN);",
"     </li>",
"     <li>",
"      Eribiotic (BR);",
"     </li>",
"     <li>",
"      Eriecu (EC);",
"     </li>",
"     <li>",
"      Erigran (PY);",
"     </li>",
"     <li>",
"      Erios (CH);",
"     </li>",
"     <li>",
"      Eritrocina (PT);",
"     </li>",
"     <li>",
"      Eritrolag (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Eritromicina (CN);",
"     </li>",
"     <li>",
"      Ermycin (SG);",
"     </li>",
"     <li>",
"      Eromel (ZA);",
"     </li>",
"     <li>",
"      Erotab (SG);",
"     </li>",
"     <li>",
"      Ery (DE);",
"     </li>",
"     <li>",
"      Ery-Tab (BB, BM, BS, BZ, GY, JM, PR, SR, TT);",
"     </li>",
"     <li>",
"      Eryc (AU, KP);",
"     </li>",
"     <li>",
"      Erycin (MY, TH, TW);",
"     </li>",
"     <li>",
"      Erymycin AF (ZA);",
"     </li>",
"     <li>",
"      Erytab (IL);",
"     </li>",
"     <li>",
"      Erytab-S (MY);",
"     </li>",
"     <li>",
"      Eryth-Mycin (TH);",
"     </li>",
"     <li>",
"      Erythro (KP);",
"     </li>",
"     <li>",
"      Erythrocin (AE, AT, BH, CY, EG, GB, GR, IE, IQ, IR, JO, KP, KW, LB, LY, OM, PH, QA, SA, SY, TW, YE);",
"     </li>",
"     <li>",
"      Erythrocin IV (AU);",
"     </li>",
"     <li>",
"      Erythrocine (NL);",
"     </li>",
"     <li>",
"      Erythromil (AT, BE, BF, BG, BJ, CH, CI, CZ, DE, DK, EE, ET, FI, FR, GB, GH, GM, GN, GR, HN, IE, IT, KE, LR, MA, ML, MR, MT, MU, MW, NE, NG, NL, NO, PL, PT, RU, SC, SD, SE, SK, SL, SN, TN, TR, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Erythromycin (DE);",
"     </li>",
"     <li>",
"      Erythromycinum (NL);",
"     </li>",
"     <li>",
"      Erythropen (GR);",
"     </li>",
"     <li>",
"      Etocin (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Etrotab (MY);",
"     </li>",
"     <li>",
"      Farmicina (UY);",
"     </li>",
"     <li>",
"      Hexabiotin (DK);",
"     </li>",
"     <li>",
"      Ilosone (VE);",
"     </li>",
"     <li>",
"      Panamicyn (CO);",
"     </li>",
"     <li>",
"      Pantomicina (AR, CN, PE, VE);",
"     </li>",
"     <li>",
"      Roug-mycin (GR);",
"     </li>",
"     <li>",
"      Rubimycin (ZA);",
"     </li>",
"     <li>",
"      Ryebact (PH);",
"     </li>",
"     <li>",
"      Rythocin (TH);",
"     </li>",
"     <li>",
"      Urycin (TW);",
"     </li>",
"     <li>",
"      Xin Hong Kang (CL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F8086369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits RNA-dependent protein synthesis at the chain elongation step; binds to the 50S ribosomal subunit resulting in blockage of transpeptidation",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F8086371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Variable but better with salt forms than with base form; 18% to 45%; ethylsuccinate may be better absorbed with food",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Relative diffusion from blood into CSF: Minimal even with inflammation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CSF:blood level ratio: Normal meninges: 2% to 13%; Inflamed meninges: 7% to 25%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Base: 73% to 81%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Demethylation primarily via hepatic CYP3A4",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Peak: 1.5-2 hours; End-stage renal disease: 5-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: Base: 4 hours; Ethylsuccinate: 0.5-2.5 hours; delayed with food due to differences in absorption",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Primarily feces; urine (2% to 15% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Abramowicz M, &ldquo;Antimicrobial Prophylaxis in Surgery,&rdquo;",
"      <i>",
"       Medical Letter on Drugs and Therapeutics, Handbook of Antimicrobial Therapy",
"      </i>",
"      , 16th ed, New York, NY: Medical Letter, 2002.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boyd I, &ldquo;Erythromycin-Induced Hearing Loss,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1991, 337(8733):113.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al.  &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America&rdquo;,",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):e25-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bratzler DW, Dellinger EP, Olsen KM, et al, &ldquo;Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2013, 70(3):195-283.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/23327981/pubmed\" id=\"23327981\" target=\"_blank\">",
"        23327981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Catnach SM and Fairclough PD, &ldquo;Erythromycin and the Gut,&rdquo;",
"      <i>",
"       Gut",
"      </i>",
"      , 1992, 33(3):397-401.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/1568663/pubmed\" id=\"1568663\" target=\"_blank\">",
"        1568663",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Council on Dental Therapeutics, American Heart Association, &ldquo;Preventing Bacterial Endocarditis,&rdquo;",
"      <i>",
"       J Am Dent Assoc",
"      </i>",
"      , 1991, 122(2):87-92.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dajani AS, Bisno AL, Chung KJ, et al, &ldquo;Prevention of Bacterial Endocarditis. Recommendations by the American Heart Association,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1990, 264(22):2919-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/2146414/pubmed\" id=\"2146414\" target=\"_blank\">",
"        2146414",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Di Lorenzo C, Lachman R, and Hyman PE, &ldquo;Intravenous Erythromycin for Postpyloric Intubation,&rdquo;",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 1990, 11(1):45-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/2136585/pubmed\" id=\"2136585\" target=\"_blank\">",
"        2136585",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Furlan V, Perello L, Jacquemin E, et al, &ldquo;Interactions Between FK506 and Rifampicin or Erythromycin in Pediatric Liver Recipients,&rdquo;",
"      <i>",
"       Transplantation",
"      </i>",
"      , 1995, 59(8):1217-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/7537398/pubmed\" id=\"7537398\" target=\"_blank\">",
"        7537398",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gholson CF and Warren GH, &ldquo;Fulminant Hepatic Failure Associated With Intravenous Erythromycin Lactobionate,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1990, 150(1):215-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/2297290/pubmed\" id=\"2297290\" target=\"_blank\">",
"        2297290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gumaste VV, &ldquo;Erythromycin-Induced Pancreatitis,&rdquo;",
"      <i>",
"       Am J Med",
"      </i>",
"      , 1989, 86(6 Pt 1):725.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/2729328/pubmed\" id=\"2729328\" target=\"_blank\">",
"        2729328",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hanrahan JP, Choo PW, Carlson W, et al, &ldquo;Terfenadine-Associated Ventricular Arrhythmias and QT",
"      <sub>",
"       c",
"      </sub>",
"      Interval Prolongation. A Retrospective Cohort Comparison With Other Antihistamines Among Members of a Health Maintenance Organization,&rdquo;",
"      <i>",
"       Ann Epidemiol",
"      </i>",
"      , 1995, 5(3):201-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/7606309/pubmed\" id=\"7606309\" target=\"_blank\">",
"        7606309",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Janssens J, Peeters TL, Vantrappen G, et al, &ldquo;Improvement of Gastric Emptying in Diabetic Gastroparesis by Erythromycin,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1990, 322(15):1028-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/2320062/pubmed\" id=\"2320062\" target=\"_blank\">",
"        2320062",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lau WC, Gurbel PA, Watkins PB, et al, &ldquo;Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 109(2):166-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/14707025/pubmed\" id=\"14707025\" target=\"_blank\">",
"        14707025",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      MacLaren R, Kiser TH, Fish DN, et al, \"Erythromycin vs Metoclopramide for Facilitating Gastric Emptying and Tolerance to Intragastric Nutrition in Critically Ill Patients,\" J",
"      <i>",
"       PEN J Parenter Enteral Nutr",
"      </i>",
"      , 2008, 32(4):412-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/18596312/pubmed\" id=\"18596312\" target=\"_blank\">",
"        18596312",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Maganti K, Onyemere K, and Jones MP, &ldquo;Oral Erythromycin and Symptomatic Relief of Gastroparesis: A Systematic Review,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2003, 98(2):259-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/12591038/pubmed\" id=\"12591038\" target=\"_blank\">",
"        12591038",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Martindale RG, McClave SA, Vanek VW, et al, &ldquo;Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.),&rdquo;",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2007, 33(3):277-316.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/19398613/pubmed\" id=\"19398613\" target=\"_blank\">",
"        19398613",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nguyen NQ, Chapman MJ, Fraser RJ, et al, \"Erythromycin Is More Effective Than Metoclopramide in the Treatment of Feed Intolerance in Critical Illness,\"",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2007, 35(2):483-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/17205032/pubmed\" id=\"17205032\" target=\"_blank\">",
"        17205032",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nguyen NQ, Chapman M, Fraser RJ, et al, \"Prokinetic Therapy for Feed Intolerance in Critical Illness: One Drug or Two?\"",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2007, 35(11):2561-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/17828038/pubmed\" id=\"17828038\" target=\"_blank\">",
"        17828038",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ray WA, Murray KT,Meredith S, et al, &ldquo;Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 351(11):1089-96.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/15356306/pubmed\" id=\"15356306\" target=\"_blank\">",
"        15356306",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reid B, DiLorenzo C, Travis L, et al, &ldquo;Diabetic Gastroparesis Due to Postprandial Antral Hypomotility in Childhood,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1992, 90(1 Pt 1):43-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/1614777/pubmed\" id=\"1614777\" target=\"_blank\">",
"        1614777",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rolain JM, Brouqui P, Koehler JE, et al, &ldquo;Recommendations for Treatment of Human Infections Caused by Bartonella Species,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 2004, 48(6):1921-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/15155180/pubmed\" id=\"15155180\" target=\"_blank\">",
"        15155180",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Waites KB, Sims PJ, Crouse DT, et al, &ldquo;Serum Concentrations of Erythromycin After Intravenous Infusion in Preterm Neonates Treated for",
"      <i>",
"       Ureaplasma urealyticum",
"      </i>",
"      Infection,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1994, 13(4):287-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/6/25705/abstract-text/8036045/pubmed\" id=\"8036045\" target=\"_blank\">",
"        8036045",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9118 Version 53.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.247-661AF214C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25705=[""].join("\n");
var outline_f25_6_25705=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086256\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086257\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8089967\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086406\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086405\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086407\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086408\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15837929\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086458\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086259\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086411\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086368\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086260\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086262\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8085309\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086285\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086273\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086274\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086288\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086289\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086293\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086263\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086264\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086266\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086272\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086410\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086461\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10962015\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086369\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8086371\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9118\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9118|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?25/51/26419?source=related_link\">",
"      Erythromycin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?3/61/4052?source=related_link\">",
"      Erythromycin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/41/42642?source=related_link\">",
"      Erythromycin (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/23/22901?source=related_link\">",
"      Erythromycin (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/32/22025?source=related_link\">",
"      Erythromycin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?30/28/31171?source=related_link\">",
"      Erythromycin (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?0/47/756?source=related_link\">",
"      Erythromycin (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/6/30818?source=related_link\">",
"      Erythromycin (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_6_25706="Hailey-Hailey 1";
var content_f25_6_25706=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61689%7EOBGYN%2F80862%7EDERM%2F74552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61689%7EOBGYN%2F80862%7EDERM%2F74552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hailey-Hailey disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical axillary plaque of Hailey-Hailey disease, showing superficial erosions and crusts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar Hailey-Hailey disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Perianal Hailey-Hailey disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 293px; height: 504px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAH4ASUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwC4p8ryjNPhQMLxkse4p8od1Z7ZRKpxhs9T3B/CkewkWXLEg5yijkketXbe6s7W0BAxME2hUGSSDyDUe06s6ZU7e6ijI80F0Fjfa6jIY/w+1VjfeXMIrdRICSoz/fzWheCQiU3KhFYZ2jlmHqaxLO2eaUGDas4fbFGRxGMZLNVq8tzJe5sWtRuCsMeHPm7yH4wFX1qppsUz27N5cjNKxc5b7qZ6D+da9xp4lsPLAEjPgORxgVFCHjnU3RIaMiH5emwcnFaRl0Ma1OUGplqNGnjZIpFjAUgDOB16iqF08dhOI/Nia6UmR9vK4HHHvVXWpp9KlnaQgrOAIsc/L1AHtjvSeG4BPO15dAxg5AJHyrjvRboCnzq7IfsN4t495JAJtSlXMcR6QL/eaq9qyxXxt7ZvteqNlriZ+kY/z2rS8W+JX0+L7HpAL3l50fHO2o9ItU0bSFSZ91zcOHllIy2T2P09KlfgWmWrXSUjjeJGM1zKpk3seBk/z9q6iKxFpp8QfajBWI3YyDxtFVdJsZtzXcsSxWaYGJOCCecn0PHT3qhPPJ4iv7q10uRo7CE7ZJZO57fU072fmTJdDOmeS9naC0JIUjzJTz+FOeaNbho4GRGjXDLjrit6109EdbS0JSygTNxOP4/XHvWNLOi3EfkRoZpF+UMOEHqx9azm+VG0EpOyM243ShpJJVlI4weorKa6kLuGHzAcY7D/ABqxqUhjaTyiZJMnewHGfQVDY2LO6vMdwDZUeprGN27nSrJaj4lMaQyZJ+bJHp2rP12/CxSE/wDLIFh65rT1CQbRsKjHzH6g9K5K/WS+lESoXkk5YD0zWqd9Dnb6mt8OdLe4me6nBZy3fnk16zbW4jB2Hb8vIx3rH8N6QdM0+ER8MFGR3ro4IXWEyPMPmPTHNaOT2M13K1wXSVfLP3o/n+tZEgd5htbhRkmtyd1kbIH7zGNveqqxLvLfKPYetRKVlc0pfEVZJngg4jLL3J/Sp7eFZ0xLIwB5wvr6VWvwwRViySFzntVq1c/ZkmIBlfJx9f8ACuOb1TR2SvY2NMVGSTbkgDGe49ana/iF3FEoYDgnjGeKz7TchknQgR+WAPZj/wDqqW4gmuJ2uGkLOqgEen0p2cgjy395myreYS6gMA27I7AVFIVjkd4RySWYds0zTN0TEN0K4qRMKX34PPPsawcraEWJPOCRjcCCeR6VLkzBSpIA7CoVieWZhJwqgH61JbgxS5BJGcEDtUXd7gyY2ouIkaTMbei9MVGju7NHGdpTgs1bD7WiUDtWBqEM++YxSbeo47it0o7smF3oaMSSKNrHcy9cH+VLICCCDz35p2nD/R0JU5A5qdlUkseM8kY6VE7PVCejKxDHnJ6ZBFRrcAuwJ2+mB396fKhXJjyQD2qvLGzZIkOQNxBHWoSu9S0i2bheC/Bx6UVRt5Zl3gSx8d8ZB+lFWqdxWOGvcajJHZxZimXhpACMetSW+irDNCY4nkUDLF22hvfNbGgXOnWjWksM+6+O4byMqR2FW9UvYIoTJMsk9wuW2J91frXpcnLqc7rub5TJOm2rlhdybwQSyxcBPTnvisaKKFpri5tjtAbbuxy4A702bULm5aSVlCAjj5sAAjg1TtnmSznSdzGJh2PytjufSpUm9Bq0JXZswtcXiMwKW0Knau0fe45JqjqVmspEVo7spUgFuuByTV3TdKnu7P7VPeCPadqRE9V7n+laU6P9ohitdlvJjDM/3Yx357/Sqirb7k1qnP7q2OV1bRdsCLdSAufnJzyoxxj3PpWNrmq2em6bBZ2XmuijlCf3kjHoAO3NWPFt7d28kq2od7hV3iaXoF/hIH8hUegeGLeysxrWttI11Kdyh/vP6YHYetUry0eiOflUVczfDmnOHfVNX3NcFcgHoijoB7V1Gm2KXUccdwSZZZBK0jHH2dFYZz6sf5Uk77EF3fIqK3+pgx1BGC59MdqbYWr3Zit45z9nZsSTDo/oB/jTcraRNqS+0zR1O5m8S6zco9w0qSMGeOLiPI6En8K0RHZWdr5Ee+K3jIkZx/EQenvnmoIzBY2gg0+MsQcMFPp3JrIjvWuZZFwJXUDB/gi9/c1HMktC3DVX2LOr6zJqKmGzg+xwgkYHOR61kTLFaRMCTKTglt2amuGjzKkQYBTyT1NU5vKECmRcSA52jsKwk29WdMYwtaOhVs4mkuGlmBEbHdGOmanvZ9ikDCBRyRwRntVuGZXsZJ5nSG3i6F+pI7YrAvpUvSZQCFHzIOm6qW1iJtNmXqEoe4Cu5G9eAP0zWl4C0t9S1mWVxiFAEU54PrWFqB8q3bcM3LnbjPOK9J8GaebLSYzuXnggDJJrWC0uctSVvdOriVECBnZFHylwMjFXJ7dllkjjdHVBkMvIb3FZzDcTH8wcDPPerOmsz237psSKSDzhl9OKHdMSTeqIJ1CFWdfn2gE0jBFiEkqYk6AdQas3KNjy0O6dR82R05rPODICWyCcEZ6VlUfu2R00o2ZXabbcLCijaSeTzmmxwuPs/XoX47gGrcqBzHvK8EYxwQKWQOL52iXcAcAD9a5m1sbSbsXkt8uG4X5st7irMzIr7GcJKW7d/rUFrcC6kMYBDIMYH06Ux0/0uRkALhQyg92xSi9SPU0luCknllcSNjiiNibhlXBEnzHJ71lrcmWaHnGV4J6e9Fxem3UOoKyB/LKj17Vm4u5SOjtWDbw24EZBNTQIcKV5Ld8Vkw3hkKyxjKPwwPY4rQtJ3QfNljgtkdjWdrA0yfzDHkk8UYUeXyCJDlvpULMjNuJ2sTkehqeE7C5YBTxwKpN2J2ZaUiFecbV6H27VEZDKzYUFT1zQq74lLcH17EU4uMIyEe/FK5asOt3wSDHiMdOabcxlJNyMDnsR1+tWB8kTMSMY3fhVIMrnzI3zn5R7+1W1cSV3dEJtUPMeVz1FFWGQscHaGXqKKzbfco8usBJY2yz+WG+UFRnqx6YqvqmtypF9igId3O+eRe3quf0rJ1bXLiRytuMW0fzSyY4yOm0euajt2uNUjEdjEqkgyMWOOvYn869eT5nZHEoOGrRc1G9gt9LJQEIQGfPQN6CpLa6n1ALPdRBYgFVI8YLe/uKq3un/ANoNbPHAwtIgEK9Nzjqa2La0jj1COFpGeZkAfH/LPn7tCjYHK50un3ECF4hArTKgDIxwAB3z/Si6DQwm8vMyTMd9pEBhQP75/pVF1+x3UaCEvIVMwRz8oUfxN+HSqd/qSzTLcQl0UfKY3O4kY4X69+OlJvuRbsWdVtPtYjv79VkSPaI4kHNxJ2/AVLcQxxAT6opudQmXENsh4T0H09TUNubqaJmm2I8CDNwT+6tI+v4tWKkN/wCJ9Rks7JZI7MHM103ytP7k/wAK003f+v6+ZNtLIks7Btc1GeS5mV4kcI0qnggdVT2HQ1r6zItkws9P8tLcqApXBz6kelPu7eDT9Ojt7KaNUiB82duFX2HrmsOS2s5UivLl5YYYCNoY/NMcenpRKS2NIp6MunTPMtYTHILe3RcZJ5c55JNV7ZZLcMxCqFBjRfVT/WnpeG9dN8J8kcJAOMehb0HtV+3tTd3BSUh5XO5mY4GR/Ss/Q6YS0vIy/IQwOCNsRIG89apBkE2MoQOOmd1R6lqD3M5RQqwIdqsOARml+zlLfdbsgdl+8euM81KTbNZPlVmVtSmgcmJ1DqflyorJ1IRMVht1ISEBmY/dUD1Na1xGs+UDhWTjco6VgSp/aCzWyN5VnnMjjnefTNWr7HLJoo6DCur61EJTxJJuG7gYB4+le02ds0L/ACMFA6AEbWOOcH1rgvAOlRvf3E1w/l2yLtjGOWx/9eu8gMe7ZcWzPEBkNG2DnHBrVJpHK5XehPgxvJEUw5AZS45FPDxM0zEhJ4cc5/1g9vpVaOTfO0jKW2gYYHqBxx9Kmt3UpJuh3c7gR1x6/gaiTNodyCZijCY7yjDBIP8AWqu1d7CXcrLz9c81tagqx2RbarhhlVHUc1ghy0jsQeu0qeorCSszp5rqxOroJPmHBAJzz1q3cFYW24ww9eoqqmzyyrjv+nSnHbHHIrEzSHB3dcf5FYKN0wuW7NwF3gHcSFLDq3pTrmRreWEOoba4cnHOBxwfx/SnpEqyQzBvk7L6rjt70ty63o3LkBGw5PZara1gZXS3+d1cDHzMB+tSYW5jjYLiXnPv60rRMr4kUgZ+X6VatIVefeQcKOPTNKWiHEFh2QlY9w2j5Wq7aSs4/eja/r/WmrFIuQpBPJOasbP3SMx4xmuZy7F30LC/vEBwpIPPrn2pkqbjjJGOQelFlJuYqcZUHmp/LULuJJOPvZzVJtozTsx9m+6MxyjjtTBmCcjsec06MAICfQHillQOOMZz1zUuWg7igFgwJ4IIp0ESiNFUBdv86RQVxhQVA6+lOhkEjMACD6GqjLSw030HNCj4c559KKYwlXgPx6elFO/kOyfU8G1qWzsH2PcecvACL0Ynril0+/tbeSWa6R/JlH7u2VsbW7Maw9NtLi+mkmn+aNMMJW6LV5bFdQmRy7xWecK2Ms5HoPSvRUWtNjGpLm1kdFE9/q0kKxMqogB4+7CPX61tG5tdGmEGnDz9Um4ZpPmKDuze/tWFbztAn2DTcNdT4LydkHq30qMapZWdydO03FxckFZrgHJd8fez6Cl13JcdNDQ1C7QXXlQyS79xM8shzxjkH8egqBfLcxSKxiiU4RQMu3/1zSx2DrY58p5DnJ2/xN6mrOmSI85htI1lvFH7yc/6u2A6gere9Gt9SdEXYLNroRpd5jt0P7qyTkM2f+Wnqe+K1da1CLRyNHtIzcXsi5uI4eo7hSe3Fcx/bZeaWz0Hlwdsl65yI/Uj1PvWzo8CWOnSvHJsgJzPeSHMkrHqQT1+tHNdeQcltWV7eyvLzUEe7iSaYDdFZR/6qEDu1Jb6dPquoSSRHJEmw3AX93COuFB+9Vi3M19aXDWrtaaSBtZzxLP9O4FW0hlFgszyNBBFhVUHbwO5FC7stvoQSPbWam1tlDpnO4jnI7/j+lY9wXEjFCxLBl4PXI5+ladu0NzLJKEZUYEp6v7+wqrdXUgZ2SILHkBnA/1bHpR8TuawkkrFA2qtbFmCs6tgIBwo9TVK8lWWUpBwFXGffFTX9xLFCyRcR5y5/vH1NY73jJEJWT77dB6e1K5MrvVjNTvbaEC3Qt5ki7eP4eO9VLqeOz0wJAAztxsQenepbmx8+IyABQ5y7d8VLYaZJc+JkUkm3jTzCqj5iFBP484rSKdzlnNJHXeGYBb6JYJNhSdocqORzksfwNdaLKK2jmH2gtMj48tV4dSflKn1OelZOl6YyQQyyyOI7hcosfrjJDHsQQRjtWtDZbLbE8CpKGXBZicjnbg9sg8/St9UtTnWuxSeJVkncMFUsPkA55HUf4U6ES29+wDbm2g7v4eOox3yO3tS3lrDDKzZfB+YKz5Jwf5+lQK7zX1zEky7onUq4HB5PFRo0bXadiK5dri9cQsNnVs9AR3qtdAb0bcqs2QSKs3WRIjCPY5YjOOGP92mKsckyySoMqCoB7+9c3Lq0dHNoFg3mlY/l+4Wz2yOaswxxpMihstcDG3uvHT6UWwSMlvLCAA7SB/Fj/8AXTokYkO+GbjafbH86zUdRuQ15dknlufmhjyB0yPQe9EM/mMfKYD5uRmkuIZlvRvTzifmUqeAM9/eqVsxhvZY1XndkuOhPar9nYpO6udQE822YsPnA+X2NRo7W11CjHcGAJzVi0j2xuAT8wHJ5HPWp73TwPKkjJOxQB3zXNIpMkVQju7D5SeBn+dSFguSV+VuMelOhG1ApX5SOe+Km2HJCgZ6isLXB6blYAbiCNqsONv86mWIKuC3B9ailjZf9WT8pzjrUd5I6pkdCOCaproCVywJURiCBu6Zz2pIJAzk4IHQVjm9WWdo3+WReqAduxrZtATGu7Az0BolDlV7lWSJcnP3gCe1KEVMuAaJtihRz9BzmmcpGQxwT05qY6bjTHTTINu9whxzn1oqpcMse3zQGJHXrRXRyX1LUrHg8JSSMxQ7otHgICoBzKR6/jWnDIkUKyyFVkZjg5yEHYAetYcVxDFbx2dlN5rJ2brn6Vu2ulxWkaXmpt87ruUseAuM5A9+ldvM+py8keW99SC5Lx2ghtn8gTkmWZ+rEfwj2xV3wro1vbWRu5QRFnhiMFsHkCqUKnU7ozqhFqo2gHqwqxq2tqLSeyZ1aKMfNzhYff3PtWXtIp36jcZWsRXmu3GoyS2VlM8VnEx8yUHCp6qPfFUob+91YTWGkt9l0lR+8nK4MmOoz6VUgtDqNvACWtNGibgYw9wfU11NuLeKFWvlENtEMRWyjBb8O5oitLvqJqz0Lmkw2VtpUbm38vT4sAkjDSEf41ZLf2mVutUJttMQ4t7Zesh7ADvWfqGpT3wtoGiEmw7odOQYVfRpW/pV6bULfSViu9aAvdVk4hgTgewUfwqPXvTceb3nsCdnbqa+oTwWNpDe6ncR28CYWCBf73rjufWs+GG41XUVe6aX7GVHkxgYEo/vH1FVYbCV7qLWvFGJZc7be1Ayin0A7n3rX1XUrm7uYpYSoEY4cABIh2XA6n2FWlbVkt9EaN1Z2trChaIxyPlC5PDDtgVzWtTxRLJDbMXt8/MDxlvT8Kl1a4kFjH9ujlact5nnSN0/3R2FYN+0k0Q2kssrcHvn1pzkVDRala6cXlwqZdLaIbpQO5HY/WkW1WaBZniwi8Iv15p0FszXAtiSoeQAqncDqTVvVZxDEltHg7GJOOlZ83KJ6mQYzHEYiXZnUgYPQetaXgCznn1uC+kmDJtbaWGVJQY2n2P+FYw3XsgSLzN0zGLcp69PlFdt4YtBbyWske5II5is0K8Mn+1j0zjNbUzCZ1un6XFIjXEd06zOwO5M7ULdCw6Zzwc81nvc3jJxgfx7SeVA6c/nWlfXRs7CaG1lO+b5JYguBtDDb+OehqG0t0i04XJXFyz+XIM9MnAGPqP1rWWuhlF2dyKJWvBFM2SGbyyRgjJHQ1h6XIU1G68yPcvmgl/UDj8q6exki0+eSyvIm+yTHc4x80UhHDAdxg9K5vSpAPP3RtIgkZEyPvruPI9uQaVrq3U0vrzPYuagqGZ0Pyx/6zaDkKf7o+lUxEsUkJ3OpdsKy8rnqM1pvG0VvhlUKcqT1Jz/AEqoE/elA4A4Xbjp3B/OsWrs1bRbhgl8tiwCnGV44IHY+/Wp4oj9maVUA2Y+Vjz/AJ6VbtZFltIVkUhGBD5HP1x3p7tGloFbPD5GOSxPelZWJu7lcpNAGZ0DORgc8Ke5NZ0ELS3MZKFYUOMdsnua2Lxyqs0pLtOVHToBxgVUtQP3glZgm8jC+uaUmrFxH210PNWKNGCg8gnOP/rVvRsHEi7fuDn3rmtPAa5kmjO6MIOMckg1t6e3mxAZILZGD6Vx1I2d0bJ3LSFJQu4nA6/WnK+CwZgc5wcdqRRkbWTb7etMUCJ1Ln5OgzWK3Bk8hC4y2DxVe73FQq9M4IParRVJo3ZgPlGSMVWmIVQ0gBGQeKctBxKcWnRrMbgBVmPGR6fSr+DGgdsYH5UyWNhklAcckA0LKSpC9CvQ9CKid+pVyVWEiAnhs9qp3LM3yhgR6+9WZsJFhBnA5FZE96se9gGKjg8dKcLtlx7k8UkkibiDnplh1opIi8kakEgYwMDNFehHRGTs2eM6bpVto0cmr6/tXKYhhHLbu2BVzxA0vibVrKcBV02OBQohzsYnkj8OBUeoaDd6xqNjqlxc77d/mWMtyAThT7cVY13WdijQ/DkPnXS5Rnx8kY7tnsa0m9LW9EYQWvNcqeItVt9OtEsbQ+ZdzfKqxH7o/pVa30qKGCCTUQSSMw2qjOT6t6n3p2j6GdPcyblutRkP7yaTlU9hW1b2zu0ht5MzEgTXLjO0HsornUWvVm/QoxG4a5CtEJ7oDKQr92EeprVew2X0P2uX7TqMvzBc/c4/QUtuNqS2+hR7jv8A3t1IMgH3Pc+1ULCG5ubm5isGfbnFxqD8sfULW0dEZtdjUvdYi0iL7JpMAuL1huYgfKp6Hee30qvbfYdElTVNakfVNenG6K3QevAwOwFQLdKWj0fwxbiYtJumuX5UN6k9zWl4esLDQb6ee6Z9S1DPlg9Xkf0Qf3RVx7/18iLF/R9Kurh5dU1vfLeEAQWW7ase4/dJ/nWnEoFy6YhIhHzGMfu42z90ev1q/DBeXMMV/qUcK27NuS2BCtg8fMf881j3+pxTyTx2K5jB2AR/dGDgZPfpRohpN6GL4nuVkZbaORZC33mJ5PvWZqNzDDpcNrbk+azhmk7qBTvEFmLRnd3/AHob+Hp07VU0uAXKNHIpDHGDnPapluNJLYl06V4jJOrnzCpRSe+euao3FpM+9QS8rcvnrWvexiG1hht0COpBZjxuPXioHYmUSxA7RjLMOvvUpW3BvsXvDlokk1mzRbYIZlO8L98AgEj3zXXRWSXEep38R8qUXTRtERzsb7rA+zAj6is7QkiiikWYsogX7TnpgFs5/PFO0fV45bmSa4k/dyEsqhcqXZu/oM5/E1upW0ZzSjd3Ny6uUvtKdD5r3Ikj81z0jOMEe2SP84qK7wt5amV0j2nnc2F3cbST6EgY9M0mnSTLBqjSxv54nDPlfvjZu7d+TxS6hDu0wTrsmMccchVQGVcrgj8sN9RV83chLsW9Qu4W0+41Fo3kaT7QsckgwyEhQgI7Y+b8hXNaf5lj4ftLuFleYs75LZIRiQ2R69/wqTxXrcl/ZfaAhWUqJZkXjsFJ99zDp7VrPbRR6LYsfKdoY2YhOQxKgnd+q4ofcaa0RAjJPbI+8OhIXr046H3qJCizJuAeVvlXHp2JrOnt4ZEgWEloQ6sWQZKrgkZ9RzWsHtIndrR8iP5cjqWHJrOD0NZ7lxbad7Vdr7cDdntnPSnx4WKdpAFwdijd6mpMSyW4jAZUYZ644ODmobt4hcTxouI1k4HXLDHSiytcnmd7CLIm8JKWbYxwcdAOP51nq4e3ljDhcktjuTnjFS3VxEkZcOqgvnyy3Iz1Oao2jrPeOrcoAQJB2PpUcpon1NHTUWEKqHarYII9/wClbKoysygDIbjHoe1ZFgV4IORkEDGDWvGU+YZyFPOPWuSqtTeL0NGOSN4FDfewcHpg1UuGEzIN3+r6/wC1/wDXprguB83IPXsTUfLyblA+U4PasCi/C/y7RjYefwqJvk3AABccmqsEn+tiydrHIJ7e3tSvcNG6oAXHANLdF8pLvYsFB3F2xjHTApI0MCMByMn5T2pjRPGWkBxgfMKZHISC0jY9QKLFJXHyZVWYNw3AFZV2m+OWNgMEcY6g1oeYxlVUQnPBx2qK9tkI2hwh71rTTiwa6Mh0syvARK2Sp4PSijT4XVHWWN2w2BtPGKK6ktDFp30PKJr641GJ7XRY/s9gp2NeEdWHUJ6k1ftbS106z+ywMIY+DJM3LyMe3uav27NKtsgUQR26hFjjXjH8h7mq9yMXZMaYlJ/1jDITPZR3NXKyRmkyeJLZYm3KwUKWKscE+5PYVTuGa7ty1zKbTTUIDsOGf2UUmo3VvaiOKSF7q7H3IO7e7VY0vTLk3DXOroJJ1UmOEH5I/f3xWcU3sW3bVivqHm2kWnWUUtnZ47DMsoPAwO2fU09rNljCXB+x6VCu0xh+X9QfenXGrW1krxxx+ddZJJiXJc+mewFUVjuLqUza0zFUIMdpHyAD3PvV6C19C55008Nva6Para2uTh8Yb3PvxXXWFpZ6Bp8c8TQvNLlYp7g4MRxnp1IPqKyrd0jVXMkVjCFI81yGIA9uxqO5ubW6C+Tm9dTtN08mcgdNo7e1NytclK5S1i4uL6JBqVwVgLbEiThn56E1HJKIYooAY1iifYoTuo96sX1pBFPH9tLvJGu8qeArEZx/KudvbO4v540ikCwxR7pGHG3uc/nUJOxbktkF55986CNS0O8AFupz2rXghazVfJTdn7gbqw6cjtzVmK1wLRQScDdlhjjFWtOlt4454o5N0yoAZDzj2FOd9jOLMi1ge7u5HnkJ8pct6AY6U1sX0LfZ1wUkHHY4HFS3s/k2Bt4V4b5i2ffkmrNlB5FhHcysAS3lhB3Of8/SpjLothyTWo7UWa4u7a2tGZ5IoI/PXoC3OT9BwK1dFwqSKU4jUxyRlRjJ6H3HUfjXPaPBcSyXcu/Y5UqeM52t0q1YpdW+q28SR+ZatmZU3fNtADAA9xnsa1v95i0dl4cBtYbq5nmBgNuUaRhzuRcoT7kcVifbYLPTNTluVIjkWNgyn5j9B+PT0FS293DdWmsS5IuRcoiROuNm3BGR3OfXjGa55DPqmoywARrJdqIw3PykZ+VQenp+VWyEiPW/PubG3Hnqzxx7icYxuP3SRwfWuqW2SCxtYVkeWU26s5wVKSHhh9OBj61yltK8qSoUVUEoiRSuAp4BP4813+rxSz6zdSRsscUSrCGAwC2MgfXilzNpjtZpHPaWY7awks9rLcRPlWPQoc4/EVqxQQLdzkPtMsSO24cq2MfkcVQMgk1iPaN0a7Y5AozjjJP1Gat3t2kf2mWI4eKQI6Hsqt8wH4YIqltcHctyXkghiZGUsjFTHt4PHWsy5uGnRfsshEhJJJHygZ6/UVpJbxqPNilXYx3q3Zh3FZdwY0lcySExspOw8c5/zmk9rArXuRtLDGpUxqX2jaGGcHocmmeYI7VZFwqsw2g9+alYRObdgqqN2Ch6tx0/wqCaLfPFDGwMakhc9PpUWa3NLXNGxM0lxMzriMDgH09vet2PhA6L8hGcd+lZUBZSxQfJkcHqO1W7RiuxB0xyp7Vx1Xc2irFksS7IRwcHHelhVsZXJUggAUSrvjVySD3J69elDyiBQSGxnJ2msrJF7kcbcsDhSRyc9acpeEncMgDB4psyoC3BZJFyOOhFSNJ5cQRgW3cVOxaZMlyo/dMNysOp71Wn2OA8YIzkDHQYpUKljuzhRn2NSOFHliMDYei9qafQa0YyzbOONu7jPY1HdTBI2DAb+596kgx5kigfd5C1Sv5CZwvB55OOlaRkG7uWYHHlBRMYWXqCM5oqvHcYzkrn3orVVGieU4+4u0iiWKOJWkXKkqQIovqe5qrbwSy4ltZdz42tcsuSD/sCnLp1vO6JAUdFbcWd8IT9PSr8kxRRBbSK+WxuiT5UHtW9k7N6mOq0RDFBpmkqZHdVklb95JIct/j1rNnv7i/keKwiaKA8PNKNpx3x7VuW1tpdrcbZW+0XB+cl/mb8u1Tz+TIEHlIkbHP7wctj0qrpq1yetzC06Gx04nJM8uMBl6ZrUaGK4QGO1uORnBbA/GmajemxmUW1jCRIcKN45Pb8KoveNeNsv7n96MbYYcgD1PHWi/Yb1d2T+W+8pHZxj94C5kYcntkdMcU67d5YFt1islMnOQu0KfvEZ/T8aY1k0kAYsIYogG5JOeevr71c0nTxOWZZCwGAvPyk9Sf5VnuVZLcyJpi8iiVg0z4zgkhfXj26VJdWsgtpJxIoV8IQP4+f/rVs3NlZtNPJC/mO/wArcAHHc4qG8trVLCAAbSDvAkPb1/wppK129BN67F6FrSG2hd2OfJZee3p+fFc7Mqowji5DjHynr1/lVzUBt83YRnBIXOe38qxpAwvgdzKhwQQaUpc+nQUI8upJJG8V45niAYj7pPAFT22pIytALN3aYtvYfdT2B6Y4FSxH7Re5kXgAAk9DVyzUp5lzawxvGjk+SzYDOVxkUk0OXmZdr51nqsCW8zfZ2cBsnKkHHP4EmuithnUbW4RQ0WZLcxhsMy5HU9sg8GszWLHyoo4XlY3ckwZdmAuCATx6dsetRy63ENSnjeNW8t1KsOc4UAjjoPQdjRF2Imr7ErQrJPqMSkrI8+4SMcSY2/LgjjmscTfZpRL5zlixcSH5WL5wQB+Va1zdNDDdzQuMyco0n8a45Xb2PfNc/O7PhFjxHC4c7x86ZHJPseKuUyIo1NPWVbizRjunuCrlWXoQSPm+uM16Beottf7ZJGDP94jlGIGUf64yBXAaTP8A8T+yLysVKtlu4I6L9P8AGuhUPb2l7p1wHMUOAhbO5Vflc+wOVz7CrTSTaFLdIl0yTEl3cCNjN5xnQqOVHA5HpirjKn9psyldsvL56bgMEn09KyxFfWyl7SRlk8tViJHH0z6HoR71oobm3tFWW084bydy8Y4OVI+nFawTcbszm0nYtuv2aK1itnRDyfKK5OT6emO/1rOvY4brUIcK0MgB+mSOlX9McbzOzbspuUHkKpGAc+vY/SsrU7lo3kXaJi6jft5IIY81T2uQm+aw0pIrAIqeWG2blHQ+v6U6KH/SY97LG4O/jpn+7+PUUl08cuJIZttuVRdw5ye5PvmprErNOZJVO3dtOf4f89awqo6Kbui+v7ueRHyBkBh/hV23KDDqOAOvdfr7VXKh3Zxk55HOc1JH+7jcxNjAAww4I+vauOaN0yxcAqg56DIweD9KgMxd1HAyMim+a8ilWXAY9D/Sh0AJUg46A96yKRKJOcg5x2PamTMrSx+WTjcSQDSHhNzsGUHBzwce9MVQjsyHKk8ii1ikWHJjUSxFSQMEdcj6UluxbBOVbrgcg0twkQdSm5toA3dy3XpTk2soZFIPXHSpas7AmMJRZ9xJDnoR3pbyJJol3YVs8kdhUeGLFZBhs446ing7pM84z39acCiljyDtdAxx1oq3PiVs5BI4ORRWri2x6dTlLOOS6LM8UMwABKgBBV1pB9lKPYbVbCrtfHHfpVdodOEpRbdklIy3znbTpNPAKtA0fH+2SQcV1HN6kcxkWAJYLapJkk785PsTVBrCfymZ7hQSAVKLkg/XtVy4a4tN0k9qXzhR5b5DfQ1US6t52GILuK4c8FX4B9xVKz3QrvoULSK0txIJBJJJnLMxyT/gK0IdSWBNtnaAy7hhwOcelDlLCWNZCS7cjJAJ9Rz1q0LqMxOItokwfvR5/lUt6AvMfDYT3jebfyBF9F6c1GWllzBaJ5cMLESnoS1LHHd/YFkYxsrHdmNcYPan20zQqiTOGiVvMYAYYnHespK+stir223Hx/ZrQOrLt3HO5zzn0zVDU7mC8aSQBgQBGuehAPArQ1OZbkxQLGuzJbJ79a5u9vUtphGELsh644B9qdT4UkOG92a91Klqq+aUzMQvHU+3tWdqMX2m7cxYTacoR0FLco19aJMQY3Mm8eo5qwksaExsAWBbOfXpS1jF3Gldi25GCqvk7Cu73IpIHlMCizh2tb4uCZGwpYD7o9R1/SkCpDBhG5Y5JIzkgf8A6qdDKrvGCo3yY+Tszen9amPw36sctzKt9SF5dmKeYmRSJJGA+bBPT2I6flV/QrHyXmVkVrpFEp3dXOSTn3AIptzpsELyPbP/AKSrKXYH5n55z7CpNRn+UITl84Z0wCc+gprt3M5Fa9uA5s5W2t5CMJUx0Y9BVCC5V53nmbLOvzYHAwOAR6EVJfTR2lpBYiMM8X72QjqQe31plm0HmzTTWzGOaMAIDwrHgD6c1fxNErRNmp4bBi1RVhQZQM0DOP8AWIT0Ofbj8jXd3sUd3p1vqEL5jCGCSReS0bfd+pU449RXO+HNN+0fKx/exICgz3H+cV0OgAwG9s502rc/vxGWzgHrt9ea6IaKxhLcqWk0rIsFwybmAAB/PP49cdqrWDsUs0mkk2DeCS2Q/B2g/T+lUL+VtNa8in3MFiMsTAfdXoCD6Akfgal0qMNpMMG9hLuMiyJyAx5Bx29D2NabIhq7JNLl2JcDzJIY5JGhDDnk8g/nVO+tguoSEOqfKVhfB4OOQfbP61LFcLDZiK5IJYESkcbX6qfp2zVa2uH1BZvNcqjEtBOvPznqPp2ppqwWbdytbNtijMoZGO5SD0yD1PvW3oriTequvmPxhuvA6/0rCvp0aMwuClwg8w46Eggce/t6VqaKRJGGKYcZKjHKDPb1BrCa0aN4nQQkYZtnlMCMLnj8KlU5lXDADJEgbr/kVWjYy3JjZvnzk4HB9P8A9VSrBIAgZSevzLzx6iuWd+hrEkEfMi7zsHzDHTJ9KdtUgkk5CgH0NNjlKEqQpUEBxjBA9aRMAKpB8scE9cisrFjJQSqxsRuJxn/GnxkxBg+Cm3GD1FV5iWyFORnAz3FSQP5kbRyMGwwXnr7UrdiiaIbnCZOw9D79qeh2oAy7dpxnPpULko5jQKWGCff6U4/vEz6/MAf5GpkraDF3lztcbmzgN7USARsuxhx1HY1XilKs3VY+nTof8KbdSkyqpwDzz7UlcYyaYmZhwp75PWimvGXcuF4PTvRWqml0K0OesXtVA+0JtjP8GwjH1JqZp9LnkK7YYxng7yDgdajuoH1Dy5reUoqnY3ltj8wari0EGI5JHIz/AMtYwwrt5XucnNc0Jxp0kaCOUIR8u9JDx71pWj2qRfZzOkxPMhkjDkD2PBrDLS2XlGCO0nLHAEalXz6elXLfWpLNNzWImLn+F1LD8DU3YGu8FpJbmGApLnnZKQRj2zyDWTc2otiZRCvIwVxxVQ6hFLcYubOeFmOQVXIxmtKIw3W6GKVhwf8AWrjihvoIqLLILVfNjO0EABeNoP8AOpJTHKPNKnZjAB6CpmSWW3xKkaJuAjKnJKj+IiqWotIsH2ZHBjVi23H65rKWrKizN+0st3MoZnVm4Y9uMYpZraMOrAMvmnqwzkVDHeRQ20kLqWuPMDnaOo9PrUkurMxaJYGUpwA3pTi1e5T1Gy7rjMMJUxJznpzUkaeUiN8pkBYDdVeOK9meLbJbojNgE9fXBp1ikry7GuRhSTjZxWTTvqaKSSLdvHFMI3lRgEJ3EfxE+30pL4W6+UI8o+5mDlsYwvSorjUhbIEMiOFyCFGDiq63aX8Ya3IECkBkk67/AE+n1pq8dyG7iPqcULpIF2yNHsz0CqT1z71SnulMkku15I41AjVF6HuR9OtMmFhFO8JUtIHxgNwF64x6g1W1S4W2t4o42aNSw+vTkH24rSyM9yRYWmLxpGvnsMjB6n1J96taZBcSfKoYsIRI2egAI5PsDVbT4kiDTbmeWThcD7q9fyrTjmS30+4hcMs8oUZPfnJ/A1UN1cT2Oz8L3SZjAG2ZtsmR6njH0yP1rS14GObS5XaNYozMkvy/dzgqw9h0P1rnPDcMhuZZ5n8tiOgGUZBgj8ia2vFrSXFpbylUQ290GcZ6/wAJP6/jmt0zF7mB4uT7XEvkTFbi0bc2TndCx5x9Ocj0qppty0WnxyIAZApR4l643dAf1B/xpLq4fzWlMCmVIzEVDcuucA8e3f2rntPvJheDaAvy7ZUUZ2kHr9Md/WqvdWFazudXeXsMUcJkjiuYTIcblw7L3GemfY9az4IDbSXMdtMEt52BVWXgHsfb8KZNfFI4VuoY5LW4bG/bhk+v1IOPpVSW/ktJmtV8spKvDPzgE9R+R/WjVKw1Zsl2Pc6tMb50ZixPy8Dcox/Kt+xhdJo3Fw3llc7ivGPX/GuQvJjBexnzkeREVzs6MOcY/AV2WhzPNFHMxATbmP5uCD6+n9Kzk9S0tDc2xbSseVGOoOcH+tTNcjYqThQUP+sU4z71WspNmwgDY2flPb2NPYmNJQY1LleARwf8iuabvqbIsSc7csWYDG5evP8AnpVKVnhf5TmXuBwGH+e1LCFjC4ADbeRnIPpReO8zKWVVPP7wf1qeUaZEyieMCI5yTx3U9wafCPKwSu5H+83r7/WkjYxyvI/3ugcDgj3qfb8shjyQw5A/9Cqetirj9mZ+o8wjCn27VAEaMEHO4HnB96gEnlBfnA2nAz3PpRJceeHKHDn370ThpctalqacF8Ef7y/yIqNGDMrNg8cCq5csiumD68/rT0ZcDC5LDPHWsne4FsOicYyO3tRVU/NyG2H+dFArGfbLJHIjz28boeS8cn9O1btnJZ3qMgHKqT+8GOK5g2L3832m0drZsYMYPyrjtg9fWtpPt0FsIp4I9mAFkU5Ug/qK9JaHM3cqy2lsLwC2Rg54+V9pzVOayXJeWeaNgSctGCR7Zq49pZrKpv4yu7hXDkcemRSWzTGOQ6Zeie3R9oSQ5yfc1MpX0Q0uXUrpb3N0oCXFrK442jKH6Y9TT4/Nt5UkmtpGiGE3iTGwD274qvcviQT3Vo0boQ2+PlAM4yWHOar67cfbYma2eSNN4bfnc5Yc9PQ0lcUtS/dahaqSkoVJkXHXGV7Y9fwqrbuJVc7iylQNjfeznqaqz6et0glhuY52YAqjDG3kcEUt5dRwqn2m0MbZAITgnn+WaUkuokVri2+ySTLccFz5hP8AQe1Z6XEUrlI5Rlflbb16Vfu7nzpbaK5jAQhnCA5cEcbc/kcVUtYxE8hdUjOd+wDBGP60lFJajcm9ETRNNCAHVCP4SxweemacLm6LPEiCJ3BGSMjnvu/pVf7T9mt8pIZAxxGpG7r7VKLi/wBPtVd4YyJRiQBssCemR2/xqVHqXzdCpPHJbCRfLBjC7meTkqR3FZ88qrqMMK/u3miAO7G1CBkEkcHgnA/CrlxcC6RACxjyfNy2GBHQH0NR3kMK2e88Sox2n+Jf6H6Ur66g9dSteKlhsiAE7MpJ2nl2HII9DiqlrEZ78zXSYU5Pl5zt/u8/zqxNbCK8ExG50UDcOnI/SpopklmtwZSJpWCuAO3f9BTTZPmaVqyFiB9wEEepqS7Q+c13mORkKBUPIfB5Uj1xVM+ULrMb5hiXduHr2FawxJpiC4XbvYunucg9fwqod0Eux0GmStZzWu5iC6ZSP+97H3A4pNY3XOnFrraBMOgOPXH8h+VVYSkuoG6LheA+/OVVhxgj39adPLuvLhHZfskChh6KSeoz1Gf51vdGRiLL59jHJLIySupdXxhgwGBWTPuTV7W7jG1mDIxjHIZlJ6emR+ta1/E8O941VzFLlew2EZwR+dUvIW7nSG2VlW6mKxTsdpRh8wz6dKuPkKWxPLcw6lYbzC80MgGXQYwR2x2IPX0rDa2ZXMhkYowV93DYGcHI7Y61reaqzq3m+U8zAGVBgOxHBI9eMZqlHaYkaZ3YSCTaQvyllPY/jzmm+zJt2IpIFS3dAyyXLNlGQ5we3PpXZ6JEW0iBVZmUYyPQ98e3bFYWmwRQTYxkD5hxyK39NAjtj5L/AC/NgjkVz1DeBtJKCo6B8ADIxx71NHMJsu7HzFBB79KzYpkuWZXKibbjaT1OOv8AWpYZVjQOOhbt2I71h6mppBQsnyFTnuen4fWogzhVywcdwewqJ5ipj+TcB2/HsfrThKjyyIqkMo3BT1x/WmtxMiaWNCyucIeSB1qGOYRuNjMGHcHgiq0pUSSlVZiBgZHWmiVUIl3MUfBzjAP196h73LWw24dmmjCYMgOdnb8ffFVpr4b1SAbZH4IJxnH9antrlWaXy2Qjaduep7jFVrW1ivJluEwQr5Az8w9a6rXgNPU3oI90KFQCpGSQO9NSPyZQHYAKSetPjzGqqpyD93tVXU7pIo0LLhs8n09q5HBN6j3ZK8pX0YHp2xRWZHcGSNWVUTPO1xnFFZum77DsX1tXs49iyvHIf4ZRuC49D3H0qzb3EayJFcFFmIygjkyH78VipdPe4dj5sPIySf3eenHr71cisdPAcSQ5kJCLITnJHfI/nXo2vqzk5rKxrzNE0LOsaSkjkZxj6e/tWHbacs8rR6cs8cqgyMFXbuyecg8YrSu7C2jiRlnnVX/iU8j6g8GoE1W8ghFskXmxrlY5kGSAfXuKi2oX00KkbLpYaK4iFzKZCGEbYIx22n254rNluLe6ilkS4NuUycSJgn2NWrm3MjxzuxjCyKC8mWV/Ueo61PeFZLZkktRHG3yK/wB5MfWjbUNSrpXkzwRzy70B5f5eGHqD3p18yxTgKyyRmM+Wjcjk/mKmjkgjjaJRsAGdxPyn2qOS3SQgbGQtgnDccdMdqW42cJfandQXm/cTPGzE+ZyORgEetW7XUp9UijVZ0kkIxJgdh0O70+taGuWEaskbIsksrnEgGMHvkdqS2sQFmEEaohRWcR9GwMfrwabelwVhbezMbOVVluVwVDchj7Gq11dzXqBWyUK8kdz1+b+VaVklymnxLNkSNkgseevX6AVmXFmbeR3BIhYfKhbBBOckN3GexrNvUpIz3vZLZzcTW+4N+6kO3aSB93Pv2qDJlfzWEqw43Rx5zn6/TpUmozSSJCki7h5gxk5Lk9f/ANdPst6zRphVAOHPdh6VLuUNjie4CzTBU8kHao+XJPTPqan06KO2keaZC8u0jLHBJ7YqeZ4EuTGsomWLoyjhh2A9MVSu7gyyWyNtXzF86Tn7ijoPxojdksvXMAtxDCSrSOd8jKflJ9Pz4rU0x/OmuIZFJPlqhQ/wHnP4Vh6Yxa5e4mYSIfuADjHatCC/3LLsGZLmVmDL1A+6QfbvW/oRcuaZLI2lXwddzuSox0IDbR+GK0Lu3it7OaOdd8EkihyCd0eGAwPVT7+1ZouGbT59pUBCoTAwQAe/5VoSF5pbxAVdZIzlX65x09/rVollm62Jdssrq8ceI/MHQ56OR+lcnqMl3hY14IyeRgk5I/CtRLxZdJw5J58tS3VCBgo38896iugJ4oDJHteRNx3d1HQg+oPWrW5D2M+2lE1tEzuRJkrIAMNHnk57DnBB96kt3Yu5lQmJPmDLk855P+ehqvDnUL2eaBisI+Vo24ztHPPc+lTRb7a4QWs7bHPzrIMhARwyn39Kl2uVHYtQTr50vlgEuSSeoXvu+lalgkkSiNJj5U6Z+nr+nWuZjt5keWaJ/lRwWjJyACOD+Nb1i0sqoTGqztym04wR7+tKSKizcikjCiK5VcfdVx/F6fj0qa3cq0kchBLgOfYntWb5k9wqpMuJUXdsIwp98+vtVm0EghDnLOWxk9RxyK5pdjZFlHMM0kYLESLkZGCnNWklaUrxiQDAcdcVVgdWDiQFZUUKSeeT/jSW83lOAxJbcVweM5qXK2oWuSXKmLzBzuA7dvQ1SeUeXheQByQOozV6e4jkLqS3ygYPXFZdwjtHuiG1g3AJ/kaTd9S46IyH09obqSWOVtkjFmHp6Y9q2NICW4AwFyc/L3HrRNGAVGGBAwcfr+FQWBZoyACpRiOfY1Tqu1hpWN+S5RIzkD5hg5/l9ay9bd44f3QXqPnPO3HtVyRldf3pyRz/AJ9PrVecLtZZ2xH1JI5J9KlSVykMtYPtsSvKpLKACRwM96KtwEYIXC4weKKOYevQgtBHb24S1/16DyycZzx0PbFaGnpbiKKKdfLXdyzfw57Z7CsnSoJgscbyhNg2iN+4PTP+NdA62ghhcldqkhtwxtYH7pP+RXYnZHC10JXVo5jBJAXtsFg2cYPoDVC7REiUpGY8sWV0fBPsR04p/wBvjjCRqs89uT8o6+Up7H1A9fSpGsF2BZJd7MQwG7Cgen1qbCvYybi7lhgbzozIpcBQ4xk+npUC3dtPcIXkk0+R22JjgM3v2NWNRsnuXGyMq4kwYhyox04/rXPTvOPM89SojQpnG5QM8cdfxqWupojRubO6Rsz+TdRbdwWMhTn3HrT7fUIkV42TayjJiGVYL7A8ZrLg1CzSCN0lZJ0Y5dMspB6A+nNRatepLblxIGZ9sZZVx1os3oFx2oyfMr2pDsPmx1OT2PvU0cT/AGONg255QQQDymT0z/jVIW6QxJ852E5BbnGfcVeguXiRvOG/A/1qHlf8RUNjKljNsgBkc74wU8tzyBnke9OldpcxPIgjcgY9AKpThFkxIxBHzbwMHkUzUYi3lGPBUqQSowQMdTUGnQo6t5YYxRHy2DARgjoQfvCnwbGUKzBCuFY9iRVCXY0aSuxwpxgHnHXJqW4jSVv3DM68EIo5/wAKH2QLzNAxMipMxAEg6r1xnv6Gq9sqXEkxVdpEvDHptA4NLNtWRUlnjm81QdsZ6Edm9D7VUWZobciLm4kYKEz05/wpwi+hEjZtEaC0hnLYOSNgxknk5PtUtnCsDLNMwMwUt5aDqCOuPrVWZA1mXVtgYop3dR6/TmtEl5ZrOaUouVUF9v3VHXP9a6VZK5la7HKi/YATlCIg+4c9c847jNXWBbTLKd2jTcV8x0b5fu8+455qhY3KTRSwPtWSDdHj1Qngk9+P5Vn6cxuZlsXdvIgmYOPu7lHI3en1ov0HJPRkq3L293OsSOyiQu8ZAxIp6Ee455pILmVb1j801sMh4jzhScqw/UGr+p2372N4do8kZyRjAP8ACfUdOe1UMGOcmLEMqk5Q9c+n+eORVp6kPa5XjcJqXl2UylTlWHTawPB+mCKs3MohdWcqPL3DnoQpyf58VmTwwC7muJd0MkhJxnALE8Z9M1as4GWIxzAzNuzFJnnd6EfpSe447WJLdwpkaMspbGFYdE7VvaezSX/OGjkOTjvj0/wrJs7V/LkyDsVm+U9h/PFaVm7SSiKJV2Z3PIpzkY4x71FRXRUDUkdS8+5vusfLk6D8amsI5SkZDFuD8ufu5/w6/nWa6Yu5WaPLIVBTOAwxUtjJ+9xA7Kz85J7+hrnk+htHYvpJ+6UyY8yQ/K5P3h02n39DUUbrNCFfO9TwT/F/9fFIrRypKzD5wclD1H09qZDGJkLjcIt3QclPXFQ9dSrWJ5pWMZnAOVGG9/8AGmwSkHay445HXac9vap2xtLkrk43YPDY4z9agiUiUsr4wDjd/FUsaHXKJt3R/oenpUNoqiWdGJZd5bI9wDUo8xiTERjowI4J61Ha/LPMUGPmxjPt/OpauUW4x8yuBu3cH3p7xRSkHG8DnHvQAI4yqnPPT0pWkUbQOoycgfzqfQVyWIImRgMOO3SioEGclWHJ70U1IdyHSbiCPUpIb+J5gg/dyr0UdwfUfyrVhhtpri7tZcnzFWeBO+0jBB/vcjjuPem3aWsdkkYzGyYYcfcHfHrVC2mgjvbq6kkCBFTaqctzn5lHb3Fd2nU433N9LFJAVgJU44QD7vvTLm4Ahy6/Nt+cdjj0/KsmS8u4p1e1kA3EHk5YKOufYjoapanc3bXY2qpmY5RP4WJ9fT1zTJK2sajNbXFvKN4ZsBNn3gv+1+FVtQv7fUQWRfLk5XAPKt/T8ap3V9NeTSC+j8uXO2bg4B9f/r1k3UkbyGS3MjMo4YcH8+9VvoykTTRQPKGJaKcDaXjIDE+mO9E1u0FoN8uLjO5QvHI55H0pIbVrllmaZJLpDkLLwfYk9q0bqKOWKa1u4dt+y5Uk5AGOx6H2pO90h9LkVnJcsWBTCp820dD7j881Hf3JWPYdpJx8qj5TUmnweXZ26+fK80Tbd5JO4j+mCKq6i3myJIRjAZfk6nvyKjRu3QetrlOCV5H3oshiPJLdsHkg1LqLSCDzIXYtvCssfO5D3x6imQOxhkSONhlgW3DPbr9KFt1Db93lEfe2Nnis5JRZpH3kZt7BJfFIYlWNFVv3acnb3YmpLaJImJVuIsxsCeTxnNMuMRXnlwvIFjO48/fPuaXTEcXEyRou5mBwf/r/AFpX0si+V3JIo1CSNbqUkc/eYcHHrnrVjTIFOprPdeWYimZP9ojgZ9O1JeqY4nDPhkbPPY1SkuW80eTgBEJLDvkdK1g7amdRX0Ll/JJdSqiKrEHexT+HB6EdxxWxFdxvbmPgEDaye4rD00bbSMhcscsSe59K0bWZEkjZVQLP8pOOUYDgH2Nap6EL3SGBZYtR2gBbjZhC/wB2RMYKH9DntTrdlttatb18/ZWkWO6Mhx5ZPA3fQ459DVl8yRLHGCbrzN8RJ4GOo+h6VUvVivFjdkJiYBJ179cYYd8cVMX1CaZeh1FY9Slt7l0lTLeRIPuSITyv4HIz9KbdT/aVeK4SEMxKg45AB4JPY+/eqFxZx3SmNxuaLJChucA4yKnXS5Wt8yXDFWXI8w8sOxDdq0M7FX+zzeag0QaTa/y7Cd28g8n+oq00LwjDyS+YuCsgHJAPQ/j3pton2K8AgkaJl2hnfkqwHDH+tW9RneSKKTjz2Xc3s3f8CR+tJ9gSZQfU7iOOUtksMhZVO3ceMD2OPXg1Lot+1uxlUlHJLgEfKw7jHoefxqtcjzRDBAAWlJOe4wM4NOt7RbjEK7kkJ3Ak4we/+NOSXUI3vodbaqNVgaRMoCuZD/z2A5yPpUxgzETC6YX72P4sDqPw61maW8qo0IQQz53hB92RMcsv16Y9atF/NZGgUBEOdp6rXJJW6HRHUFUGR57aPay4LoxycH09qmmhUW+6CPYzDJZGIKnsR/KkmAEigHEmCAf7w/w9qckgEwQxsCOTnhl+vrULuW9Qg82BVF1hxjJdOh+oqzuilh2xkHjgA9fQipYyW2viMMDggDhh61TvY4ydghC7s4IHf6/yqXYaBrlFVWikCk9R13H3FJaHcPmADt8xz2z3+lReSkaq8KqGPJyOQfT3p/mkOs4CgtwR0xU2RRpTyLGozjnuBn8arLeRyTsFOT0I9arzTnd5Z3bWByVHT1FV7aJEctECqnHfmmkuXUaWmprLKh6hgRxkDrRUDmRjljmisnFN6oNCxf2rNbvLbrJd20g3As23De3oR6VkaTlZFZYzLcAhi7Db8pPKkd8EEZp9qk0dtGI7ySaFju2k8Lk4LfhWjfPFaSQBF2Im6J3PIXdwWz6HA/EV6TVlc4PI1JdNt7KCS7aRWiYBxn+Edh/SsfTo7lUuZpHAkc5RSufLXsM+mOc9KZezw2VpFBJNJcIZkBReWUHuPUdKjvrqa0VCm1oHbAWTP5Ajpmsua70LUdBtyxhlcPECQvmGRT93/GsW4sPKv4pkYi2mbcxUDa/cEj68Gtp7mWFwRGQGGCD3H+c1T1WFXeKQLshXl40ODg9SPcGqU9BtWI41haQx7AzjOWHXk9qtLEllcbvNSQyxh4938O3qpB745FMaeySASP8AJcDjeflKgdCR0qheStc2qyF4tjuNjoeSPcVN7FvWxVa5kjZxAGG45TYO49qp/aZbmCL7VEvmjJyPlLev04rSu5w2yAhXbAJcHaw+lZV1ZvDbpcJIrgtjBGcHuKb1VzPqWbR96fvXVbkAEvjG4Hp+nWoxGXgmclQV4K9z9KxrVmjhYsZA0kxVc8qqqP8A69aGn7GjjWNnuLksQFiHLHoBUON5XNYysiGSPypchsCNcqfT/Hmn+Q5iVkHDDcx6YJ/lU2s2N5p1xELpkL7gGi6gBgc5I7isye6mWae2aUCMffVOSfxpWV7yNHPm1iLc3YkvFhDAqpG4nuf8KsW8MUcMm19o8z5Cw6+n+FZsMYLB4gBHg7f681anfPkqJNwQg4Xkt7VpHRGUndmwY2ht/LwylQDjHOaadgJMB3QuM4PVfrUtmtxM24n96WLYJ4we1KIo1jkWQ7S4LAYyGrW19CFpuR2M0gufs8oCSHIVugJ9M/lV26j2Ts0mRAzCNiowUkK8bvbPeo9Pkt55PIkUMwYAq4yDn+lWTbRedIu5jbS4YPuJMbDtk9vTNEVqVN6ECRmY5RQlxHw0gG4g+o9Qan+1lbc8CQMAoCjrjg49D3ogiaCSdFXBXgY459h2BHOPWqt2fJSZrdTidSQo5AAIyfY/rVLsZMklaPypQ25SrgBx9P1qCBY/IyxZHZjjbnYMcH6D1FQTh1KysS0bjYxHIYnoceo5q7eri1GxATsyDnq3ce2RS66gkZWoSNE+9PMVSdpxwQe5+vH8jWyfKlCyQZAUgMcclfX6j1rFile9i2O4RVPyvnqw6Z98d+/erWn3IjBRWMcqEgZGQT6H8KclpoKL11NZ92SCQ0SEFSvJTjn8DU7yi5Z1Vh5jj5lAx5o9R6fSqe8L5wBC7kz83YgYPPftU1jJ507pOAMYA29c46j61hI3iWYHeO2hXbvRc/e7g8EZ/wA4NTPcmWWNwHIX93v9fc0bWGTvG5OOnyt6g/WmhV8qRow2w8suO/8AnisHpoalm0uEE7q3/HvKQw/2GrSniEgKLjIG5GPr6GsJ8NHvicZI4LcEn0P1/mK0ba43wrJztx0bt60lZMGmRP5wwQA23kAdMf8A66jTczmTbk8HaOCR/wDW9atTyxxp+7O5WzgA1lPdFbnYhA24J9v896fJpoUtS6fnkyQV4wB60WybnKkgN6ikjl82LBGFPJB6qfamTMIZdxIJJ27x0PsaiwzRimBTBG3HHTOaKzTOyfdAYHs3BH+NFRzEWJNNnjSVSwL205KyKi5MY/vY/Spb6Rp7eSPSN4gjjLReYQ+RnGB6gY6HkVgWmp+TPG+Hjt1PlJIvAyPbr19atWV05yyHyxcM8jE/czj7w9D7dK7pPSyORLW5HqGop+4CoN7IDH2eFlYBkPsa2re5gu5FgcjY4BCnnof0IrlLqQxarHM06TrcxEShxzE3Zh/Kr32v7RcedAI4JNgiaVz6c/nUW1NL6G3qLOpaOzwXPQvyB9f6VWkSOyum+0yA223cxY8AnqPp3qla3V7A6NapDKrnG4nAUA9T7VJqpeWF3nXOCeByCcULsPzKlwk19emI5MBx8394DsfwqC9hRgUGWBPyxjClT2I7VpW0kY/dMGSLAOO4IHb1pfskQBklYSqgyzD5T14FD3Kvoc/tRx++WMMcgl/lPsQKzb62uVVHhlWNt5YKTmNiB0I9609Rie5LStIWZSSCwwRWJMyW0Mdvdybmd92VBO8EZyD29KpN7mctHYkt4EubSOe4lkhluCZQkZyVHcp7cZpdIebTb60nNxDLZRy73ljG1zgZAbH5Z9ao38DKiXMZK2wGyIZ5QegPpntVKfVfLtprWO3BklUpuA2gZIJyK00Isy7c+IbuXUp2vXMlvKxycYKegqvqd7btqO/TpQ8ckY5A6H0NY1pvNx5Vy/ynJOe/pmp70hIhDGxVcY4GC1Q1Fu7NFK2xOmoyMrRKfKCkZJ7euB6cVvaWghVbmFZfKOPM3nkHuAfSuZt7cx3W47yxUbd3UH0960Uu5LGB8lmRuqnp7VcWrEs6wXykxyRKw+bayNTZJnhmjDgG3JGxuoQnsfaqehst5k3G7eB8yD+Kr1sscsU8Hl75E3qynJxgf0xnNUnZsTdtCykqxzM3lp5hGVwOOOCK14CLqMTWsUceGKlVPy59x+lYYBhMG4fv0w2M5Deo+uKuKxtpDJG5ELjcwA7j09yP5Vdr9ATVie7aQSwsMLJGNqZ/u/8APNv6GqMod5J5reQMgOWVhghScZHvmtmfZP5YMbSxXEYEePvdeh/PJHbFc65kt7m4hnVmw4j3E/ebOSfY5/Ol10F0LM1sJLOSeEOJIjlgh569Md/UVGzySRuyjzYyQQucZHt/j2qa4d3twI5P3n8J6F/9kj1qCEtMJyuI50+ZUPBz3qYvS42V4gsjsYVzuOGTgEMOhP1/nUmnQgXpLK7Ajf07dD+R/So4W+0TZAC713DHcjr+fce1aEEgeWGQ5GEcADrgjoP8KcnZExVy7PHEIzHI+zcAgb+6M9fw/lVazlE7kL98dVHVCDzj+Yqa/aG4shIJUEkLKS3Yr03Y/Q1Foyi3MpmRlLscc/dY9s1g3ZanQtS7bSM44cb845Pf3qSSVk3GEMhYlZF67c9vp/Kk2wyybkX98oJcDjcfUe9MuXcK8rgsOjEd/rWMvI0RPJIkyAYKKuQSOcHrz/On2r4jcMpKnkHPyt9PT0qihDOXhYbWx75+tThgsTBA2w5DKefxqZPqOw95opIn2ZLKCAMYz/skdjVGfyLARF2eS5l/eKveMZ5z6/SrRIt5s4JQgbiOo/xqG7jMqh2ZS8e7BXjg/wBK1hNWswafQm85QuUOFbse1SM8hiWPIaPOScZIPp9Kyo5p5pYlWJUjQhCWPbsa0GgcHahO39KUo9UO/ck5YDbgqOlFM2jAw5FFYc1ugzD0ya3kCKIs749zyMehJ5HNaNmIbq0Nraqd3l7kjXk5B6qfUEdK5LTbW5g0y3lgkZkMatMAc4GMnaPWukhtXhmikiZY42y6Engtjn6ZHNdcrN2OJIqeIbr7XPBLHCqKgEcqgYz9PfPaptKjm+2TSTqrINofcPunGVOO+RkH3pmoyxxXUAQLJB5pklUH24P48Z+lW7GKURhp5FLzBgf6UtUikbbzwyW8CW8KxSW5+baCA4J6n3FVb2Ulo1K7LdXUOyngnsp9DUlvctJbzLtKSjg5HPHGB61j6qBBamSQuMHBxyGHfI/zipb1uPZGvK8MqJNKp+Rgwx+p+tNgBvbe4Tdw2DGw7kHp9SM1y8l3ezJH9jYOqAiVhyY8dN3sfWp/DepyPeXHmSRQyIhQxyHGW/kadmtRvYkvJHNwUjzGkY2sWPPt+dcnqdtMJM20p8s/vQpfkYOMA+ntWuzXBupGCxyNkiSOU43A/wC0O/vVC5Ny0/70eU5JGxVHH+z7inF2V0DXQz4Lp5LUwuf9X2PBxUxNsbbyZ97yKuBIRkqB0Hv/AEp17bzv5c3lxMYuob5d645Uke361bSaya332sRbeNsm/G9AMZBHrWsbNaGbvcw4HCocLvwTuz/DT3nVpZo5duVI27+DtxwKhuoyt3M1sVWIOVIPOfen3sCvamaRiZdnzDHBXOP0NK2pT1LFnc+axEiuqPwpAyAOmadqyMLKTaAIiAB3A78HvSWO6wxIJMrwmWP3PQZ9M1e1O3caeZCnlrIgd4TyrZ5z7H6VV7LUS3ItN5toHSUp5eSxHVR7+tbSXDJHvtmK3Sq2Cp5z7evX9a5vSkhFomyWXcVz8w4GOi574q/pxuDKjKodXcruBww4yD6UJasm+h0EBllsbe7wGTaQTxkeoI+tEqyRlotzBHIZSD905z/9emWszQnzQg3kESRlcq/vj196Li5Zx5bja4AMUg+62P5HIxitSbWZ0tveJcQ7XcLcRbXLL/y0Q8Ej/aH6jFY8iRS2MW1T9oV3jZWzhjk4OfWliBvIEu7UbZGG54x/A2eo/HqKoWVxi3u4JgRPHMcpnOCeePc8EfjS1YPQuWpa7kEZ2qwiMhZ2Axjg/j2xUcRhuoT5mVlyfnTPP49vXn3qs8e+RJHcSxOQzFOCCR8y47EfzFWoo2tnBR8zgnzCB8rgH5W+uOvvUtWKTuQxW0kDMBhSST5g6Z9fpUiwKtxvj3sqgghjn8QR+PNOabEBmtwpiclcYOUx7UlhfJIZhHsYx9Sp+4P8P8mk2+o1uSiJHkDIxfYxyjHIIPWnQMLZzDMS0RODk/dOOPqCKlZUWRJbcgykfOoHBBHHFVdTC3dozW7ZdRuIzwCP8CP61k10Nk9DRlKNIqoWJA47H86bDJ5u8XG4jgJ2/HPrUFnLm2jEgKseSe/1+hq5cSH5i8WCwBPoT7Vi9C1sOQmF+eDgMrjjI9x61LFIqynacjOSnqKqwmZWUSBGjI4Pdc9RUkky70VgQwJw49Pr7Vmy0W5WVsnHP8JP8iP61UuonymcBDzkc49vpV3cXdS5AnAyH7N9aryvvEhZdjdT6CpBDI8xv+85jxyeuKnjmWMEbsgnIHp9Kq/OGBIDJjhRTljyQUGUU/jVKTQmjQbawDcIT1x3oqqZQw+V2Tk5waKOVMk4rSZLu3gmmWcxJG5jlRk4WTrg+n8jT4p7+e0jiNuPJIALByMsOjD0x0qrqMN2l3fBGZRAgF0M8Srn5SffbznvV3UJp/ss1t5wMSoqp8uGbPQDH86633OZEbXbC2DSsPMRwjQ7RyueSPqDyK6Gzv0YvtANuxCIpIDM3XpXEPK11PHJtMw2mIlTjBxxg+xrWtJjjyo8i8iztjPG7Pb2I5x/9eny3GtNDXuLyRCzwytCYZCWX7wJz09s1U1TUGks51YqjbCxjJzuHcqfX2qIFZmaMuokkQBmJCnf2J9D/Xise5jl2/Zr2bch3eXL3JAztPoe49aTjpqO5NLNPb2tvd6ZNtZ4BFPnhXXsGH171m2V4ssrymIrJ0lXPIx3zW6s0D2jZOH2lJMLlc4xn6dDWDeIttfJNZKJQ8QWYDkZolEFKxo2l4I0Bk+e3dsH+8n90j29RVtjmQEhG3bW3JztOOT+PpWDbRWr3CPhjbnlgGyR7Y9jWlbSyQbnjwQTg8ZGPcf1qJKxa1H3c3lLKkowudqsB6/0rHkIW8VxxG+IyfX+6f6VLrLPJFuyVXhiM849fpTfOjigHmoeRnbjoR0+laQWhLYwwOnnAdSTkZ6EdxSsXcRqiksQVO7jPPNCThYMSQhkRSWDHBJ9Kps0xnjlZ2aULnnt7UtbXYnuab2Uk1uYlZdzEowYdCa0NKLjwq4lXdNCJIyznIAHQD3rMScSQA/MJUIc7e46fnTmvDDpl0tq7TQztub0TtnHrWj2uKL96zMfQbieaN7YuzIZCSO6n1H6V110sKWsf2JihUZLHkZAHB/xrkvDEcbXOJJGiBdk8wf3scDPautS0uHhjNrIsiGPBBOSfX8RWkFbUxk7uxp6TKLi7EMwGSvELnBBxxg1eMUb2pEKhpY+MP3HTBH9az7OwMssAkO5lyUUty2O3tVp2jS6dopdkjJvHG8KT1BHpmml1G3poRxE20zxKdkoGVGflYHnr9ePUHFRa1dojWeqRxsCxCSquP3gHIz7gk8/hUmqfubQm6CLdIiShojujkDcgg+vYqeRzVaIJsmgkjV0d94A9eDj6iqasRF3JtOKyNc5ZZFZtyFeBJwNwqeazWTcbQssmSdob5gO5P0/UVUgto4dQuLfb98Abgce6sPfsavnm3R84IHEq8Mfp+lZ27lpmU9xPBPLbuqneoZcHjcRz19e1IsU7xi7RRBJEfv54Yf3X9vetWSNUBkuAgBwGVxwpz0rOvnW1niS0k2W8o3PHIDtLe3+yRVKHuk8/vFzT5vtAbzyVbIJUcMv1/x71LeSi2LSumfMIUFRgMTxUEDeaqsI40dBtG45GCemfTNaMUSyBHmBZQDuQnofb3rllvc7IrQdBZrHbRyKRtGCM+h6j2P+FWknbyoY5F37eAf4iM9D602KTyyqkq6kZB7N7GoJwTId/wAqsQcf3TWO5SRO0gEjrkcjBD8Mvsf8aJ3C2xRzhiRsPdT71BdXCsiK6ZdR8rYzn2PtSR26lwZcq3UAHgewqGtC0TxMTEEbdlT90c49x7VOiPsOXBOcqf731qBQQ/QDI5I9qSMOS7plAOGB6H3FZsoeuQ4IJTI+72FJ5mA4jBzjJH9aYZkD7DkgDqT0NQyu0hYKCGU9jzj1FCeghxdjhgWyw5wKKb5jYAPzf7XrRS0CxU1aG5e7vbmOIrB5YSUOOfLH3WA74Pb0rn7TSzesb1J8wBQNg6dwePrXeTrJd2zsu7eFBdc8ugPT8DWBqOnrlprJ/Jllb5oXUgMcfeHvxg/hXoR7HK11KcEEEDeQGTyyCSgON3qR71nS3UK6msyyFiiiNmUZ3DPJPvjH5VDC5a5d2i8wLw/PEbe596uQ2zC1udsZSBhuBBByfWqtbcRPII57m3nEOZFZi6jjzD1Vh9cCo9Stzds93cxKob5kjA+XI6/Q9fyp13emFbHbIro/y5K424H/ANfFRiKR55FklBRh92VsB/THoaT7MPNFG3gls76OHzcxSnckjdEHoT/I1KLWC3lBSZG2HKv0/A/nWJdzm31CNotzRIGjkgc5Uqf4c1ZsWtXh86OTKdGV/vIfcdx70rqw92JD/o00jKrK24BlUAgjHJB9faryvHln3su09CCOfaq88iyMAY1GRjdnIJ9PpThKogRcyK6jHIyGHoDWd7uxa0RBJKJEKghoipjZR0P+FZdzJIYfKY7WjXBYdW9Mn0NXZdudyZXK5bI4x6Y9agvFjd7cRBegBwcA/X/CtovQyluRpK5nD52r1Ldc/WlupQuWLcBSBipZoxDbo0Q55Zoz1P0rPvz5csRACLwM9jnp+FLcCWG8ijBklLbzHwPU9qswXESaUke0qG3Fz33E5zWXcW8sZhklAFuzsmxWBIx1P0qSaBoJzblv3Zi8xWNXsieb3g00Ml1IsDqfmEjofutj1H9feuw0q8jENxc2wIt2JJj6GMnv9K8+sLgQ3BL5DM2F9CM11cSeYf8ARiFjyNzEZDDPSqVyGrm7PPcz3UUbvi4k/eM6fLsUd/x4FbO63hszOIgxQHcpHOCOo981y8LIutJvzA32Y7ctncVbpn6cfhWzfGOHTZskBmKBfQgsAavViVkFrFO2oIjXMcEY2sE+/gnnJ7e341d/sv7LkW4ZFc+YqZzn1A9/SpoI90HmGON2z6cye3scZ/Iipts1whjL45zs65HUAehp7q4k9TGkmd0IBjaS2JMRA5lU9Vb6etamhy2tzZyvMxZXXMcanDJn/JrN1CGfaXSJA8f7xcgggqeT7gjgj8axLa6ne+1CYKIUEe9VBzkegx70pWT1Gk2tD0GSK1BsY53WZ5GQyEfdIHJ/pWV4za1XTpIym24R1aGQDjB6Ln1BwfzrG8PXEUdzaPqLy+S7Z8zqqg9sdv5VpeK5hdWVywLTiOMIuOMKGyCP8auL90zkveH6cu+OJnwolRWO3pkjPTtV5AyCMMDsU5yO1ZGjE+QpZiYw21T3A7fgfWt+2/eRAsDjcQR6mvPq6PQ9GGwxFkEjKoGQOVx8pHtUDmRfkwVHJDNzV5mSGcM/+rddvT0/lSyEtFujcMVOcj/PpWPMaWM2LCS8KSDwR3571cXDxmKXqwycnoPUUwxrJiRADg5IB/lTmj3x4I5Qc46kHuKQ7DwWijAcAFePr9RUE0pjBC/IeDgdDUJlIkwSSeh5/I0jux2ebgHpj1p8qKQ9gGiygGcdR0qszsHyisfcdR/9apYxhiYiCGHPNVpGb7RuVjkArgdCKziknqBLHM5Hzsm7vRUcqJK5Yrg9DzRSUW9USa7TtEVVcrbzEtGx/hPdTVW8vHkiSGVvnAxChHKAnljVa9kQQl1nco3JXG4IwqNvLnjgkDjziCC3XryAfau1NGDV0QrZRQRSRtMElkdcMuMyJ9PUc1XnnltJEjQqbaRywyvCH0P16/Wreszn+zkeKAF0G1ieQG7YPXHWsW7vB5dulwG2TIuWxyfaq8yFvYqyxywXUYu33xMpIVeQpz1qe73XNqZim0g8jPGehK+3tWzcQR3V1Cq8iMZXaeSves++CxXkENoZDbzKd6KPm6/N9M8U2rqwttSqtgsNo0rKsgwJB2O4+h9qw9Thij1SJohiaRdytj5GOM8j+YrbkuSLd0aQxlJuEZcgY5xj0NZc6PNEDHFty29Oc7Ce9DsgWoDgqFGFdgro38Len0qx5yLCYyjHYSWU9cA9vUVVW3ufLnmcpIgJJkTjBqxIvmwRSRozfKeV6hvX6Vg9GXuU7tyzx+aw8uQZVh29AfqKoXJEafOfnU/eHRvStYWwkDRs4UbVIXqCP/11XbT0dPMLZTnKAdD6VtDuTJELymdiwfKBAFz1GB1/OqYbNtcxTg4z97rjOMEfjVptOTCspdQ3VFP48VnXrMpkhLBzt3ByOvoPrV9SCKVXEiuSHQNjehzg/wBPWo2ujzEZCBgqG9B6VYsdjzDzzwx5Gev1qveALPMoA24IQED8zTRL3sZ4ZV2l2Cw4O49uv+Nd94altrrT22k7PL6dwfT+tcLemF4fLUsAAWbAxz3rf8KybbOdFy8cRDFSOQG6g/jTTsxNXOmuIlmiS6Ckyxt5ZJGRjH/6/wAq05rWS70lzGQxCiUKGyG/3fxqhazOxmRlDhQCr5zwehP0JwaWO6n0+aOGIFonYr5GMmPPbP17VV0mSk7HSWc0Fw/mW5MkJtxIwzg9f/QlxnNaTSI1tEyFHYIxYoMHcvRsdsj9Qa5nQ5F2XAUGK3nkaa2ccMjkYaM+3BP41uiVrWx8ubyQkUissjffGB0HfBBrVbEu5YuoknRVdh5zqJQ+75fcfj61x9tYRpc2skTERzxSEbui9Rj6dPpXSyE3Vq8sO6IgDyh2Kdz9c9KyZF86xkjUlZFRiqgY2MOh/wAaGr7hfojn7iWeB4hPHIu1sMexU9RnvWxFey2kaq7CXT7tfL3KM7FyCyt37CqE7tJcw2zqVV1zx0IPce2eadaCe3gaSSBpIt+WXPJPTI9eKzbaRSXMdDYW8chnjjZQAcgdVdD0/wA+1aUXmxxSxStiYKcY6NnofrWJp5FoqzWitJb7SUHcJ3X3x1rTmlE9n50T/MBuDeoPauGe9ztjsXo5A6bSSzg8gjIxiljT7PtZiSjDgj+H2PqKrWDZJkXOTzj1GKlnlk+bLExEc+1ZN3RsPVo0mZEAYEZGB19qit7jMhQkebzwe1EA2lSSQW+ZST0/+tUbBVl/ejaT1br3o6huVNUZLdWlJKqBgn+lEcvmQI6gFSaq62ZJLdlUBxuA69aq6FJNFbNFMnAY7e/GOla8q5bgma+5YmQFf3bD73apii/KX5HYY/lUZT90nfPpT4oztZWbJNc7SWiHJkbbSxKsoJ6g9aKjCKP9Yhc9iD2ooTEVILlEzsQK6ux/Xv8AUdKRQtvLLJhoUZudh3YHGGxTZrf7REskezaRhtpxnoePSqZMgvXRpWZduBu4bPr9cfnXR5mG2hcupo7mKSRDlh/dHDYOc+xqnfSJc2bGPGDtfcBgqegI/lUgRIb1DCyRrOvzg/d3Y6+2azdShnguibVlGSSqEEjOOR9M1cZdxNFuG4AeGQhXwhQIMjHfI/WobeSVNWSd2ddykDd1A9qx2eXcPPLR+U4bGOB9PpV2+ul8zEYmeJE+ZzzwevPaqjbQhjdRugfOYqHbcdu8diO9VrSYXMEUByroNpz3Pc+4oklWZ3VgyQkkRvjd19ajtbgPaiKKANJHySO574NNu6BIJ3aGSMAlQuV9nHqf8avWap5IWKR41C8EHke49R7VWRoiRNkyIy8HHT2x2qEMd7tEwjXqVIyCPWslfoX0CS4a0eR5UO5T+9G3gD+8BThLuKvG+4P8wK87qJluZSTuBCDGeuVJ6e49jWbII4p5vscbpGMgLnhT3/yK2WxPqXmkJmwWKOfu+3+FZWpqjSBThSTtwPX1/GrESebGJJwzBW2uwPfsaguEXzWJB3YUEdR9RVbK7Ie5TkETIibgZI8g7eCfcGp9QSJrSGGFNrYDSMwydxHQewqveoqFXT1HbGfWm3LkIBKzZ6MVPUdqUW9RNFKaIszQqFLbScjuBV/wbclZ5AwZopAEc+3pVGaVskiNiv8ACx6/Sl8Nzyx3TRKvzkYA6VasmS1od3puRLNODuj2hADwcHOau30LQz2Fwkh4ZVYnnB3Ag/mP1o0uAzxTP8kStsVlJ5ye49hUmrSrBpzRuBuRQUAOd2Gz/jTQi7ZSNNCyuykOjSrIDt2kNyfY0NHezzrK0KOIyrx5cA4/vEdz7VBbKjraQqjD5GlkyecN/CfqauLNvmKhmaPYgO4dgDkfrWiempL3uWbrUlhu5ZJ/3c8w3uoXCqPYentVGeSW8TKxvDAXyCDyx+npVvT5BFG0gHmIE2F8biMnn61bniQM3luo5yGBxux0/StOhmtzHeKGGFxqNkZhGxxcx5IXnoR1HX86uQXS29os0IF3aMctGR80bYPGffFVLq9n0rzLxYkuoZE2TwtnoeA34ev0plpeWF2LZLMFZ5YyJstjntx3rNopXTLNpdJ5jCA+ZbscjPDDIp8MvlFgkg29FY/xEnoR6j+VIkI+zhlTGxidoHU5/qM1FM6FoltmJibdITjkYPT25riqRszug9LmpHcCI/u8BC5Vfb/OTV2aTlGySCCTj+eKxLYNNFHkAM2W9iPatGIuqEKeoxgn+RrnbNkSlCoDKw/3RyPwqHeXUqT+PtTS+3DJyvQ8dD3pQgwOMKTn6VOoyuJAGMeN/HAHODTrdYwQE525znipo1K5dozg8ggdDTZZQwIGGJPPv7/WmndAWIx8u9SGz1zUBuE3lA5BxkU2MHZnHHJJ9arXGMDooPRvSly33EkTvIScICQPSiqschUYT5vU5oquTzKsRNcmyiB8rzCpMShOCx7H8qyolaWVJZGcHcQT6H1AqSS4WIFpFEn3SgjY5Qn265FKbnfb+dHEAkblW3noT0NdD0Vjl3dy48mxVSaFc5JyOhGOv0NZ0KMsrLL5ih/9W2ckDp+VEt20NwokSUSYyGVsjaR0+lUr2/kHllSUkjAUKVIyPTNSloNvW4XE7XIZivzM4VmI4OOP6VLPcRoqxspAPzBx0/3G9qqX7m6kDQt5Svl5FJ+6e/60/wDdlXUxt90Iwzkk9yOx9a0tYjcUtEYJUIKqjcIOAQTwfbHT8KrSBbSQSKp24yyj68H2NNvY5I7J/L5kifO7uynsRUcDQvM0UkrlsDD5yRkVTa6CWhbjkKIT8u5uhx/So5JEwGj+V8HBxkEdCP64qK2ZGkMdyrIE4ZscemfbpUczsT8vyqDlT3I6ZxUSXvXKT0LMc0n2YqjqjBfmDDt2/wAKpRki5M0pEQZRjA70XIkWSLLBlPyll4H0pZZAmwyY24I346H3H9a0i7IllWFzbXVxEvmeXKeccjjpj86bORGdyHIPDHHQUXquyebGNrRgZx0Yf41EHKkBsEAcY9D/ADFMleYyfdM2MsUGDjPSqkiESN5w+bsB0NX1UvbyNCeEAJz/AEqldhm+ZhtK/qf8KWwyC5ceWoxjAwCO9Q6BIP7TjDOV2NuyPSpSgmTaBtfHQ9QKoaYzx6qO2SQcH8KpLuS0erwxNcOkdvIzR7c9gcbh0NQazEJdMuLhF2hiqEHnHOCPb/69R2l19iFtOTiMbkbn7oGBVnUblJ5haCARxTushyeQM9cfWtLKRFzV0QbHxdN+8IDlux4wF/Ko7WdpJNTcgB0YnGM4XGR/OpYQ0c0bzEMy/dO3GBWHqk7DW5IIG3CTazqp5yD0z6f41d+VInc37bFrYogKqVQfXJ9ferkUB+ypwflALPnrmmQQfaol85UVg3yoOufc1YkDRHY4PYdKemiGloQ3FrHPEyy/KhjYsvqB1rnJPC13BaQ3EFws8YQBVQ4eIsMge/FbP2u7kn8uyZCvzK+4hQ59Kg1KO/1PVFiZ2XzVDFAcLG2AB06/WiSVrkxb5ilY3EggeMl5PKXHmZ5HtjtzU1s73DysD1Gd4HXA5/CptW0l4IwsLYmwPMYkAEE4H09auWMbQCWGUFJkUIiqeDn1/nXNKCudcJaXRZtIg9uoiXnOVx/D7VZkTj95hTjgfzpTD5AQIeqBsLwOvNOeQZJYZ54OOnvXHKFjZPsVkbBKk7lB6gdvelmLYCRgFTyD/dppmERDhNof5Wx+lDuNigA8dD6GhwtsyrgZ2CGIhiOuOuaij2kjd8p7cUTMqMrO3zdcinwsJtySYHoRUpdBaiNJsIAJHqeuPeo5RHPkKe33hxipJEaHAznjrVdlJPXaTzxSv3KQkEWA2CQc8gUU1flZtxAPTBoqPZ82omzm7WVrmZXHJjJjUn72OoJNW7md4olUkFpflUt2bP3W9ves8SJY7fJZZY3HnFwMeU/dc9x/jSmV7qDzY2RHDZZHHJPbNdzimjkUiS0kVJYwylVJLxqecH+JfcA5qHVbgFHDr2xGw6qM9T7VEskcgHmZjkjUsyOOh9R61Gt1C0wXJUOmGLHOfYUktbopvSxTu5GhNuylcMMFvQep9qvW0ki+fu2K247l7BgMH8D1/GqDeWW5VvvdDxuHtUnmNGroqDBfbk9wOmfQ+9VbuK5fU4C+W67yvQnt6fWstnUkozDY5wrZ5+h/GmXzmILLC+2VegI4PsaozzO1sJRs8zcDlf5UJdQb1NgzqkjeRkuvDlvcc5HpVOG8czKzr8gO18dvTFV1lliikeWH5kBDMrdfepY5N7RkABXG046fWqkmJMU3ECytA7nyi2STyV/pT7iVBFLHG5PUgtzlcVEYljDIwADAqOP89fWqIgZI3OSWXgAdQP8A61CsNuxfglxESqlRxuU9f/1VUP7k7FzsBOM9V9KfDM0Spn5uPu4pquZZJmdWKlfxP+fWnaxIzzmOHGCxA6HBNNaSMIwP3QMk5/Q1HbqAzAA4IyD702RkhkICq6ty47bvb2o9Q2IpJWTBQfN2PeoLRSb3G0e5z6ninkr5bMpIYencU22TdfwPuOGORihbiZ6HbWoltYPNjO5GI56kmpbYNNdyTOhwF8uNvZe4/HNZdxPIuw2ZJGdnzcgZ6nNa1tfSta+UYFhKAFWYnA/Toa02Ean2uORRKHw0YwPesyK1a5vb2Q5Se3VZE2j/AFin7y/XA/SnCKaNUuBA3mY5xypBHr61Y02VFvfPjX5XT5kLfd5AP5HBrRWZnLQ0LSffArq26Hue6+n4VfkncWzpM2XCkBz/AErMgg+zvPEjMsaOFz1ypGQCO+OadAJEnljdhKETK5H3lz0pSuioSTLenzK0FxAdkcYmJTIwc45wferk0xhlSMNG0cSZJ4DkN2z3FY1hHGJJVkkAh3NgkE7GB4z7e9Zb3KFpJN+QTgZ6cen41fMuW5EYXqWN/U9RRmuJpv3bYC/KByBVayvHk1K5mAYpI3G7kAYxuFZdzbtLYt5m7y1I346gn09q0tOOPJVsqMfKcfe9Cfw7VyVZto7KcEmbCSm4TaM5zgZpzMYlOSDkYx6GkjAiX5h1J+bFMn/elVJwR8xP06VyXb3NttiRUyDkcbevWo1hVoycljnt2p+7bHjOVI7etM3FQrqTnqfUUMaGPGuMScnpSpGqjOOOn0pwwRuAG08HPWkldsZXqePrU+YDHUrCVVs8nrz+tVJi3lH5sMOR/wDWqw/yooB2k9B7e9QXYDIvH0IoS00AzyrPgtIQaKeI2QAID06k0VpoJtGHO0qRzTKiLGG2MBz+nYVSuirKY7YhJDgMff8Awp906/aJnVpAZCfMRuQT7evSkhKFGd9i8AoCe1dN1bU5OXUmhMUgUzlmLDjB6EdR/WopooXUPGQShGTjBGe/+NRFnK+bHhCrAlAMbh6/UVJLK0pjnJwZeScD5uOv0PcVmtNUXa4XCKiRCQ/uz8yt7+3tVWceUGeTGGPMgIPUdPpT7l2khTYoAQHOOnXr+NRxQB5GQMFyOVY1d+grFdLYyTM2Q6LwATgDPcVdjiVYVTAZFTByOKpRyG22ow3xEcZ5ZD6Vd5aF/m/dr1J7Zpp23FYiWFGl8vcVYLtZW756H6YqmbZrbLo671x8vY/Wrd1MFhV0O+SHCgnqF9PcVAlzHJludhYMAeccUb7C2Kksv2hSpzubkAdVamPIwEUsu7zTxnoMelWLpI5ZlJ2Y2kkL0X3qpqKSRogiZzGRkhgMbvb2p2sCEW4jRlUtJnJJGMEewqYScEgYPQMO9VIlMikiMvKqkgdMY65/CpFYSw5U9BnPrQgFmZjOzINuRtK/zqu6hotpPT7rDnH+NPbdJGWRsMBk9s1X8wOFJBVs9AMii/UCNg1tIqyABXH1qqp2Xse04G7AANWLorI4IyTt71TT/j9hBIGWzwOntTA9FsutuXA8lug64JHX866hZfLA3oSNpwByAM9PrXO6TLBIkBnITawKk+grokUeZcRx9VG8Nn5ST1ArVK6M3KzHBTDORA2DtyF/hYfSqd0UjEWUIbcUJHIwQcHPseasbyJ1PmFZCgXDDg+9Ls8yOMIP3IJwxP32/wAPendj5Ux9oWuUWVwxkKgk92PrU11ayPaqsZKzg7kYjp6g0mhjbpqMTtY5Iz0IHH4VcE+SqFtu3k7vTH6/WhttIIRsZFtNI9zJ9oh8mNwQzdicY+U9DyKlt9PstQhAhv4onQnbHcfK3vz0q/qUm/R4I/MjCtKEI65zn8uaoPY6Lc2Uf2C/nNxgl4ivA7bQOuc1nbQ0XxEGrL9ktEt/OMlxKwBAPGRz+WK1bJkfqOAgGwjr3NYd3a5iWKNjuhkAcYJIXqDmtrwzYTyRvLcSbgTxn+HHFZv3lY221bLrSCNim75MfKDyR7VCyyrk8nI6jt7VcnhiR45DIAVfLjbzgdPxqxJNA0ToiffBA7H8ay9mr6srmdtEZ1osrREMpOxsZTnP/wBapYhukLAEZ5UVFEyxQkwJtYfdOTnjpUkDOCGyQCQST3PfFRJxtoWr9QZR9/uOMdxSEjr1HT6UjNuYnaQAeCKfIhjQgY3duwrK2oyvIuQCfvjgc1XfaFKsCeckNVlEJAdgDg9TUMwDks33Qeg6mqT0E1qQSIzkFfl46ZoqaVF3dc+3pRVq6RN2cVJC5spZUXfg5UfdbeTwV9/aq89/GYHSSIRTJhjxlCev51bEt0kaGORHBPMZPfHDfUVn6pa77yH7KrbpsF16gN6itkc1xXmmliXzU2g/MGHGfTNNsYZnVlw+EUyAj+7/AIinCILCySFRIMr1+9/hV+3uY4rWJXXKqcSORyjdM/THOKacWws0jOtrh0ikRmXezbQ3QNn0qJpIo5A0nyk5+XPT3FPubeKC4a3ZVZo2+8OQQejD2/xrLvHCl8jIIzuPSla24cxauplkTamQC2Vf1UjpimxXigeWzphvl57kdKpMxki4OO+R296WRMxlUZC5G7p39abTYJl1btoVwxyue/celNdlkvpJbaIRROwCovQZ7D3qq0qsoZlLEcbu4P0pVbZt3AugO7IOOfWmtrITLjbizqjZcEfw5qvlkV0IUkdUPoe4qGeRTLvgkYMepz94+tNALYWVghDZ57U5dQTHRDyrgS27EDH8XUNVYAo25QAD0Hof/r1NLKyqhKZY8FunFNkkEmFYqVxgEDA//WKEwI5ciNVVvlHTPFNI2LwSSOfeppmaWRIlQMUAw3Y++KqkBuCfmJ70gFkiDxb921ufrms5j5d7CcHaGBOa15o9omdAFjIB2k8g+341j3zEXK+Z8p3AgYp2sxXPRrJPKtYzvBwTwR0BGRW7HIluIJ0IePYRtJwQO4/wrB02eOG3UNltwyCf4vStSNpRKIii5j2uADnvz/PNarYhluOSQrKJ8fMNgHXYD0qzNut1VoHDwxKV2t6Hr9KZqGxl8yMguhG4DvgipJvmDIMBnUggfpWiRKepbslVbRVQYKZG1uCAeakulR4oUfCqMNu7qapK63NvGsrFZ+FLA4IweRUkgETb5QZISSoJPGcd/Spki4O249J47vzXnitpI/NVfOfKkbRweOOTxVu2ubRZPOsUSGZQUaUqOcnmswzRrbxP5eA4wy9h71NbSWtqrCQAo538cZPtUSNFHQu318yQyRtlV8oZ4A3kNnj8DVrRLl0sNjOpBYncq9ycnNcpe35vdPMIHlhJdseeSoPUZ9MV0ek28qQorvuj2jKjjP41nUlZaGkI9zRkhWVixySvAx0x6VBPhCgHCuP1qeJlDOu77nGDTJVy/LYGeM9hXK9dTdDVhwVBIOeMikkcYOwcg44qcAeSUB46Z96jSFWO8N/vZ7VHqVcWONRgqd6nnHp7U2UfOMHIxggdvapW3KRhckDnFV8GKRQ+Dk5OO1HKIa65X0HbNVHkIiO4bQeAR6VckQEHJOOvHWoXBY7GHGMkU7iKbH5R1+vHNFSbFXhgrc8Z6iiqUmLTscvFi5VmZvKdm+eMAYDY6/Src9xJa24QAR5UjeqAEr/+uoLxRa3cE0Cghl2SKw4OP/rUpaS5tyHJCfwEfw46D6Vs31RypFO4ntmIlnCKW53N0LY68VjzSNNIsytgHgDHBHerJgedGLkbc5+UfoR6VZNqqwkMm5cAcHjI9Keg72MaVpZEDRbTgEk56g1ns0Yb5yTEBgjH8XYVemV0gmKBiOjydAFqtM0P2SMRybmJ+ZsYxitN9SGQxwxRc/aOH5IA556r9aeWEbGS3jbY5IBbnAHbP9KZOgEcMiYO3OQejHNOtpgLCWMEPlwWHp70uyERM7sgdDgD9efSn7ZLiKSTdteIZZfVc9ajdwyohXcwO6pon2RzXE2V3J5KjHJz149vWkkNsoguZwz4ZUHC460/zTJG5O3C4OD1/OluXXA8lgyuMN7VE8Q2M5IwRnHrjpT8gHNMxLHhiOd3pTkg3bmjfhQc+9RJKojUMoC7izD+99aEkLMWhJK9NvqP8aL6gOhdpJH3EkAcc9QKSVlV+4BOQT1pyMDEpUc54zxk+9RPLGxKE/e6EjpRuAl3KWiDhjwME98dqzp3ZovmOVTop5rQdlRRG3zAcFuoNZN0rqdzZAJOP8KLgd7aCV9LiVQGHVPXHB/Kt+wnjlVf3n71GCup6gHrmue8PyubO3w5VQu1T6E9RW61huImiIDsux+OGI9feto7Gb7FyeaOGFo0bzA+ArL357flV63fz7642uoQMAM/T/69Y1vGzq6y7W2HKxdM/Q1PHctbTBlBCyAFS4x04wT3q1K5Lia08LKzeUwEhOCpHX/CnuG+zE5G3uCePenfaR9lPmKfMZMKcc5psMh8hUDqr4LYIxkVUmosUbtXIUs3a3BS4hJx8iGT5SD0I9KparPLILW1bLeQAoXHTPbj3qYxpbzkwqXRsv7gd6WW8gQie3Q+YGBVHHJPvXNL7jtggubBn3qqGGMlGX5uSeMj+ZrrpHjTYsZwqjArlLN3uNXLN+78uMSSZP3if5cVvQgSRnyXyQeR2H0rGTLiujLIOJHUEc4bJ7UrbnjO3LNn6f5FREeXwDkjls1OiE7Q2cZ5HrWVjW4saGRSc4AOSKshkJKfcJH4miMKpYrjI4P1pFjhUlwSXBGRilshN3FICkgkgdMdzVd3BVsZB7EirkisQXUYGPlHf6mqu3kllJY8kGpvYEQJEZFYrlQO9RyEqhcAEHoPWrkjAIcADPb0qr5e4nf931FAzPZzgF8kn0FFW/Lcswj7c5FFMnQ5K/L7GhkibyVYnf1MePSnWUkTqjybnA6jdsyP96p3uYlkdpGEZUbQF6dKoLIERlGSWH3UwOlbWOdlmSMSuJNOjllUEr5cgAlH4jhx+tZM3LSBG+XGdpBxx6VejcRCB/tcsTZ3qVIO1h0qrqd1BKi5IE2c7hyM5yR9fSq5epF9SG7tkaA7bvbPIQrRsvG09s+xrK1PTlD7YHZiOo7lhwQPUe9SzRO7GTzctxtOMj6Gi1jkKHEjK69JF/hP17VV7k2sZXztFh4iwGSQRgj3qxZ2iy/O5MUbAZYjG76DuK2bVJLW4a7eHzriIDzBKPkQN0J9z2FUL+OG6vWRbslxwqsNo/Ajj8KdrCuQzWYhugm6E7QCrMSN3pWbcNcNMyXEQDk/I3Qbe4B6Vbltpnl2xyEkkjDKRntRJC1lYpHcqA8r/NE3WMAH5iO2c0b7DRnXYjRYwgKN1kPXn0HtUMsZaFXCkpnGR1qREQHccsgGRz3+tNEkgVxnGfmJpvUZGilozGSAT9189PY1X3tAxHQA8jPQ09ZWAZFG4yDbjHrTpIcRkSOvmJgHHOQemf5UgHy3qMsYGckHLH3PakYK0YARVweSTxVIqDIQwO7PI6EUx5NoZf4e1AWJJ5ANwU7k/Ko5GLjjBPTnof8A69Qht6MMduR6VG7YAC8EUDOw8Ns0xhgj+UYzhvUV0XnSx3BLTbeRwOlcXoMrMARy6kjryK7OILcWoZlJKjP0PatIttaGbWupdadWnjYH526Y7HP6jFXAFWeIsysjNjk8HIqjB+9UAoqSggqeg+o/lWiFE9ufL2hm52n+A56fmKoZNHEskRQOVw25V7Z7GoiZBI7OBlcHJ55FRiV/tMsUTY+UBie3rg1ajnlQMp8tnIxkiocrlpJENss07uyvlck8j7o65qSFzb3siybRNjKkjIIx2qlcTz290zQBVd05GODz/Wrum3ZupHikgi/doMk8svGOPaounc25Wo3WxZswsct3uCtJL904AyMdRVmK+kgRIjhATwR3rNgikF+BcSIE2/eHO0D/ABq3pEZvLu7Nz8oI/dO3Y54rN3e5SaNyz/ekK3cZz6/StFdgQhsrgc5qC1t1BVmHI4AzgUs25JeAzE/3j271Ekug1dksTZG50wo6D1qSOJnTzCQoz0PWmhmlX5RsTHPakuJCqY6J33Hr9Khl2CRsPhFLOw5Pp9KQPsTD4AHAUdce5oV8rgkrnjiggZyAMnkn+tRcaI3VU3DOWPJx/WmFSU/eNgj7qDvUhfMpRMhTyWxTJXA+XO7PAo6gx2Gz+7wBjsKKIwyr8pVR15OKKtRvqZ3Z53PLFBI7TIrxE4yBnFSraoxhlilVrdhkqBgKfrTLm4MYV8JKpDA5GVIPXNZkszlcq6+STjavBFbxaOeVzRn0i5SeNbVUkP3xmQYQdwTUCafGuSt3Ajj5pAw788cdfSoIrmeLzDHuj8wY4OM59v6UzesASTJJHTBwcf8A66rmV7ImzJLqCx3PHvmHmj5tse3DeoBpttcLbs++EIFO6RWPIx6e/wDjSyTcGZwcEgruP8qqTTeZBLGYC7EYBZuQwOTzRe4NC3mpz3Tskf7u2aQEL6Y/vevFUJLeOS4YGRRHjerDvnsKSZ2RYYygdgAWK9/rR+4iuhIyeZF3Qtjt7U3ZvULdhs8k3llRJK0TfdcEg8dcVFJuurVyw8yaMgAk8up6A/Q4/OrH7yQhUDyIxwFCk49DmrFtY/Z7uxieRTJPKolQf8s13DAJ9TxSTE3YgkRLZJLdQnmIv7wnkO3Rs+wz+lY6OMYMa5OQSeQRWvfbrYX3mbPt10zRsvURoT834n+lZiqVUIygEdVP86L2GiMxPbxyxrgSSq4WQjoAM4Hv/SsuN8Lj5uRjHYiteXcYi+7O1sEH+Lv+YFV0VMgJuKgkqPbv9Ke4FFxuk8w5yVww7g1XcDkEsTV68SNJQ0Th4244GMH3psaj75Uqf72eKdtQuZyKC45wDx1pjoRnPH9KmmVY2IwdrDimb9xzgMOcj1pDL+gyeVeKecjnHr6iu+0yVoDuiKkdDu5GD0rzW2bZIsgcDbzg9a7TS7kSxHA4PXHb3q4NpomSudICxAEsL/J9xwONw9PpV6zjYwtNC24uSRGeTnv+NZdtfOgEjSHYCcx59uoqbT7greqYXaIE7iR2P9DTasEW9mW7aCSXzZlwe/FakYQBCZFyo4+XPP1rO80wTSTHARjl1U7ck+n49qgkkkeBfnRFfOJPQd6T7GiT3ZYS8QXErErkKWVsZB6is4zhZUlhyJ9vOD949Kj01liliEh3RsT1Gcg9q0dItEnup1mGFjPyBWzk/wCFQ3fU0vy6M0dKsg0T+a6sQ+WcHO4+n4VtW9rGkQXHA6A9cdax9JDlXh6MHzIB1B/z3roo0LEEEq3HOMhh/SspLuVHQIm/hBJPXmrO5mUYIz6kdKfJFGNpZgSeMjvUYQc7AQvpnjNZstD/ADFG1FJz6/1qLylMpdmO3GMk5/SlOwlSv3/4hSxJv3N1Vj0JqLlA8nlZULnAzg1GLhFG0/K59OKdcrGshIbee4qnOhG5lPLD06UMZa84BGy2TjAIqJWJIYkBeuccrVdUKbTuOR82cUr3SyAx8j1I9Ki4mSmRcnJ5z165oqg+M4B4HHXmiqcrE2RxNmQ0iAq0sLYZjjGw/TvVvUYredllhiEavkZLfxDrkVUu7doFLQSbVAOQpBAqa1uIZbMqYUyFB85iSwI9K7Pi2OJlOTfAiyEgpu5yDlfxqOWRoXZFhdSQOHHK56EVJcTvfNK00jlWwdpPt1NVAhV1fcWc4BBOSB2x7VOhdmIybpkaR235P0qeMsZmicrlBjdj7y9iP60k8sRj2LBvcEljnnHpVazaNJ3U+ahAypHJz+NPfYTLdw0LIfMBWZhiMqeOOxrKuAkZdVdTls9fT1q7NDLKmWZWRTuBA/n6VRiQpJiVAxY9f5iiyFqOtZX8oxrcMg6BVBGR6ZqzYq0EwmkmzHCfNLjkZzwp+ppY7KW8h2QDYVIwxIXNSrp8UekuovIHLXGcYO12C42g9PXnpR6CdiiJLNpWmMUst1nmJ32g/T/CodUjjSWJ4hIVdAyb+qjup7ZB/pVt9BvVgWYQKpJI+aVePUdar39xHHb2lsyhyhYsN2eDjgn6807XeoX7GZcONhjjkMoJDHaOCaqgBAxDbXB4XpkeoNSM8ryYjUDJ4Zeg/GmzRDeWYjIGSRzRs7jI1ki3AOSEkYBgRyBTkgVWeOclC3KlTlWHTPuPpzUcqeZAcH98rDAA4ZT1/EfypbaKbARk3xjnnopqtAKtxa+XhJD1+ZSpyD9KZHDseNsKy5528jFaBVtmZFZkBOR2PofY0wwBELxEgHrnrn0oGUGg2u4U9+Oe3vV7S7xrdlAIP+zmo5UDIoB+cdvUVTCbCGUHA6ZoA7Ozu/OdAY2O0YXPHNdDCGaIKy9Pmyo6/WuGtNRDlTkIy44J5z6j+tdVZ6sJIVCYQgFXz0B9qV2nZjjqXZiZFESvlx86nsfY1BLeG5YIqhY0bk+meORVdr4XUoZEXBABfsffH0qe0huZ2f8Adbomk2hwMMRUcxq3e1i1phVJWR2DYDfxYzgcGtvQLNood5Yoz4ckjk57/SqmiaQP3iXAUrnMbdPzrqLeyFvt2jeMY9QPald2uhrVtjLGMwXhMAPmEYYdiOozWxE27aEHXqPQ1niARSEoDub7wJ4FWI9sYJ3dqhtlqxdZ1ACkKT0AqGRiIRvxgnoOKqZDMGYdGBGfWpGn3lk+X5eh9vSoeoxscgfcSTkdT60SbYyrITgd6SIKUPzBQR+R96bs3AhuVPGAalN7lJjjOrct16ZPT61DubauOCM/jSMU2NGy8DkHqKpyXJjHG0HdjnrUeQ9x0lw7qoKgbjwfSmSOkQLZO49B6+1D3IFvhscnNUJJywAOFIz0/pRyiZI91uckAD9KKzXkYnPXNFapNoi5FJkugCxRupyEC8MKo6kBOiuEjik4BAOA/wBff3qC8u5H2PGQkiEHCjHHvUM0h8syMeTywPXit29LnMkTSH/RuFCkOWB77u/4e1Quot2ErD765B/2T7VHHMoJUsgVv4sf1q8jzSxOIv31p03gDt9e1GyBEMtyjWjCPkkgNleQ1U4GUGRncFs5Bfr7Vc0nbc3M9p5XyTDCMAcRuOV59O341R2XRlcy2zyRAlWaM4K4PP4j0o2FfsOkZF2qkjF267T0z2FQXEabnWMMoznk+3NTtbllkktoGU7SAC2SPetFNDH2GF74PNKRvkCt2/hQe57mk2gsUPLNtaxy3UrS28vMcY48we/oM1UEk+qTMHGVhT93bw/KMeg/zmr91ot5dXKvcPsZ1GFUcKOw+lJL4c8kIolfaTk7cjFNySDlZnPDIqKsmmlSv3TIxVR9fU1VkWB5XVEaRQMlE/oe9dQnhh5ZFinuG+YgBpCePzrbh8KQWsQRRhwuS5OOfWk6i6ajVNnnUcLyxSgxmJeMIvAA9z61LZW55aGIlgwUllyPf8K7O3tdls6SxBgrnGR/KmvaSBWMKGNQeT/eNJ1ety1TOX/sxYwHA2ZJwOoB9KVLLygxBPluOw4z6V0dxboAJCN27BYEdT6VE0LMGljzFEBggHP1pKfQfszmPsHmKqx7iWB4PG3/ABqrJpcuCsfI/vA11gtVi3MC2/ggnuO1OeHbEC5J69aPaNFKByA0wBVLMdv8QYYIpt3poVQVywPPJ610UiDyxtJ9D6VW2RbTuBz7elNTZLgcpcwRxhQVk83cQQRgEf4itDQ7iKSRorkgHaVBPG4dh9fer+r2kgj34VgQGb2z0rIWNrWSOcKC0bghWGQT/hV3TIsdroqRXSxyvGsYjfb07+9dXbxLxsPzA8Y6Vw+ha5CUuTcNFAu7IQ+hP9K6u2vCqYBJ4yD/AJ9qxmmmbwtY2jIpkwhCn25/Cp4JWBwXKqTkk81lRt5v7yP5hgZBpxkdn2x9RwSf6DvU8zZdkbCTAszKxfPc9DTw6A7FbDkZGe9Z8bsEIIGeOfWp/MQSxsSMAfe6/lUuWoEuMOVyQG4696CjJKABuz6npSSEvIWiBJ6HJ7VNA/mBWUZK+/NSK4ZK/eYABcGlZSRgN90ZznrTZdxkJZwV6nFMd9uGXnPWrQCsjCNgCcD1rnr6VJdTaIuBFCpLMO7dhW5czDITccNnisu5t4wxZVAZurHpTTtsC13K4femDnaO/amrgH5nGcVM6ptwgLZ44FVLjERC7uenSq0BsZIVDcHj2OBRVeVizZQE9jgUVSgnrYgfN4Tv5VST7SuCOQSBjjPSqz+G4ZopFlkke5VtoEZ4PpjNdarm6kYKyQiE4YAZJb0FT3MEb2rSbEQFSo2/wn3/AMa02WhlynCQ6NPFHAsgAViTGC+CCPX6itGG1JvYlmUtGASFCnp6e1dFbaZ5k4bymlXygu4jOH7fQmrdpZgXEtw7SRkj7vXOOuPQ0MfKZVlYMkaKYwiyMSMc4HpVq7tI5R5zRAyDhwi4V/8Aax6+tbtvHawqHJSVRk88kD0FPtLqBox5bpk8khalOxXK9zCfTflRoxEDGu7OO3oR7UyOWUgxgJPKgIGxcDb1rT1BftEuxQFcLnf61Zs4ls0jJiG09QKV7D5Dl5ZcAKbcwmTnczcDHeprWBwqzXMYKk7WK+3Q1tzRQySYihEjdie2fas6K0dmEMsh8sHGwcZxzRJq1gSZFq0YEAlDDdkAKDyBVxI/NCZYjcuDnoTT7q1RVCbgCxAOBVhlDRGNkwM9RWPoa2M+WwTJCsQWXue/tVL7P9lYDJbOc56fX61rwglQXOWB71BeyYIO0HPPNLmad0wS6GK8CNbEeXggD7o65NVHh27xw6N/DW08UnBKjbjGAapSPHGxy23PfFJN7oZR8tSwztU+/wClVLqN3TMYUjJGM9K0nRDKXXHzLjPaoZIwy4CbcHDBu4pJ2Y+Ux0gwpEi5OPwqvJCgcZ6HjIrbZBt+7/8AWqjMhxgdfcZzVKRLiZFzAH+UkgN0BNZd3bbVJ5wTyDXQTpj/AFhz7jiqF5CjYOc+g9BWqZEonNS253HZ8wANXNI1ebT5FWXMlvnp3T6f4VbuLUgmMpwTxuHPSs64tWXIbGccECtE11Mmux3+l6tFdxo8UisgB3AcEe9aAuNrgId3OQT2/wD115RG01tIZYWKuP7vf/61dJpHiJXCRXYEcinAcdD/AIGs5U+qLjU7noEDq3G75uvXpU4ZH5zyOuKwLe4jyrrwTxkd/rV2GXJCpkE55PYVi195pc2BPsLBm5PJHrQkrgqVBAY8H0qkmT8xII9B6VJ5wGPmx6DNUovcC3PdIi5JO/pn1qE3DFhsAy3r/Osm7YTTRSbnVh8rjHDc9a0rST92u+LAB4IOa05UtLiv2JVcqwMijLcHnApWt0YjDDHfP8qZPcI4KfeOcZxyDUao4jUHdtA4BPWjlQgmKxHC4J6/LVKRAW3Scrjv/KryBSQQVY45welBjjJVZgc/eOKXLbYVzMEHm8qpHqBRW2sMJUYxjHAPWiqSdtLCJbNI4Jh9niJKxbmb+8c+v5/nV+VGf5VESQuflBb7tFFXbQSNHT7qe0juILe5VIboBbgKoIfHI/yKqySGNREqo6oSCyk4PvRRSk29C1FISyiMjyZKgkHHHAP0p7wgSFVi2sANxHTPrRRWTdloUhLOFi+JOJTzuPSrLQM0JO0yEDBHTkUUVN3dFWsiolpLIuVDRjrkCke0CzIJCxKchuh/Giild3aAfKibmG08EAbj+dR7M/cZQp4IY0UUrgiORUICoSGznPXB9qqm2IDyKTv689AaKKXVFDnR2TLgYHfHSsye3SUFCgbcMEn1ooppAiosBt0ZSDkfNg9Kc7oUDIvO3qOp9aKKl6DsVJFLrwBx79DVRowVc7eR1ooq+UllR0VlI4z1ziqM0O5spxgdPU0UVS3sJ6lW4hYjIGSOh9DVaeDeCfunp65oooTIsjPuIAc5BUn+LPSqVzDkDanRcEjv70UVonZGTRPp2pXWn4CMXg7o3T8K6nStZhuiqpIUfqVY4/8A10UVUopoItm1Hc5Y4JyewNWo3Rxuc5yOTjOKKKhK7sW2WIZImOYR7EnvVgqVG3cAG/hBooqrWQNjoXiICsxJPGB2/GpZJRs8pQQg/iPNFFEtFdBYW3hjiBIGOO/eo/NdmIbBQcgCiih7sSJluYyPuqv16miiilzCuf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25706=[""].join("\n");
var outline_f25_6_25706=null;
var title_f25_6_25707="NonGI sympt celiac";
var content_f25_6_25707=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Nongastrointestinal manifestations of celiac disease in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Skin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Dermatitis herpetiformis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Others (see table)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Growth and development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Short stature",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Delayed puberty",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Neuropsychiatric disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hypotonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Developmental delay",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Learning disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Headache",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cerebellar ataxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dental enamel defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic bone disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iron deficiency",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25707=[""].join("\n");
var outline_f25_6_25707=null;
var title_f25_6_25708="Common pain behav elderly";
var content_f25_6_25708=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common pain behaviors in cognitively impaired elderly persons",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Facial expressions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Slight frown; sad, frightened face",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grimacing, wrinkled forehead, closed or tightened eyes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any distorted expression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rapid blinking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Verbalizations, vocalizations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sighing, moaning, groaning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grunting, chanting, calling out",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Noisy breathing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asking for help",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Verbally abusive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Body movements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rigid, tense body posture, guarding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fidgeting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased pacing, rocking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Restricted movement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gait or mobility changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Changes in interpersonal interactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aggressive, combative, resisting care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased social interactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Socially inappropriate, disruptive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Withdrawn",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Changes in activity patterns or routines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Refusing food, appetite change",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase in rest periods",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sleep, rest pattern changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sudden cessation of common routines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased wandering",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mental status changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crying or tears",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased confusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Irritability or distress",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Some patients demonstrate little or no specific behavior associated with severe pain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     AGS Panel on Persistent Pain in Older Persons",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25708=[""].join("\n");
var outline_f25_6_25708=null;
var title_f25_6_25709="Risk factors breast ca 40 to 49";
var content_f25_6_25709=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F83694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F83694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Factors significantly associated with increased breast cancer risk for women aged 40 to 49 years",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Risk factor",
"       </td>",
"       <td class=\"subtitle1\">",
"        Breast cancer risk ratio",
"        <br/>",
"        (95 percent CI)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Source",
"        <br/>",
"        (reference)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        &ge;2-fold increased risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        First-degree relatives with breast cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        1",
"       </td>",
"       <td class=\"sublist_other\">",
"        2.14 (1.92-2.38)",
"       </td>",
"       <td class=\"sublist_other\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        2",
"       </td>",
"       <td class=\"sublist_other\">",
"        3.84 (2.37-6.22)",
"       </td>",
"       <td class=\"sublist_other\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\" colspan=\"3\">",
"        Age of first-degree relative with breast cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &lt;40 years",
"       </td>",
"       <td class=\"sublist_other\">",
"        3.0 (1.8-4.9)",
"       </td>",
"       <td class=\"sublist_other\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &lt;50 years",
"       </td>",
"       <td class=\"sublist_other\">",
"        2.17 (1.86-2.53)",
"       </td>",
"       <td class=\"sublist_other\">",
"        BCSC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Breast density BI-RADS category 4",
"       </td>",
"       <td>",
"        2.04 (1.84-2.26)",
"       </td>",
"       <td>",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        1.5- to 2.0-fold increased risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prior benign breast biopsy result",
"       </td>",
"       <td>",
"        1.87 (1.64-2.13)",
"       </td>",
"       <td>",
"        3*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Second-degree relative with breast cancer",
"       </td>",
"       <td>",
"        1.7 (1.4-2.0)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Breast density BI-RADS category 3",
"       </td>",
"       <td>",
"        1.62 (1.51-1.75)",
"       </td>",
"       <td>",
"        2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        1.0- to 1.5-fold increased risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Current oral contraceptive use",
"       </td>",
"       <td>",
"        1.30 (1.13-1.49)",
"       </td>",
"       <td>",
"        BCSC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nulliparity",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        1.25 (1.08-1.46)",
"       </td>",
"       <td>",
"        5-9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Age at first birth &ge;30 years",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.20 (1.02-1.42)",
"       </td>",
"       <td>",
"        5-9",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     BCSC: Breast Cancer Surveillance Consortium; BI-RADS: Breast Imaging Reporting and Data System.",
"     <br/>",
"     * BCSC estimates from published analyses.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Nulliparity was calculated in two ways. Estimates indicating significantly-increased risk for nonparous compared with parous women were similar for the meta-analysis and the BCSC data. Estimates comparing ages at first birth that included nonparous women provided significant results for the meta-analysis only.",
"     <br/>",
"     &Delta; Results were not statistically significant for the BCSC data.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <ol>",
"      <li>",
"       Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001; 358:1389.",
"      </li>",
"      <li>",
"       Kerlikowske K, Cook AJ, Buist DS, et al. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol 2010; 28:3830.",
"      </li>",
"      <li>",
"       Ashbeck EL, Rosenberg RD, Stauber PM, Key CR. Benign breast biopsy diagnosis and subsequent risk of&nbsp;breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:467.",
"      </li>",
"      <li>",
"       Pharoah PD, Day NE, Duffy S, et al. Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 1997; 71:800.",
"      </li>",
"      <li>",
"       McCredie M, Paul C, Skegg DC, Williams S. Reproductive factors and breast cancer in New Zealand. Int J Cancer 1998; 76:182.",
"      </li>",
"      <li>",
"       Chen CL, White E, Malone KE, Daling JR. Leisure-time physical activity in relation to breast cancer among young women (Washington, United States). Cancer Causes Control 1997; 8:77.",
"      </li>",
"      <li>",
"       Althuis MD, Brogan DD, Coates RJ, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control 2003; 14:151.",
"      </li>",
"      <li>",
"       Sweeney C, Baumgartner KB, Byers T, et al. Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control 2008; 19:391.",
"      </li>",
"      <li>",
"       Reinier KS, Vacek PM, Geller BM. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women. Breast Cancer Res Treat 2007; 103:343.",
"      </li>",
"     </ol>",
"     <p>",
"      Reproduced with permission from: Nelson HD, Zakher B, Cantor A, et al. Risk Factors for Breast Cancer for Women Aged 40 to 49 Years. Ann Intern Med 2012; 156:635. Copyright &copy; 2012 American College of Physicians.",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25709=[""].join("\n");
var outline_f25_6_25709=null;
var title_f25_6_25710="Gem plus doc for advanced sarcoma";
var content_f25_6_25710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58713&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58713&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Gemcitabine plus docetaxel for advanced sarcoma",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: 21 days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Gemcitabine",
"        </strong>",
"       </td>",
"       <td>",
"        900 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV (for soft tissue sarcoma if no prior pelvic radiation therapy [RT]*)",
"       </td>",
"       <td>",
"        Dilute with 100 mL normal saline (NS) (final concentration &lt;40 mg/mL) and administer over 90 minutes (ie, 10 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per min).",
"       </td>",
"       <td>",
"        Days 1 and 8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Docetaxel",
"        </strong>",
"       </td>",
"       <td>",
"        75 or 100 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV (if no prior pelvic RT)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Dilute with 250 mL NS (final concentration of 0.3 to 0.74 mg/mL) and administer over 60 minutes.",
"       </td>",
"       <td>",
"        Day 8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        MODERATE (30 to 90 percent frequency of emesis). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        Premedicate with dexamethasone prior to docetaxel administration",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Infusion reactions to systemic chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Docetaxel is an irritant but can cause significant tissue damage; avoid extravasation. Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        This regimen was designed to include primary prophylaxis with granulocyte colony stimulating factors (starting on day 9)",
"        <sup>",
"         [1]",
"        </sup>",
"        . Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Docetaxel should not be administered if serum bilirubin is above the ULN or if the AST and/or ALT are &gt;1.5 times ULN concomitant with alkaline phosphatase &gt;2.5 times ULN",
"        <sup>",
"         [2]",
"        </sup>",
"        . A lower starting dose of gemcitabine may be needed in patients with impaired liver function. Refer to UpToDate topic on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor CBC with differential and platelet count weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess basic metabolic panel (including serum creatinine) and liver function tests prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess for neuropathy, pulmonary toxicity, and fluid retention (weight gain, shortness of breath, peripheral edema, ascites) during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        The original protocol used the following dose adjustment parameters",
"        <sup>",
"         [1]",
"        </sup>",
"        . For febrile neutropenia or a platelet count &lt;25,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        lasting more than five days, reduce dose of both gemcitabine and docetaxel by 25 percent for all subsequent cycles. Delay treatment by one week if the day 1 ANC is &lt;1000 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        or platelet count &lt;100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        ; discontinue treatment if not recovered to these levels after two weeks. If day 8 ANC is 500 to 999 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        or platelet count 50,000 to 99,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        , reduce gemcitabine and docetaxel by 25 percent. If ANC &lt;500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        or platelets &lt;50,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        on day 8, delete day 8 doses of both drugs for that cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurotoxicity:",
"        </strong>",
"        For grade 3 or 4 neurotoxicity, delay treatment one week; if neurotoxicity resolves to &le;grade 2, resume treatment with docetaxel dose reduced by 25 percent of the previous dose for all subsequent cycles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hemolytic-uremic syndrome (HUS):",
"        </strong>",
"        In clinical trials, HUS was reported in 0.25 percent of patients receiving gemcitabine",
"        <sup>",
"         [3]",
"        </sup>",
"        . Consider diagnosis if the patient develops hemolysis and severe thrombocytopenia, with or without renal failure or central nervous system findings. Discontinue gemcitabine immediately and permanently. Refer to UpToDate topic on \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Pulmonary toxicity:",
"        </strong>",
"        A variety of manifestations of pulmonary toxicity have been reported in patients treated with gemcitabine. Discontinue treatment immediately and permanently. Refer to UpToDate topic on \"Pulmonary toxicity associated with antineoplastic therapy: Cytotoxic agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hepatotoxicity:",
"        </strong>",
"        For bilirubin level &gt;1.5 mg/dL, hold docetaxel for that cycle. If bilirubin returns to &lt;1.5 mg/dL, resume docetaxel treatment in subsequent cycles",
"        <sup>",
"         [1]",
"        </sup>",
"        . Gemcitabine is commonly associated with a transient rise in serum transaminases, but these are seldom of clinical significance. There is insufficient information from clinical studies to allow clear dose recommendations in these patients. Refer to UpToDate topic on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Other toxicities:",
"        </strong>",
"        For all other grade 3 or 4 nonhemalogic toxicities (except alopecia), hold treatment for up to two weeks; resume treatment when toxicity has resolved to &lt;grade 2.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, doses should be recalculated.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; ULN: upper limit of normal; AST: aspartate aminotransferase; ALT: alanine transaminase; CBC: complete blood count; ANC: absolute neutrophil count.",
"     <br/>",
"     * In the original protocol, patients with prior pelvic radiation therapy (RT) received 25 percent lower doses of gemcitabine (675 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     on days 1 and 8). This lower gemcitabine dose was also used when this protocol was administered to patients with refractory, advanced osteosarcoma",
"     <sup>",
"      [4]",
"     </sup>",
"     .",
"     <br/>",
"     &Delta; In the original protocol, patients without prior pelvic RT received 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     docetaxel, and the dose was reduced to 75 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     for patients with prior pelvic RT. However, given the toxicity seen with this combination in a randomized trial of gemcitabine plus docetaxel",
"     <sup>",
"      [5]",
"     </sup>",
"     , many clinicians consider the 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     docetaxel dose to be too high for off-protocol use, even in patients without prior pelvic RT. Off protocol, we give docetaxel 75 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     on day 8 of each 21 day cycle, with a reduction for prior pelvic irradiation",
"     <sup>",
"      [6]",
"     </sup>",
"     . Another alternative is a lower dose weekly docetaxel schedule of 30 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     on days 1, 8, and 15 of each 28 day cycle (with gemcitabine 800 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     on days 1, 8, and 15)",
"     <sup>",
"      [7]",
"     </sup>",
"     . This schedule has not been prospectively examined in sarcomas.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Hensley ML, et al. J Clin Oncol 2002; 20:2824.",
"      </li>",
"      <li>",
"       Taxotere&reg; (docetaxel) injection. US FDA-approved package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on January 3, 2012).",
"      </li>",
"      <li>",
"       Gemcitabine hydrochloride injection. US FDA-approved package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on January 3, 2012).",
"      </li>",
"      <li>",
"       Navid F, et al. Cancer 2008; 113:419.",
"      </li>",
"      <li>",
"       Maki RG, et al. J Clin Oncol 2007; 25:2755.",
"      </li>",
"      <li>",
"       Hensley ML, et al. Gynecol Oncol 2009; 112:563.",
"      </li>",
"      <li>",
"       O'Shaughnessy JA, et al. Clin Breast Cancer 2006; 6:505.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25710=[""].join("\n");
var outline_f25_6_25710=null;
var title_f25_6_25711="Mular lesion bartonellosis";
var content_f25_6_25711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F76799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F76799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mular lesion (eruptive-phase bartonellosis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This child from Peru developed an erythematous, round lesion on face.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Maguina, C, Garcia, PJ, Gotuzzo, E, et al. Bartonellosis (Carrion's Disease) in the Modern Era. Clin Infect Dis 2001; 33:772. Copyright &copy; 2001 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_6_25711=[""].join("\n");
var outline_f25_6_25711=null;
